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ABSTRACT 
 
   
 Clinical outcomes of infectious diseases are controlled by complex interactions 
between the host and the pathogen. Epidemiological, genetic and molecular studies in my 
mentor’s laboratory provided evidence that in invasive Group A streptococcal (GAS) 
infections, genetic variations in both bacteria and patients influenced the severity of GAS 
sepsis. Allelic variations in class II human leukocyte antigens (HLA) contributed 
significantly to differences in the severity of group A streptococcal sepsis caused by the 
same virulent strain of the bacteria. HLA class II molecules present streptococcal 
superantigens (SAgs) to T cells, and variations in HLA class II molecules can strongly 
influence SAg responses. However, the bacteria produce a very large number of 
additional virulence factors that participate in the pathogenesis of this complex disease, 
and it is likely that host genes besides HLA class II molecules are also participating in 
modulating the severity of GAS sepsis. The main focus of this Ph.D. project was to 
identify additional host genes and pathways that may be modulating the severity of GAS 
sepsis.  
 
 To achieve this goal I applied a systems genetics approach, involving genome 
wide association studies (GWAS) of GAS sepsis in the Advanced Recombinant Inbred 
(ARI) panel of BXD mouse strains. We used this panel of ARI-BXD strains as a 
genetically diverse reference population to study differential severity of GAS sepsis as 
ARI-BXD strains diversity mimics the genetic diversity of human population. We 
assessed several traits associated with differential host responses to GAS sepsis, and 
analyzed variations in these traits in the context of mice genotypic variability, using 
genome-wide scans and the sophisticated analysis tools of WebQTL. This allowed us to 
map quantitative trait loci (QTL) associated with modulating susceptibility to severe 
GAS sepsis on chromosome (Chr) 2 and Chr X. The mapped QTLs strongly predicted 
disease severity (accounting for 25–30% of variance), and harbored highly polymorphic 
genes known to play important roles in innate immune responses. Based on linkage 
analyses, gene ontology, co-citation networks, and variations in gene expression, we 
identified interleukin 1 (IL1) and prostaglandin E (PGE) pathways as prime candidates 
associated with modulating the severity of GAS sepsis.  
  
 To further investigate mechanisms underlying differential host susceptibility, we 
analyzed genome-wide differential gene expression in blood and spleens of uninfected vs. 
infected mice belonging to highly resistant or susceptible BXD strains, at selected times 
post infection. Our transcriptional analyses revealed common pathways between 
susceptible and resistant strains associated with innate immune response, e.g. Interferon 
signaling pathway.  
 
 Since our data has pointed to a strong association of differential response to GAS 
with innate immune responses, we explored if differences in the numbers of relevant 
immune cells among the BXD strains played a role in their differential susceptibility to 
GAS. We found no significant differences in numbers or percentages of immune cell 
populations between susceptible and resistant strains under normal, uninfected 
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conditions. However, depletion of neutrophils and/or macrophages significantly increased 
the severity of GAS sepsis in both resistant and susceptible strains. Taken together, our 
data suggested that differences in mobilization and/or function of these cells between 
susceptible and resistant strains might play a role in modulating differential severity of 
GAS sepsis.  
  
 In conclusion, we found that variations in the severity of GAS sepsis have a 
strong genetic component that is complex and multigenic. Different combinations of 
genetic variants influenced the onset, progression, and severity of GAS sepsis and disease 
and ultimate outcome. Our overall approach of systems genetics, where we 
systematically dissected genetic, molecular, cellular and functional differences that may 
be associated with differential host susceptibility to GAS provided us with tremendous 
insight into disease mechanism. The knowledge gained can help the development of 
better diagnostics and means to predict disease severity based on a set of genetic and 
prognostic biomarkers to help customize patient care, to apply effective and more 
targeted therapeutic interventions and improve disease outcomes in septic patients. 
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CHAPTER 1. INTRODUCTION 
Pathogenesis Mechanisms of Streptococcus pyogenes  
 Streptococcus pyogenes is an important human pathogen that can cause a wide 
spectrum of diseases with varying degrees of severity (reviewed in [Cunningham, 2000; 
Kotb et al., 2003]). These diseases range from mild sore throat or skin infections to 
severe and often deadly ones, such as streptococcal toxic shock syndrome (STSS) and 
necrotizing fasciitis (NF), known as flesh-eating disease, giving the bacteria its nickname 
as the flesh-eating bacteria. Certain individuals develop post-streptococcal non-
suppurative sequelae that include glomeronephritis, acute rheumatic fever, post-
streptococcal arthritis, and neurological disorders collectively known as pediatric 
autoimmune neuropsychiatric disorders associated with streptococcal infections 
(PANDAS).   
 
 The wide range of diseases associated with Streptococcus pyogenes infections and 
their varying degrees of severity has intrigued us and other researchers to study the basis 
for the variable outcomes of the infection. Research groups have long debated over which 
is more vital towards the final outcome of streptococcal diseases, the bacteria or the host, 
with evidence supporting each side. Lately, it has become evident that interactions 
between host factors, which are influenced by their genetic background, and 
environmental factors, and the bacterial arsenal of virulence factors shape the final 
outcome of group A streptococcal (GAS) infection. I will briefly review the bacteria 
virulence factors and then elaborate on host genes associated with modulating the 
susceptibility to infectious diseases and sepsis. 
Streptococcal Arsenal of Virulence Factors 
 Streptococcus pyogenes expresses multiple virulence factors that are tailored to 
their human host. Not all of these factors are expressed at the same time as Streptococcus 
pyogenes (also known as (GAS)) senses its environment and accordingly restructures its 
community to where mutants that are best fit for specific host environment are selected. 
These mutants have distinct genetic expression patterns. Examples of GAS virulence 
factors are shown in Figure 1-1. Some virulence factors are secreted and others are 
surface bound, of note, superantigens (SAgs), which are a large group of secreted 
proteins (exotoxins) and are associated with severe GAS sepsis and STSS. GAS produces 
virulence factors that specifically impair host mechanisms of bacterial killing; for 
example, GAS interferes with host signals for neutrophil chemotaxis, migration and 
function. Streptococcal chemokine protease A (ScpA), also known as the complement 5a 
(C5a) peptidase, degrades host C5a an important chemoattractant. Meanwhile, 
streptococcal chemokine protease C (ScpC), also known as interleukin 8 (IL8) degrading 
enzyme, degrades host IL8 thus impairing one of neutrophil chemotaxis factors (Sjolinder 
et al., 2008; Gleich-Theurer et al., 2009). Streptococcal inhibitor of complement (SIC) 
inhibits complement membrane attack complex and was also recently associated with 
inhibition of several of the human innate immune machinery namely, lysozyme, secretory 
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Figure 1-1. An overview of group A streptococcal main virulence factors. 
 
 
GAS displays multiple virulence factors depending on site and stage of infection, shown 
are selected virulence factors. Each of these virulence factors has been tailored to 
counteract one or more of the host defenses. For example, ScpA (streptococcal 
chemokine protease A, also known as C5a peptidase) degrades host C5a, and ScpC 
(streptococcal chemokine protease C) degrades interleukin 8 (IL8), with a net result of 
hindering the recruitment of neutrophils to site of infection (Hidalgo-Grass et al., 2006; 
Sjolinder et al., 2008; Zinkernagel et al., 2008). Streptococcal inhibitor of complement 
(SIC) as its name suggests, inhibits complement membrane attack complex and was also 
recently associated with inhibition of four more proteins of the human innate immune 
machinery namely, lysozyme, secretory leukocyte proteinase inhibitor, human α-defensin 
1 and LL-37 (Johansson et al., 2008; Minami et al., 2009). M protein binds and 
counteracts host’s counter-regulatory factors e.g. host fibronectin. Streptokinase (Ska) 
degrades human plasminogen into plasmin thereby, dissolving blood clots. EndoS, 
endoglycosidase S; FBP54, fibronectin-binding protein 54; Mac, Mac1-like protein; 
MHC, major histocompatibility complex; PFBP, pyogenes fibronectin-binding protein; 
Sfb, streptococcal fibronectin-binding protein; SlaA, streptococcal phospholipase A2; 
cytotoxins streptolysin O (SLO) and streptolysin S (SLS); Spe, streptococcal pyogenic 
exotoxin (aka superantigens (SAgs)); Smez, streptococcal mitogenic exotoxin Z; SSA, 
streptococcal superantigen A; GRAB, G-related α2-macroglobulin-binding protein; 
NADGH, Nicotine adenine dinucleotide (NAD) glycohydrolase; and TCR, T-cell 
receptor. Source: Adapted with permission. Mitchell, T.J. (2003) The pathogenesis of 
streptococcal infections: from tooth decay to meningitis. Nat Rev Microbiol 1: 219-230. 
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leukocyte proteinase inhibitor, human α-defensin 1 and LL-37 (Johansson et al., 2008; 
Minami et al., 2009). Another example of GAS interfering with neutrophil killing 
mechanisms is Sda1, a potent DNase produced by M1T1 (GAS strain under study). Sda1 
dissolves neutrophil extracellular traps (NETs), which are DNA filaments produced by 
neutrophils and contain histones and antimicrobial peptides, allowing the bacteria to 
escape the entrapment and on mechanism of killing by neutrophil (Aziz et al., 2004b; 
Buchanan et al., 2006; Walker et al., 2007). 
 
 According to site and stage of infection, GAS virulence factor genes are turned on 
or off to survive the host immune response and adapt to its environment. How the 
bacterium does that is not completely understood, but it is postulated that according to the 
environmental pressure, GAS selects for the most-fit mutants, sacrificing even the wild 
type. This has been shown in several recent studies by our group and others (Buchanan et 
al., 2006; Walker et al., 2007) and reviewed by (Aziz and Kotb, 2008; Bessen, 2009)  
 
 In the studies discussed in this dissertation, I used a hypervirulent clonal GAS 
strain, designated M1T1. This hypervirulent M1T1 clonal strain, along with M3, M18, 
and M28 strains, has been associated with the resurgence of the severe GAS sepsis in the 
1980s (Johnson et al., 1992; Hoge et al., 1993). M1 and M3 GAS strains have displayed 
highest associations with severe GAS sepsis (STSS) and NF (Hauser et al., 1991; 
Johnson et al., 1992). Our research focus has been on the M1T1 strain, which has been 
consistently isolated over the past 20 years from patients with both noninvasive and 
invasive disease displaying varying degrees of severity (Chatellier et al., 2000; Johnson 
et al., 2002; Ikebe et al., 2007). The hypervirulence of this strain is believed to be due to 
the acquisition of virulence factors through horizontal gene transfer, recombination and 
mutations (reviewed in [Aziz and Kotb, 2008]).  
Streptococcal Sepsis as a Model of Host-pathogen Interactions 
 In studies presented in this dissertation, our focus was to determine the basis for 
differential host susceptibility to one of the most severe GAS invasive diseases, 
streptococcal toxic shock syndrome (STSS). STSS is an invasive disease of GAS, where 
bacteria reach an otherwise sterile site in the body, e.g. blood, and the patient has 
hypotension, plus two or more of the following clinical symptoms that are indicative of 
multiple organ failure: renal impairment, coagulopathy, hepatic involvement or 
respiratory distress. A STSS case is classified as probable if GAS is isolated from a non-
sterile site or fluid, e.g. throat, and the patient displays hypotension and two or more of 
the above-mentioned symptoms (Lappin and Ferguson, 2009). 
  
 The pathophysiology of STSS has multiple aspects and is associated with host 
interactions and response to the bacterial arsenal of virulence factors including 
superantigens (SAgs). The Kotb research group has found, through epidemiological 
studies, that the severity of GAS sepsis is associated with allelic variations in human 
leukocyte antigen (HLA) class II (Kotb et al., 2002). Patients with GAS sepsis expressing 
HLA class II (DR15/DQ6) haplotype were protected from severe GAS sepsis, whereas  
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those with HLA class II (DR14/DQ5) haplotype were at high risk for developing severe 
and often fatal forms of the disease (Kotb et al., 2002; Norrby-Teglund et al., 2002; Nooh 
et al., 2007). Ensuing studies, in vitro and in vivo, dissected the molecular mechanisms 
underlying these differential responses and helped to dissect the role of GAS SAgs in 
severe GAS sepsis and their interactions with HLA-II (Kotb et al., 2002; Norrby-Teglund 
et al., 2002; Welcher et al., 2002; Kotb et al., 2003; Kotb, 2004; Nooh et al., 2007). 
 
 Whereas HLA-II allelic variations clearly influenced disease severity, it was clear 
that other host factors must also be participating in the pathogenesis of GAS sepsis 
because different inbred mice that do not express HLA-II were also found to display 
differential susceptibility to GAS sepsis (Medina et al., 2001).This observation was 
interesting because mice are normally less susceptible to GAS SAgs because they have 
an inherent poorer affinity of MHC-II to GAS SAgs. Therefore, other bacterial virulence 
factors, other than SAgs, and hence other host factors, other than HLA-II, are also likely 
to modulate differential severity to GAS sepsis. Moreover, the bacteria produce a number 
of additional, important virulence factors that must also participate in the pathogenesis of 
GAS sepsis.  The overall aim of my study was to identify additional host factors 
modulating susceptibility to severe GAS sepsis and to identify host genes and pathways 
involved in this disease (Aziz et al., 2007; Abdeltawab et al., 2008). 
Infectious Diseases as Complex Traits that Require a Systems Approach to Better 
Understand Them 
 It is now established that infectious diseases are a manifestation of complex traits 
modulated by the interaction of host factors and genetic background with the pathogen 
virulence factors and other environmental factors. Complex interactions between the 
pathogen virulence factors and host immune-related genetic makeup determine the 
progression and outcomes of the infection. Host genetic variations modulating 
differential response to infectious diseases have long been studied (Hornef et al., 2002; 
Fortin et al., 2007; Carvalho et al., 2009; Chai et al., 2009; Deghmane et al., 2009; Ko et 
al., 2009; Zhang et al., 2009a). Variations in host response can be attributed to variations 
in pathogen recognition, prior exposure and preexisting immunity, immune regulation 
and/or quantitative differences in the immune response mounted to the infectious agents 
(reviewed in [Frank, 2002]). Variation in host recognition of pathogens and their 
virulence components can arise from a number of factors, including variations in many 
immune genes, including genes encoding pattern recognition receptors (PRR), and major 
histocompatibility complex (MHC) molecules. Also, variations in genes involved in 
immune regulation can strongly affect the host response to the infection. An added level 
of host immune response variability arises from polymorphisms of key immune-related 
genes.  
 
 Two main approaches have been employed to identify host genetic 
polymorphisms associated with infectious diseases. The first approach is to examine a 
candidate gene or genes for polymorphisms and analyze the distribution of these 
polymorphisms in patients or infected subjects vs. a normal group. The hypotheses are 
usually based on plausible associations based on the mechanism of diseases studied and 
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prior reports in the literature. The second approach employed is genome-wide association 
studies (GWAS). In GWAS no assumptions are made as to which gene might be involved 
and a scan of associations of phenotype with genotypes is performed. Such approaches 
have been widely applied in animal models and moving forward with using human 
subjects, as more projects like the human haplotype map (HapMap) (Frazer et al., 2007) 
and the Wellcome Trust Case Control Consortium (2007) are establishing genomic 
repositories for case-control studies of common diseases.  
Systems Genetics Approach – Definition and Tools 
 Systems genetics is an approach that studies the effects of multiple genes on 
modulating disease phenotypes. Instead of the classical one gene, one disease approach, 
systems genetics attributes variations in phenotypes of a trait to a network of genes or 
loci that are in turn affected by environmental conditions (Sieberts and Schadt, 2007). 
Instead of looking at one gene, systems genetics explores one or more quantitative trait 
loci (QTL) associated with a given disease or complex trait. QTLs are regions within the 
genome whose genetic variation modulates quantitatively a phenotype characteristic of 
the particular trait under study (Lynch and Walsh, 1998). Determining the association 
between variations in specific disease phenotypes or a trait, with variations in genotypes 
of a reference population can be used to locate a QTL. One of the methods used for 
mapping QTLs associated with complex traits is genetic markers-trait association. 
Genetic markers associated with certain loci can be inherited in linkage disequilibrium. 
Generating populations with linked loci in disequilibrium is achieved though either 
crosses between inbred lines, or use of the out-bred populations. In this study we used 
recombinant inbred mouse strains that are fully genotyped as a genetic reference 
population for mapping QTLs. 
 
 Recombinant inbred (RI) and advanced RI (ARI) mice are a genetically diverse, 
segregating reference population that affords a powerful tool for systems genetics 
approaches (Williams et al., 2001; Peirce et al., 2004; Tsaih et al., 2005). RI and ARI 
strains have been successfully used to map quantitative trait loci (QTLs) associated with 
various phenotypes and diseases (Hardy et al., 2001; Grizzle et al., 2002; Chesler et al., 
2005; Miyairi et al., 2007; Abdeltawab et al., 2008). RI and ARI strains of mice are the 
progeny of two ancestral inbred strains. For example, BXD strains are progeny of mating 
C57Bl/6J (B6) and DBA/2J (D2). B6 was mated with D2 to give F1 mice; all F1 progeny 
are identical, yet heterozygous, with one allele from the B6 parent (B) and the other from 
the D2 parent (D). Those F1 hybrids were then crossed to generate an F2 progeny, each 
with random patterns of recombination. Pairs of F2 mice were designated as “parents” of 
an RI line, and are then sib-mated for > 20 generations to achieve homozygosity for each 
genetically distinct RI line (Figure 1-2). This breeding strategy accumulates 
recombinations and random assortment of polymorphic loci. The breeding scheme used 
for generation of ARI strains is slightly different from RI strains and was adopted to 
increase recombination events per ARI strain, resulting in roughly double the number of 
recombinations per strain compared to a conventional RI strain (Williams et al., 2001; 
Tsaih et al., 2005; Shifman et al., 2006). ARI breeding scheme involves random matting
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Figure 1-2. Breeding scheme used for generation of RI strains of mice.  
BXD strains are an example of recombinant inbred mice strains (RI). In this Figure, a 
scheme of crossing C57Bl/6J (B6 carrying B allele) female to a DBA/2J (D2 carrying D 
allele) male is shown. A representative one chromosome is shown. The parental strains 
chromosomes are homozygous and when crossed, their F1 progeny are identical and 
each chromosome pair is heterozygous carrying BD alleles. F1 mice are crossed to 
generate F2 progeny with random recombinations. Randomly assigned F2 pairs are 
designated as parents for a BXD strain, and are sib-mated for ≥ 20 generations to 
achieve homozygosity. Advanced RI (ARI) strains are bred using a slightly different 
scheme, where at the F2 stage, mice are randomly mated till generation 9 or 11 
(according to the adopted breeding scheme (Peirce et al., 2004)) avoiding sib mating 
and even cousin mating to increase the number of recombinations and diversity of the 
genetic pool. There are currently > 80 ARI-BXD strains available for genome-wide 
association studies.  
 8
  9
of F2 mice till generation 9 or 11 avoiding sib mating and even cousin matting to increase 
the recombinations and hence diversity of the genetic pool. After reaching generation 9 or 
11, pairs of mice are set as parental for a designated BXD strain and are sib matted for 
~20 generations or until each chromosome become homozygous (Peirce et al., 2004). 
The net result in both cases is a mosaic chromosomal pattern of both ancestral parents, 
B6 and D2.  
 
In the studies presented in this dissertation, we used the BXD panel of RI and ARI 
strains. We had found that parental strains of BXD mice, B6 and D2 strains, showed 
differential response to GAS severe sepsis. We found that D2 were susceptible to severe 
GAS sepsis showing high mortality and bacterial loads in blood while B6 were relatively 
resistant. This differential response of the BXD ancestral strains to GAS sepsis motivated 
us to use ARI-BXD strains to parse out genes associated with differential response to 
GAS sepsis. Figure 1-2 shows the breeding scheme used to generate the BXD RI panel 
(explained above). The BXD strains are derived from B6 and D2 strains and consisting of 
homozygous, inbred lines, each of which is genetically distinct. There are now more than 
80 BXD strains. Each strain is a clone, as the recombinations become fixed after 
approximately 20 generations of sib matting, so each strain is renewable and the number 
of mice that can be tested per strain can be infinite with high reproducibility of results. 
This is in contrast to using F2 crosses, which have recombinations and have been used in 
mapping studies, however, F2 crosses recombinations are random, and therefore, it may 
be not possible to reproduce results obtained using these mice. In contrast, each BXD 
strain has a unique set of recombinations different from the other BXD strains and is 
renewable, where we can test the same BXD strain several times (n = ∞) with highly 
reproducible results. The high number of recombinations of each ARI-BXD strain makes 
these strains genetically diverse, thus mimicking the genetic diversity of the human 
population (Williams et al., 2001; Churchill, 2007; Peters et al., 2007). The use of BXD 
strains as a reference population is facilitated by the fact that BXD strains have been 
heavily genotyped with approximately 580,000 SNP and microsatellite markers 
(Churchill and Doerge, 1994; Shifman et al., 2006). In addition, the genomes of the B6 
and D2 parental strains have been fully sequenced with 4.5 million SNPs, 450,000 indels, 
copy number variants, and inversions, facilitating the dissection of mapped genetic loci. 
All taken together makes the BXD panel of ARI strains a very powerful tool as a 
genetically diverse reference population for genome-wide association studies. 
Overview of Aims, Results, and Organization of the Dissertation  
Aims of the Studies 
 The overall aim of this dissertation was to analyze the role played by host 
immunogenetic variability in influencing differential susceptibility to severe GAS sepsis. 
To accomplish this overall aim, we first wanted to discover loci associated with 
differential genetic susceptibility to severe GAS sepsis. This was done by performing 
genome-wide scans for mapping QTLs associated with differential survival of a panel of 
recombinant inbred (RI) mice. These scans revealed multiple QTLs on mouse 
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chromosomes (Chr) 2 and X. Next, steps were taken to fine tune and explore additional 
and interactive QTLs modulating severity of GAS sepsis. We fine-tuned the mapped 
QTLs to narrow down the list of candidate genes at mapped QTLs. To narrow down the 
candidate genes within individual mapped QTLs, we used additional BXD RI strains; 
chosen based on strains haplotypes also known as strain distribution patterns (SDP) of all 
BXD in the region of the mapped QTLs.  
 
 We then applied bioinformatics tools including linkage, gene ontology, co-
citation networks, polymorphism analyses and pathway analyses to prioritize our 
candidate genes list. Next we aimed to identify genes and pathways modulating host 
response to GAS sepsis and validate those specific genes. This was accomplished by 
multiple approaches. We first compared the gene expression profiles of resistant and 
susceptible strains pre- and post- infection and validated differentially expressed gene  
identified with quantitative real time PCR analyses that revealed multiple pathways 
involved in modulating differential susceptibility to GAS sepsis. We then validated these 
pathways by studying the kinetics of soluble biomarkers, both cytokines and lipid 
mediators, associated with these pathways. We then aimed to analyze the cellular 
populations modulating differential response to severe sepsis and identify cellular 
mechanisms of differential response to severe GAS sepsis. The results of the studies are 
outline below including organization of the dissertation. 
 
 To identify correlates for survival, we explored additional independent and/or 
interactive traits associated with severity of GAS sepsis. Accordingly, we assessed 
variations in the number of bacteria in blood as well as dissemination of bacteria to 
various organs. Interestingly, both traits mapped to the same QTLs on Chr 2 associated 
with modulating survival but not with the one on Chr X. Additionally we found that there 
were interactions (epistatic effects) between two mapped QTLs on Chr 2. We also found 
interactions between Chr 2 QTLs and the Chr X QTL.  
Results and Organization of the Dissertation 
 In Chapter 2 of this dissertation, I will discuss the establishment of the mouse 
model of GAS sepsis where we analyzed genetic, environmental and non-genetic 
covariates that might be contributing to the measured phenotypes. We standardized our 
model so that the observed phenotypes were mainly due to genetic differences of the 
strains (heritability) rather than any of the underlying covariates. The covariates studied 
included mice age, sex, and body weight, in addition to bacterial inoculate. This study is 
crucial, as phenotypes associated with complex traits can be affected by interactions with 
environment and/or other covariates, thus masking the actual gene networks associated 
with the trait under study. Chapter 2 was published as a peer-reviewed manuscript: Aziz, 
R.K., Kansal, R., Abdeltawab, N.F., Rowe, S.L., Su, Y., Carrigan, D., Nooh, M.M., Attia, 
R.R., Brannen, C., Gardner, L.A. et al (2007) Susceptibility to severe Streptococcal 
sepsis: use of a large set of isogenic mouse lines to study genetic & environmental 
factors. Genes Immun. 8(5): 404–415. 
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 In the next chapter (Chapter 3), I will present how we analyzed disease 
phenotypes in the context of the mice genotypes which mapped two quantitative trait loci 
(QTLs) on Chromosome (Chr) 2. One QTL, between 22–35 Mb, that strongly predicts 
disease severity and accounts for 25%–30% of variance (calculated using hereditary 
tests) was highly significant (likelihood ratio statistic (LRS) 34.2 i.e. P < 0.0000001). We 
also mapped disease severity to a second QTL on Chr 2 (LRS 12 P < 0.001). Both QTLs 
harbor several polymorphic genes known to regulate immune responses to bacterial 
infections. Candidate genes within these QTLs were evaluated using multiple parameters 
that included linkage, gene ontology, and variation in gene expression. We identified 
interleukin 1 (IL1) and prostaglandin E synthases pathways as key networks involved in 
modulating GAS sepsis severity. Chapter 3 was published as a peer-reviewed manuscript: 
Abdeltawab, N., Aziz, R.K., Kansal, R.K., Rowe, S., Su, Y., Gardner, L.A., Brannen, C., 
Nooh, M., Attia, R., Abdelsamed, H. et al. (2008). An Unbiased Systems Genetics 
Approach to Mapping Genetic Loci Modulating Susceptibility to Severe Streptococcal 
Sepsis. PLoS Pathog. 4(4):e1000042. 
  
 In Chapter 4, I will present our attempts to identify molecular and soluble 
biomarkers associated with differential susceptibility at multiple stages of infection. I 
explored changes in the genome-wide expression levels, where we examined differential 
gene expression at early stages of infection in resistant and susceptible strains and 
compared it to late stages of infection. In addition, we sought to examine patterns of 
cytokines, as soluble biomarkers, associated with late and early stages. Chapter 4 is a 
manuscript in preparation: Abdeltawab, NF, Kansal, R, Mukandan, S., Bangar, H., 
Aronoff, D., Senn, T., Jordan, M., Williams, RW, & Kotb, M. Genomic & soluble 
biomarkers associated with different outcomes of Group A streptococcal sepsis reveal 
underlying mechanisms of differential host susceptibility. 
 
 Next, in Chapter 5 we wanted to examine the role of these genes and pathways at 
the cellular level. We immunophenotyped selected resistant and susceptible BXD strains 
where we examined and characterized the relative percentages of blood and spleen 
cellular populations at normal uninfected selected resistant and susceptible strains. We 
concluded that migratory and functional differences rather than cellular availability might 
be a possible mechanism of resistance. Subsequently, we wanted to dissect and confirm 
the cellular response in our model by depleting neutrophils, which are known to be 
associated with susceptibility to GAS infection. We blocked Gr-1 receptors, which are 
receptors expressed on the surface of neutrophils and some populations of monocytes and 
dendritic cells, this rendered resistant strains susceptible. This led us to more experiments 
on analyzing the role of neutrophils and the associated host pathways modulating this 
response. Chapter 5 is a manuscript in preparation: Abdeltawab, NF, Bangar, H., Kansal, 
R., Williams, RW, & Kotb, M. Host-pathogen interactions in Group A streptococcal 
sepsis: role of macrophages & neutrophils. 
 
 Finally, I will discuss and summarize the results of the studies done in this 
dissertation in Chapter 6, in addition to future directions of this project. 
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CHAPTER 2. SUSCEPTIBILITY TO SEVERE STREPTOCOCCAL SEPSIS: USE 
OF A LARGE SET OF ISOGENIC MOUSE LINES TO STUDY GENETIC AND 
ENVIRONMENTAL FACTORS 
Summary  
 Variation in responses to pathogens is influenced by exposure history, 
environment, and the host’s genetic status. We recently demonstrated that HLA class II 
allelic differences are a major determinant of the severity of invasive group A 
streptococcal (GAS) sepsis in humans. While in-depth controlled molecular studies on 
populations of genetically well-characterized humans are not feasible, it is now possible 
to exploit genetically diverse panels of recombinant inbred (RI) BXD mice to define 
genetic and environmental risk factors. Our goal in this study was to standardize the 
model and identify genetic and nongenetic covariates influencing invasive infection 
outcomes. Despite having common ancestors, the various BXD strains (n strains = 33, n 
individuals = 445) showed marked differences in survival. Mice from all strains 
developed bacteremia but exhibited considerable differences in disease severity, bacterial 
dissemination, and mortality rates. Bacteremia and survival showed the expected negative 
correlation. Among nongenetic factors, age—but not sex or weight—was a significant 
predictor of survival (p = 0.0005).  To minimize nongenetic variability, we limited further 
analyses to mice ages 40–120 days and calculated a corrected relative survival index 
(cRSI) that reflects the number of days an animal survived post-infection normalized to 
all significant covariates. Genetic background (strain) was the most significant factor 
determining susceptibility (p ≤ 0.0001), thus underscoring the strong effect of host 
genetic variation in determining susceptibility to severe GAS sepsis. This model offers 
powerful unbiased forward genetics to map specific quantitative trait loci and networks of 
pathways modulating the severity of GAS sepsis. 
Introduction 
 There is now overwhelming evidence that specific genetic factors influence a 
host’s susceptibility or immunity to many infectious agents, and modulate severity and 
outcome of infectious diseases (reviewed in [Skamene, 1983; Roy and Malo, 2002; 
Frodsham and Hill, 2004; Kotb, 2004]). Infection with group A streptococcus (GAS or 
Streptococcus pyogenes) represents an ideal model for studying effects of host genetics 
on disease. This human pathogen causes a wide variety of conditions ranging from sore 
throat to invasive life-threatening diseases (reviewed in [Cunningham, 2000]), and the 
same strain of pathogen leads to different outcomes in different individuals (Chatellier et 
al., 2000). Our laboratory provided direct evidence that the highly polymorphic human  
 
                                                 
 Source: Reprinted with permission. Aziz, R.K., Kansal, R., Abdeltawab, N.F., Rowe, S.L., Su, 
Y., Carrigan, D., Nooh, M.M., et al. (2007) Susceptibility to severe Streptococcal sepsis: use of 
a large set of isogenic mouse lines to study genetic and environmental factors. Genes Immun 8: 
404-415. 
  13
leukocyte antigen (HLA) genes confer high risk or protection in rheumatic heart disease 
(Guedez et al., 1999) as well as in streptococcal toxic shock (STSS) and necrotizing 
fasciitis (NF) (Kotb et al., 2002; Kotb et al., 2003). In GAS sepsis, allelic variation in 
HLA class II molecules plays a major role in modulating infection severity, primarily 
because they serve as binding and signaling receptors for superantigens (Kotb, 1992; 
Kotb, 1995), which are the primary trigger of the severe inflammatory responses that can 
lead to organ failure and shock (Norrby-Teglund et al., 2001; Proft et al., 2003). 
 
 To systematically identify additional gene variants that modulate susceptibility to 
severe GAS sepsis and to elucidate how they influence disease outcome, we sought a 
robust experimental model of the disease with attributes that incorporate roughly the 
same level of genetic variation as that of human populations. Small numbers of 
conventional inbred mouse strains have been used previously to study differential 
susceptibility to GAS infection (Medina et al., 2001; Goldmann et al., 2003, 2004b); 
however, these models are limited in their genetic variability and cannot be used to map 
modifier loci. HLA transgenic mice are appropriate models for GAS sepsis (Nooh et al., 
2007) but these too are generated on the genetic background of conventional inbred 
laboratory strains. 
 
 The genetically diverse mouse reference population of recombinant inbred (RI) 
strains, which can be likened to an immortal population of human monozygotic twins, is 
an ideal model for our studies. RI strains are generated by the crossing of two inbred 
strains followed by ≥ 20 consecutive generations mating among siblings (Bailey, 1971; 
Taylor, 1978). These types of strains are frequently used for studying genetic variation 
and mapping quantitative trait loci (QTL) influencing disease (Peirce et al., 2004; Chesler 
et al., 2005). The BXD strains were used recently to study variation in the pathogenicity 
of bovine spongiform encephalopathy and to uncover genes modulating anthrax and pox 
lethality (Benjamin et al., 1986; Melvold et al., 1990; Watters et al., 2001) 
Among the different panels of RI strains, we selected the BXD set produced from an 
intercross of C57BL/6J and DBA/2J. The parental strains are known to differ in response 
to many pathogens (Plant and Glynn, 1976; Anthony et al., 1989; Boyartchuk et al., 
2001; Mahler et al., 2002). The other notable advantage of this particular panel of RI 
strains is that both parental strains have been sequenced (Waterston et al., 2002). This 
makes it possible to use reverse genetic methods to test modifier genes (Williams, 2006). 
We have 80 BXD strains that are being extensively phenotyped and genotyped. 
 
 As a first step in exploiting the BXD strains to study the genetics of GAS 
susceptibility, we have studied the influence of differences in sex, age, body weight, 
inoculum titer, and genetic factors on disease development. Our main objective has been 
to develop a protocol that can be applied uniformly across the entire BXD set of 80. Our 
second objective has been to measure heritability and evaluate prospects of mapping 
modifier loci. We show the genetic and nongenetic factors that determine whether a 
mouse is protected from or susceptible severe GAS sepsis, we evaluate the contribution 
of each of these factors using multivariate analysis, and we discuss the proper measures 
that should be followed to design experiments using this novel and promising mouse 
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model in other infectious disease and for elucidating the complex events of host-pathogen 
interactions. 
Results 
 The main purpose of this study was to adapt and standardize the BXD RI model 
to investigate the genetic and molecular mechanisms associated with susceptibility to 
severe invasive GAS sepsis, to determine the nongenetic environmental factors affecting 
the model, and to test whether the genetic variations among these mice would affect the 
progression and severity of invasive GAS disease. We used 717 mice in the study: 218 
mice in the preliminary phase, 445 for the initial statistical analysis, 307 of which were 
selected for the final analysis as detailed below, and 54 for the time-course experiments. 
Survival Scores Show Differential Susceptibility to Severe GAS Sepsis 
 To assess the phenotype ‘susceptibility or resistance of mice to severe GAS 
sepsis,’ we calculated a survival score for each animal as a quantitative trait: among 445 
mice tested in six experiments, a notable variability was observed in survival scores 
measured as days post-infection. Interestingly, the distribution of the survival scores was 
not normal but multimodal, showing three groups (Figure 2-1-A), the largest of which 
represented animals (n = 208) that died early (in less than 2.5 days). Another group 
included an intermediate population (n = 125) that survived between 2.5 and 4.5 days and 
the third group (n = 112) survived for more than 5 days and up to the entire 7-day 
observation period. This pattern of survival was highly reproducible and predictable from 
one experiment to another with slight variability in the boundaries separating the three 
clusters in each experiment. 
Bacterial Loads in Blood and Organs Show Various Degrees of Bacteremia and 
Tissue Dissemination 
 The bacterial load in blood (calculated as ‘bacteremia index,’ BI = log CFU/ml 
blood sampled 24 h post-infection) was measured for 396 of 445 mice used in six 
experiments.*In contrast to the survival scores, bacterial load followed a normal 
distribution (Figure 2-1-B).  With the exception of a few mice (n = 6) whose blood was 
sterile (possibly due to injection failure), all mice had bacteremia with counts ranging 
from 125 CFU/ml (BI = 2.097) to 1.72 x 109 CFU/ml (BI = 9.236), the mean BI ± SE was 
5.2 ± 0.07 reflecting a highly symmetrical distribution. Correlation analysis showed an 
inverse relation between survival scores and BI. The Pearson product moment-correlation 
factor of –0.430 (Figure 2-1-C) indicates that the BI accounts for 20 – 30 % of variance 
in mortality. 
 
                                                 
* In some cases, mice died before their blood was sampled and in other cases, the bacteria were 
too numerous to be counted by the plate dilution technique. 
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Figure 2-1. Distribution and correlation of survival scores and bacteremia indices. 
Histograms showing the frequencies of survival scores (A) and log CFU/ml blood, or 
bacteremia indices, BI (B).  A. The distribution of the survival scores of 445 animals 
from six experiments was multimodal, showing three clusters representing a susceptible, 
an intermediate, and a resistant population. Bars representing the intermediate population 
are shaded in grey. B. The distribution of BI for 396 was unimodal and symmetric, with 
the exception of six animals having sterile blood (leftmost bar).  C. A scatter plot 
showing the negative correlation between survival scores and BI.  Pearson product-
moment correlation factor is indicated. 
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 In addition to counting bacteria in blood, in some experiments we determined the 
bacterial dissemination in different systemic organs (mainly spleen, but also liver and 
lung) to estimate invasiveness of the disease.  Among 335 mice with confirmed 
bacteremia, only 14 had sterile spleens while the remaining mice had bacterial counts 
ranging from 102 to 3x1010 CFU/spleen, with a median count of 1.3x108 CFU/spleen. 
Bacterial loads in liver and lung were determined for 77 mice, and the median counts 
were 3.16x109 CFU/liver and 2x109 CFU/lung, with a wide range of variation. 
Statistical Analysis Evaluates the Confounding Factors Affecting Mice Survival 
 The variability in animal mortality and extent of bacteremia is not surprising and 
matches that reported in human infection (Davies et al., 1996; Basma et al., 1999; Muller 
et al., 2003) and in mice strains (Medina et al., 2001). However, in this particular set of 
experiments, it was necessary to determine whether this variability reflects genetic 
differences between different BXD strains or is it mere biological variability caused by 
confounding factors like sex, body weight, animal age, or experiment-to-experiment 
variability (due in part to differences in inoculum size or other experimental error). The 
large number of animals used and the availability of replenishable inbred BXD lines 
made such analysis possible and efficient. 
 
 First, we examined the effect of inoculum size. In preliminary experiments, we 
conducted a dose-response study in which we exposed animals to bacterial inocula 
ranging from 105 to 108 CFU/ml to find an optimal dose that would kill animals rapidly 
but would also discriminate between susceptible and resistant strains (data not shown). 
We chose an inoculum size of 107 CFU/ml because it showed clear differences between 
the parental strains (C57BL/6J and DBA/2J). However, because it is difficult to 
reproduce the inoculum titer in every experiment, and because precise counts could only 
be determined after injection, it was important to examine whether the inter-experimental 
differences in inoculum size had an effect on survival. Slight variation in inoculum size 
had an insignificant effect on survival (r2 = 0.1%, p = 0.533) Figure 2-2-A. 
 
 We tested whether sex had an effect on survival. Male mice (n = 235) had a mean 
survival of 3.49 ± 0.12 days and a median of 3 days, slightly higher than female mice (n 
= 206) that had a mean of 3.25 ± 0.12 days and a median of 2.3 days. This difference did 
not achieve statistical significance (p = 0.153) Figure 2-2-B. 
 
 Subsequently, we tested the effect of animal body weight and age on survival, and 
each of the two factors, independently, showed positive association with survival scores 
(Figure 2-2-C and 2-2-D). Whereas weight had a correlation of 0.29, age has a stronger 
correlation (factor = 0.44). It is noteworthy that weight was directly proportional with 
animal age between the ages of 40–120 days. Based on these findings, we decided to use 
animals in the age range of 40–120 days and to correct for age effects using a General 
Linear Model (GLM). 
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Figure 2-2.  Effect of non-genetic factors on the survival of BXD mice and their 
parental strains. 
Scatter plots showing the effect of the inoculum size (A), the mice body weight (C), and 
their age (D) on their survival.  The effects of these confounding factors were evaluated 
by linear regression and Pearson product-moment correlation analyses, and the values 
of r2 and correlation factors are shown when necessary. B. Box plots of animal sex 
versus animal survival in days post-infection. The significance of the effect of sex was 
tested by the student-t test, and the p-value is shown. D. Vertical dashed lines show the 
range of animals selected for further analysis. 
  18
Analysis of Covariates Underscores the Role of Genetic Background in Determining 
Animal Susceptibility to GAS 
 Having determined the effect of several major cofactors on survival scores, we set 
out to determine the complex interaction between these covariates and the genetic factor 
(i.e., the mouse strain). At this stage of the analysis, we filtered our data set to exclude 
mice that were outside the 40–120 days age range (see above) and we selected BXD 
strains that had been used in at least two experiments. Table 2-1 lists mice selected for 
final analysis. We took advantage of the multimodal distribution of survival scores 
detailed above (see Figure 2-1-A) to define a survival index (SI): animals were given a 
score ranging from 0.25 to 3, with increments of 0.25 (0.25 for most susceptible and 3.0 
for most resistant). The use of SI was superior to survival scores as it normalized the data 
across experiments and minimized the unavoidable experiment-to-experiment variance in 
survival scores caused by slight differences in inoculum size and other systematic sources 
of error. 
 
 Finally, we performed GLM analysis of covariates using ordinary least squares 
ANOVA to determine the relative effect of covariates, including mouse strain, on 
survival (Table 2-2). This analysis revealed that strain was the most significant predictor 
(p ≤ 0.0001), followed by age (p = 0.0005), and weight (p = 0.02). As shown in Figure 2-
2-B, sex remained an insignificant factor in the final analysis (Table 2-2). From the 
GLM, we estimate the main effect attributable to strain (a measure of heritability) to be 
25–30% (42.21/152.44, see Table 2-2). This GLM analysis was not only helpful in 
assessing effects of several factors, but it also allowed us to generate a corrected relative 
survival index (cRSI), which was used to compare the strains and determine their relative 
susceptibility—correcting for differences in age and weight (Figure 2-3). 
BXD Strains Exhibited Phenotype Variability Outside the Range of the Parental 
Strains 
 The comparison of cRSI values between different strains (Figure 2-3) reveals the 
stark effect that the genetic background plays in predicting how long a mouse will 
survive after being exposed to a high dose of GAS. Some strains have very low mean 
cRSI (e.g., BXD66, BXD97, and BXD61) and are highly susceptible, whereas others are 
almost completely resistant (e.g., BXD87, BXD92, and BXD69). The difference between 
the cRSI values of parental strains, shown on the two extreme sides of the bar chart 
(Figure 2-3), was more modest than the variation displayed by the different BXD strains. 
This finding underscores the complexity of the trait we are measuring (susceptibility/ 
resistance) and highlights the fact that the survival phenotype is modulated by multiple 
loci. 
 
Following the same method of building a GLM for covariate analysis, we 
corrected the BI and the log CFU/spleen by calculating the coefficients that express the 
contribution of ‘mouse strain’ as a predictor for BI and for spleen dissemination (Figure 
2-4). As shown with the inverse correlation between survival score and BI (Figure  
2-1-C), most strains that were judged susceptible based on their cRSI (e.g. BXD60, 
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Table 2-1. Mouse strains used in the final analysis of this study. 
 
Strain N Age 
(Mean ± SE) 
Body Weight 
(Mean ± SE) 
C57BL/6J 11 75.55 ± 3.76 21.98 ± 0.90 
DBA/2J 12 88.92 ± 3.79 23.74 ± 0.59 
BXD43 11 91.45 ± 5.05 23.92 ± 0.77 
BXD44 11 75.09 ± 7.96 22.67 ± 1.88 
BXD45 20 80.00 ± 4.48 24.10 ± 0.72 
BXD51 16 74.00 ± 4.39 23.32 ± 0.89 
BXD60 13 68.38 ± 6.31 24.28 ± 1.63 
BXD61 9 57.67 ± 0.53 20.13 ± 0.64 
BXD62 14 62.14 ± 2.26 20.70 ± 0.71 
BXD64 12 96.67 ± 2.38 22.46 ± 0.77 
BXD66 7 90.57 ± 6.30 23.66 ± 1.19 
BXD69 14 73.93 ± 5.63 21.48 ± 0.70 
BXD70 17 82.00 ± 4.83 24.11 ± 0.81 
BXD73 14 86.14 ± 2.01 22.40 ± 1.24 
BXD74 14 77.00 ± 7.14 21.53 ± 0.97 
BXD75 22 74.36 ± 4.16 23.69 ± 0.74 
BXD85 16 78.69 ± 4.97 26.72 ± 1.42 
BXD87 8 89.00 ± 3.78 19.50 ± 0.74 
BXD89 23 87.22 ± 4.48 23.71 ± 0.56 
BXD90 17 83.71 ± 5.09 27.40 ± 0.81 
BXD92 14 81.86 ± 1.82 27.48 ± 1.66 
BXD97 12 98.33 ± 4.24 26.68 ± 1.09 
Total Cases  307 80.33 ± 1.123 23.66 ± 0.240 
 
 
 
Table 2-2. Analysis of Variance for Survival Index. 
 
Source df* Sums of 
Squares  
Mean 
Square 
F-ratio Probability 
Const 1 937.56 937.56 2911.80 ≤ 0.0001 
Wt 1 1.73 1.73 5.37 0.0212 
Sex 1 0.19 0.19 0.58 0.4452 
Age 1 3.97 3.97 12.32 0.0005 
Strain 21 42.21 2.01 6.24  ≤ 0.0001 
Error 282 90.80 0.32   
Total 306 152.44    
 
* df: Number of degrees of freedom. 
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Figure 2-3. Differential susceptibility of BXD strains to invasive GAS. 
A bar chart showing the mean values of corrected relative survival indices (cRSI) for 
different BXD strains, arranged in ascending order.  Parental strains (C57Bl/6J and 
DBA/2J) are shown on the two extremities of the X-axis.  Error bars represent the 
standard errors of the means.  The total number of animals (n) used per strain is indicated. 
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Figure 2-4. Variation in bacteremia and spleen dissemination in different BXD 
strains. 
 
   
 
Bar chart showing the mean values of corrected bacteremia indices, cBI, (A) and 
corrected loc CFU/spleen (B) for different BXD strains, arranged in ascending order.  
Parental strains (C57Bl/6J and DBA/2J) are shown on the two extremities of the X-axis. 
Error bars represent the standard errors of the means. 
  22
BXD66, and BXD75) had higher cBIs, and vice versa (e.g. BXD69 and BXD73). 
However, there were exceptions, e.g., BXD44 had a negative cRSI and a negative cBI as 
well, and BXD92 was one of the most resistant strains but showed intermediate, rather 
than low, bacteremia (Figure 2-4-A). Additionally, when examining the bacterial 
dissemination in spleens of different strains (Figure 2-4-B), most susceptible strains had 
high dissemination and vice versa, again with exceptions, e.g. BXD69. Conversely, the 
parental strains were this time clearly on two sides of the spectrum, with DBA/2J having 
the highest spleen dissemination and C57BL/6J having one of the lowest values. 
Collectively, the data suggest the existence of different mechanisms leading to mortality. 
Controlled Time-course Experiments Show the Kinetics of Bacterial Spread and 
Confirm Results of Population-based Experiments 
 Having generated data with large number of mice and with strong statistics, we 
moved to confirm the population-based study through time-course experiments that 
would clarify the kinetics of bacterial dissemination or clearance in the early hours of 
infection. In one representative experiment, we selected animals from six strains 
predicted to have the following descending order of susceptibility BXD61, BXD60, 
BXD51, BXD73, BXD89, BXD69 (Figure 2-3-A) and we infected them with the same 
dose of bacteria, then sacrificed three mice per strain at 18 h, 36 h, and 60 h. Overall, the 
results were as expected: All mice developed bacteremia, and their organs (spleen, lung, 
and liver) were positive for bacterial dissemination, but the kinetics of bacterial 
dissemination/ clearance were quite different. Strains BXD60 and BXD61, predicted as 
the most susceptible in this experiment, behaved as expected with highest bacterial loads 
in their spleens and highest rate of bacterial invasiveness, estimated from the slopes of 
bacterial dissemination in their organs over time (Figure 2-5 and Table 2-3). BXD69 was 
the most resistant strain to bacterial dissemination, with the lowest bacterial loads in 
organs and a tendency to clear bacteria rapidly (note the negative slopes in Figure 2-5-B 
and 2-5-C); this behavior matches its rank as having one of the lowest cRSI (Figure 2-3) 
and cBI (Figure 2-4-A). A similar pattern was displayed by BXD51, an intermediate 
strain that tends to have lower bacterial counts in blood and spleen (Figure 2-4). More 
interesting, however, was the behavior of BXD73 and BXD89 strains, both of which are 
resistant strains that showed delayed bacterial clearance in the first 60 h.  While BXD73 
had bacterial dissemination in organs an order of magnitude lower than BXD60 and 
BXD61, BXD89’s counts seemed to follow the pattern of a susceptible rather than a 
resistant strain. This underscores the dissociation between the speed of bacterial 
dissemination and animal mortality as separate traits. A possible explanation is that 
BXD89 has an attenuated immune system that may delay bacterial clearance but that 
does not harm the host. 
Preliminary Quantitative Trait Loci Mapping 
 To provide accurate QTL mapping, we are conducting a more extensive study 
with more strains and more mice per strain. However, with the current number of strains  
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Figure 2-5. Kinetics of bacterial dissemination in lung, liver, and spleen of six BXD 
strains. 
 
Scatter plots of the bacterial dissemination during the first 60 h of an active infection in 
spleens (A), livers (B), and lungs (C) of mice from 6 strains with different 
susceptibility to GAS sepsis.  Color regression lines indicate the rate and extent of 
change in log CFU bacteria/organ versus time for each strain. 
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Table 2-3. Extent of invasiveness in time-course experiments, as measured by 
bacterial loads in spleen, liver, and lung. 
 
 Mean ± SE Log CFU/Spleen  Regression 
Strain 18h 36h 60h r2 p 
BXD51 5.19 ± 0.12 5.44 ± 0.50 3.91 ± 2.39 6.80% 0.466 
BXD60 4.29 ± 0.35 7.22 ± 0.24 7.50 ± 1.26 47.90% 0.039 
BXD61 4.26 ± 0.37 4.57 ± 0.35 8.64 ± 0.32 81.40% 0.001 
BXD69 2.31 ± 1.19 4.10 ± 0.67 2.79 ± 1.41 0.60% 0.84 
BXD73 3.48 ± 0.48 3.74 ± 1.87 5.11 ± 0.32 14.60% 0.35 
BXD89 4.78 ± 0.31 6.16 ± 0.13 6.27 ± 0.96 29.50% 0.131 
 
 Mean ± SE Log CFU/Liver  Regression 
Strain 18h 36h 60h r2 p 
BXD51 5.71 ± 0.13 6.43 ± 0.54 4.06 ± 2.53 9.60% 0.385 
BXD60 4.45 ± 0.39 7.92 ± 0.26 8.03 ± 1.25 49.00% 0.036 
BXD61 5.64 ± 0.27 6.20 ± 0.74 8.39 ± 0.06 72.70% 0.004 
BXD69 4.22 ± 0.13 5.31 ± 0.58 3.31 ± 1.67 6.80% 0.499 
BXD73 2.24 ± 2.24 4.24 ± 2.12 5.49 ± 0.38 23.80% 0.22 
BXD89 5.21 ± 0.33 6.92 ± 0.16 7.74 ± 0.96 56.50% 0.02 
 
 Mean ± SE Log CFU/Lung    Regression 
Strain 18h 36h 60h r2 p 
BXD51 4.60 ± 0.33 5.43 ± 0.38 3.01 ± 3.01 7.00% 0.46 
BXD60 3.97 ± 0.28 6.55 ± 0.13 6.93 ± 1.09 52.20% 0.028 
BXD61 4.62 ± 0.33 2.68 ± 1.40 8.26 ± 0.29 39.00% 0.072 
BXD69 2.83 ± 1.42 4.13 ± 0.65 1.26 ± 1.26 12.70% 0.346 
BXD73 2.50 ± 2.50 2.74 ± 1.52 5.01 ± 0.90 19.10% 0.327 
BXD89 3.90 ± 0.28 5.77 ± 0.16 6.66 ± 1.50 42.00% 0.059 
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and mice we used the WebQTL tools on the GeneNetwork web site 
(http://www.genenetwork.org) and were able to exclude certain sites that could have 
possibly contributed to the modulation of GAS sepsis severity. For example, our human 
genetic association studies in patients with severe GAS sepsis revealed a strong 
association with HLA class II haplotypes (Kotb et al., 2002). It was therefore interesting 
to determine whether any QTLs map to the H2 locus. Although the parental strains 
differed in their H2 types (the C57/BL6 mice are H2-b while the DBA/2J mice are H2-d), 
we could not find any hint for significant QTLs in the H2 region on chromosome 17. 
Instead, our preliminary mapping results suggest two significant QTLs on chromosome 2 
that we are currently verifying and fine-tuning using additional mice and strains.  The 
insignificant contribution of the mice H2 locus was not entirely surprising because the 
HLA class II association in humans is related to the role of these molecules in presenting 
GAS superantigens to T-cells. While superantigens play a crucial role in the human 
disease and in HLA-transgenic mice (Nooh et al., 2007), they have little contribution in 
the BXD mouse model because GAS superantigens are poorly presented by mouse H2. 
Discussion 
The Strength of the BXD Recombinant Inbred Population Model 
 Clinical and epidemiological observations provide evidence of strong differences 
in human susceptibility to GAS infections and the severity and outcomes of diseases 
caused by the same strain of bacteria (Hoge et al., 1993; Davies et al., 1996; Kaul et al., 
1997; Johnson et al., 2002; Kotb, 2004).  For example, we have previously demonstrated 
a dominant effect of HLA class II allelic polymorphisms in severe GAS sepsis (Kotb et 
al., 2002; Kotb et al., 2003). We also provided biological confirmation of these 
associations with HLA both  in vitro (Kotb et al., 2002; Norrby-Teglund et al., 2002) and 
in vivo (Nooh et al., 2007).  Despite this strong association with HLA class II 
polymorphic alleles, we realize that sepsis is a complex disease affected by multiple 
interactive pathways. To identify additional pathways and polymorphisms contributing to 
the stark difference in the severity of GAS sepsis, we explored several animal models that 
may be suitable for this genetic study. While non-human primates represent an alternative 
to study human GAS infections (Virtaneva et al., 2003; Virtaneva et al., 2005), their use 
in immunogenetic population studies is expensive and impractical due to their slow 
breeding pattern and small progeny, high cost, and ethical issues.  Meanwhile, regular 
laboratory mice, which share ~85% gene content with humans (Jackson, 2001), are not 
sensitive to invasive GAS infections (Miethke et al., 1992; Welcher et al., 2002) just as 
certain human populations are not good models for certain human diseases because of 
their genetic resistance. This natural resistance of mice to severe GAS sepsis can be 
overcome by the use of high infectious doses, less resistant strains, or transgenic mice 
carrying human HLA class II (Nooh et al., 2007) or human plasminogen (Sun et al., 
2004; Cole et al., 2006). 
 
Despite this, successful attempts were made with standard inbred mouse lines, 
e.g., BALB/c, C3H/HeN, and CBA/J, C57BL/10 (Medina et al., 2001), and DBA/2 and 
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C57BL/6 (Kansal and Kotb, submitted); whereas these studies were quite informative, 
conventional mouse models are limited in their genetic pool, and thus one may miss 
important genotype-trait relations. Our choice was thus to use one of the genetically 
diversified mouse reference populations generated by the international Complex Trait 
Consortium (CTC).  The CTC strategy, known as the Collaborative Cross (CC), is to 
construct a very large set of RI strains from a genetically diverse set generated by 
intercrossing conventional inbred mice (Vogel, 2003; Churchill et al., 2004; Peirce et al., 
2004). 
 
 RI strains are an ideal resource for systems biology research as they provide a 
reproducible, highly varied, and diversified yet controlled set of genetic backgrounds for 
functional genomics, QTL mapping, and identification of interactive gene networks 
modulating disease phenotype (Valdar et al., 2006). Being inbred, RI strains are 
perpetually renewable, and have many advantages over F2 or backcross populations. 
Experiments performed with RI mice can be repeated in different laboratories and at 
different times with expected reproducibility. This adds high statistical power. Because 
the ancestral parents are fully sequenced, the genotyped RI strains afford a powerful tool 
for identifying genes within QTLs and are particularly useful for mapping multiple and 
epistatic genetic effects underlying complex phenotypes, including those seen in 
infectious diseases (Caron et al., 2002; Churchill et al., 2004; Peirce et al., 2004; Ouburg 
et al., 2005; Roy et al., 2006). 
 
 Among the different RI sets of mice, we found the BXD panel more suitable for 
us than other series (e.g., the AXB set) as the BXD series is much larger, almost 3-times 
more than used in any other series of experiments and because both parental strains 
(C57BL/6J and DBA/2J) have been fully sequenced (Waterston et al., 2002), and have 
been shown to differ in their response to many pathogens (Hormaeche, 1979b, a; Mitsos 
et al., 2000; Boyartchuk et al., 2001; Boyartchuk and Dietrich, 2002; Mitsos et al., 2003), 
including GAS (Kansal and Kotb, personal communication). 
The Complexity of the Phenotype 
 Susceptibility to a particular bacterial infection and disease severity are complex 
phenotypes likely to be contributed by more than one genetic factor, and by networks and 
pathways modulated by gene products. Our attempt to attribute one or two sets of genetic 
loci that predispose mice to or protect them from certain infections could be misleading if 
we fail to take the complexity of the phenotype into consideration. In this study, we 
explored the response of a panel of 20 BXD RI mice (plus the two parental strains) to 
infection with the same dose of GAS and monitored them over a week post-infection. To 
quantify the animals’ susceptibility to GAS and the severity of sepsis, we measured three 
variables: animal survival, bacteremia, and dissemination in systemic organs (spleen, 
liver, and lung). Our results provide solid evidence of the complexity of our phenotype.  
One manifestation of this complexity is that BXD strains exhibited a much wider range of 
variability in survival (Figure 2-3) and bacteremia (Figure 2-4-A) than the parental 
strains; yet, the two ancestral strains were on the two extreme sides of the panel of 
bacterial dissemination in spleen (Figure 2-4-B). This behavior is likely a result of the 
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random assortment of many polymorphic loci that accentuate resistance or susceptibility 
to infection depending on the pattern by which they are inherited from the parental strains 
to the offspring. Another consequence of the trait complexity is that the different strains 
did not show identical patterns for the different measured variables (Figures 2-3 and 2-4). 
There was a significant correlation between survival and bacteremia (Figure 2-1-C), but it 
only explained 25% of the variance. Differences in the kinetics of bacterial dissemination 
to organs of BXD strains in the first 60 h of disease (Figure 2-5 and Table 2-3) highlights 
the uniqueness of each strain, and shows the importance of following the course of 
infection at multiple time points. 
 
 Our analysis indicates that bacteremia and dissemination to organs were major 
predictors of disease severity and mortality; however, it is likely that other factors 
contribute to mortality including severe toxicity and inflammatory responses in blood and 
organs. 
The Power of Statistical Analysis 
 A major part of our study was dedicated to the optimization and standardization 
of this novel mouse model. We conducted preliminary experiments to optimize the 
inoculum size and volume, the number of mice to be used per strain, and the best 
randomization scheme for injecting mice and recording the data. Subsequently we 
generated a large data set from 445 mice, and we used this data set to estimate the effect 
of independent confounding factors like sex, age, body weight, and inoculum size (Figure 
2-2) as well as the combined effects of these covariates (Table 2-2). As a result of these 
analyses, we filtered our data set, bringing the number of analyzed cases to 307, after 
excluding animals from strains that were tested only once, and those that did not fall in 
the age range where age and weight were colinear. The analysis of covariates also helped 
us to estimate the contribution of each factor in predicting susceptibility to the severe 
form of GAS sepsis therein allowing us to correct the measurable traits (SI, BI, and Log 
CFU/spleen) for significant covariates. Correction for age, for example, was a vital 
alternative to age-matching all animals, which is not feasible because the breeding 
scheme of 20 strains cannot be synchronized practically. The ability to use a large 
number of strains and to repeat experiments using the same strains added power to the 
statistical analysis. Combining the genetic diversity of the RI strains with statistical 
analysis allowed the dissection of many factors contributing to infection phenotype using 
relatively small numbers of animals and a large number of strains. 
The Preliminary Quantitative Trait Loci Mapping Results 
 It is rather risky to attempt to identify QTLs using only 20 BXD strains, and this 
was not the intention of this study, which focused on developing the model and 
identifying significant covariates affecting the severity of GAS sepsis. Nonetheless, we 
were able to exclude plausible regions as major contributors to GAS sepsis severity. For 
example, we can comfortably exclude any contribution from the H2 region on 
chromosome 17. Although our previous studies showed strong association with HLA 
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class II genes (Kotb et al., 2002; Nooh et al., 2007), it was not surprising that the mouse 
H2 allelic variation does not contribute to GAS sepsis severity because the mouse H2 
molecules are very poor presenters of GAS superantigens that are pivotal in mediating 
the pathogenesis of the human disease. The BXD model allows us now to map QTLs and 
identify additional bacterial virulence strategies involved in the pathogenesis of sepsis. 
The latter are usually masked by the overwhelming effects of superantigens in human 
studies and the HLA-transgenic mouse model (Kotb et al., 2002; Nooh et al., 2007). 
Preliminary mapping studies pointed to two regions on mouse chromosome 2, which 
harbor many genes of relevance to immune modulation. Ongoing studies using additional 
strains are expected to confirm and narrow down these QTLs. 
Conclusion 
 The BXD RI strains afforded a good model for the analysis of traits that 
contribute to severe GAS sepsis. The genetic diversity of these strains exaggerates or 
suppresses traits seen in the parental strains. Having standardized the model and set major 
criteria for selecting the animals to be used and analyzed, we will continue generating 
data by using more BXD strains and bioinformatics tools to map QTLs and determine the 
genetic basis for the large differences in disease susceptibility among these animals. 
Mapping QTLs is likely to identify gene variants (polymorphisms, SNPs, or mutations) 
that underlie the remarkable individual differences that are a hallmark of host-GAS 
interactions; however, our long-term goal is to generate a disease roadmap by revealing 
the networks involved in these inter-strain differences. 
Materials and Methods 
Mice 
 The BXD strains are completely inbred strains generated by repeated mating 
between siblings starting from F2 intercross progeny between C57BL/6J and DBA/2J 
(Taylor, 1978; Taylor et al., 1999; Williams et al., 2001; Peirce et al., 2004). In this 
study, we used 717 mice belonging to a set of 33 BXD strains along with the parental 
strains, C57BL/6J (B6) and DBA/2J (D2).  Among these mice, 218 were used in the 
preliminary experiments for optimization of inoculum size and experimental conditions, 
445 were used in the population-based experiments, and 54 were used in the controlled 
time-course experiments. The animals chosen for final statistical analysis of the 
population-based experiments (n = 307) were those that satisfied all the conditions 
determined in the study (see Results) and that belonged to a BXD strain that was used in 
at least two experiments. 
 
 The animals were mated and housed in a pathogen-free colony on hardwood chip 
bedding in microisolator cages at the VA Medical Center and the University of 
Tennessee Health Science Center, Memphis, TN. They were maintained on a 12 h light-
dark cycle, in a room kept at 23 °C with 50–60% relative humidity and were given tap 
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water and sterile irradiated rodent chow (Harlan Teklad, Madison, WI) ad libitum. All 
protocols were approved by the Institutional Animal Care and use Committees of 
Veterans Affairs Medical Center and The University of Tennessee.  
Bacteria and Culture Media 
 We used the clinical isolate, GAS-5448 (Kansal et al., 2000), representative of the 
clonal M1T1 strain that has globally disseminated since the mid 1980s and was 
associated with severe and non-severe GAS infections (Chatellier et al., 2000; Aziz et al., 
2005). The bacteria were incubated in Todd Hewitt Broth (DIFCO, Detroit, MI) supplied 
with 1.5% of yeast extract (DIFCO, Detroit, MI), or THY, for 17 h, washed twice with 
sterile phosphate-buffered saline solution, PBS (GIBCO, Carlsband, CA), then diluted to 
the final inoculum size with sterile PBS. The original isolate had been aliquoted in THY 
stocks containing 15% glycerol (Sigma, Saint Louis, MO) at –80˚C.  Before each use, the 
bacteria were spread on blood agar plates (Becton Dickenson, Franklin Lakes, NJ) for 
colony isolation and sterility checking. 
Experimental Design and Infection Scheme 
 Before the start of each experiment, we randomized animals to avoid bias in the 
order of injection, weighing, or sampling. We kept males and females in different cages. 
Animals were infected via the tail vein injection with a 2 ± 1 x107 CFU/mouse (unless 
otherwise stated).  Twenty-four hours post-infection, blood was sampled for bacteremia: 
20 ml was drawn from the tail vein and diluted 10-fold in sterile saline (SS).  During the 
observation period (7 days), animals were weighed twice a day (8:00 a.m., 4:00 p.m.) and 
checked for survival three times a day (8:00 a.m., 4:00 p.m., and at midnight). We 
dissected spleens, livers, and lungs from mice that were sacrificed at specified time 
points, as well as animals that expired prior to sacrifice, and we homogenized these 
tissues using a rotor stator homogenizer (Omni International, Marietta, GA) in SS, and a 
sample was used to estimate bacterial loads. 
Design of Controlled Time-course Experiments 
 Time-course experiments were designed to investigate the kinetics of bacterial 
dissemination in the early stages of the infection. These experiments were performed 
following the same procedure as the population-based experiments (see experimental 
design and infection scheme), except that equal numbers of animals belonging to each 
strain (typically 3 animals per strain per time point) were sampled for blood, spleen, liver, 
and lung at 18 h, 36 h, and 60 h post-infection. Regardless of the specified sampling time, 
all animals were bled through the tail vein (20-50µl) for determination of bacteremia at 
18 h.  At each time point, the animals were dissected, and their organs (spleens, livers, 
and lungs) were homogenized in 10 ml SS each. 
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Bacterial Loads in Blood and Organs 
 To determine bacterial loads in blood and organ homogenates, we diluted 10 ml 
of either sample (tail vein blood or homogenate) serially (up to 10-7) and plated 10 ml of 
each dilution (as well as the original sample) on the surface of blood agar plates (Becton 
Dickenson, Franklin Lakes, NJ). After 24 h incubation, all plates were counted, and the 
number of colony forming units (CFU) per ml or per organ was calculated (CFU/organ = 
CFU/ml homogenate x 10). 
Data Handling and Statistical Analysis 
 Results were recorded three times daily (or whenever an animal died).  Data were 
reviewed for accuracy and consistency at the end of every experiment by a different set 
of investigators.  We dedicated a considerable amount of time to data recording, error 
checking, and filtration after each experiment. Mice lost due to factors unrelated to 
infection were flagged in the database and excluded from the final analysis.  We 
performed all primary calculations and sorting operations using simple features and 
functions of Microsoft Excel.  Excel files were later exported to Data Desk (version 6.2) 
software (Data Description, Inc., Ithaca, NY; www.datadesk.com), which we used for all 
statistical analyses and tests, including clustering, correlation analysis, linear regression, 
multiple regression, and general linear model (GLM) analysis by ordinary least squares 
analysis of variance (OLS ANOVA). 
Preliminary Quantitative Trait Loci Mapping 
 For QTL mapping, we used the web-based complex trait analysis platform, 
WebQTL (Wang et al., 2003) available on the GeneNetwork web site 
(http://www.genenetwork.org). WebQTL evaluates potential QTL at regular intervals and 
estimates the significance at each location with a graphical representation of the 
likelihood ratio statistics (LRS). 
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CHAPTER 3. AN UNBIASED SYSTEMS GENETICS APPROACH TO MAPPING 
GENETIC LOCI MODULATING SUSCEPTIBILITY TO SEVERE 
STREPTOCOCCAL SEPSIS 
Summary  
 Striking individual differences in severity of group A streptococcal (GAS) sepsis 
have been noted, even among patients infected with the same bacterial strain. We had 
provided evidence that HLA class II allelic variation contributes significantly to 
differences in systemic disease severity by modulating host responses to streptococcal 
superantigens. Inasmuch as the bacteria produce additional virulence factors that 
participate in the pathogenesis of this complex disease, we sought to identify additional 
gene networks modulating GAS sepsis. Accordingly, we applied a systems genetics 
approach using a panel of advanced recombinant inbred mice. By analyzing disease 
phenotypes in the context of mice genotypes we identified a highly significant 
quantitative trait locus (QTL) on Chromosome 2 between 22–34 Mb that strongly 
predicts disease severity, accounting for 25–30% of variance. This QTL harbors several 
polymorphic genes known to regulate immune responses to bacterial infections. We 
evaluated candidate genes within this QTL using multiple parameters that included 
linkage, gene ontology, variation in gene expression, co-citation networks, and biological 
relevance, and identified interleukin1 alpha and prostaglandin E synthases pathways as 
key networks involved in modulating GAS sepsis severity. The association of GAS sepsis 
with multiple pathways underscores the complexity of traits modulating GAS sepsis and 
provides a powerful approach for analyzing interactive traits affecting outcomes of other 
infectious diseases.  
Introduction  
Infectious diseases, like most human diseases, are modulated by complex traits. 
Susceptibility and clinical outcomes of infections are often a manifestation of interactions 
between the host’s complex traits and the pathogen’s virulence components. 
Identification of genes and molecular networks that influence host responses to infectious 
agents can provide a disease road map that would focus the discovery of effective 
diagnostics and therapeutics.  
  
Group A streptococci (GAS) are classified on the basis of surface M protein 
antigens into more than 100 serotypes, but recent studies showed a high degree of 
diversification within a serotype that is driven primarily by horizontal gene transfer (Aziz 
et al., 2005; Sumby et al., 2005; Walker et al., 2007). It is widely believed that such 
events are responsible for the emergence of highly virulent strains in the 1980s, including 
a hypervirulent M1T1 clonal strain, coinciding with the resurgence of severe invasive 
                                                 
  Source: Reprinted with permission. Abdeltawab, N.F., Aziz, R.K., Kansal, R., Rowe, S.L., Su, 
Y., Gardner, L., Brannen, C., et al. (2008) An unbiased systems genetics approach to mapping 
genetic loci modulating susceptibility to severe streptococcal sepsis. PLoS Pathog 4: e1000042. 
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GAS infections associated with streptococcal toxic shock syndrome (STSS) and 
necrotizing fasciitis (NF), also known as the “flesh eating” disease (Low et al., 1997). We 
showed that this hypervirulent M1T1 clinical strain can cause sore throat or mild 
bacteremia and erysipelas in some patients, while in others it can cause STSS and NF 
(Chatellier et al., 2000). These findings suggested a strong role for host factors in 
modulating the outcome of infection by this highly virulent strain. Indeed, we found that 
allelic variations in host HLA class II haplotypes are associated with markedly different 
outcomes of GAS sepsis in humans (Kotb et al., 2002; Kotb et al., 2003). We confirmed 
these associations using HLA transgenic mice that were expressing different HLA class II 
alleles (Nooh et al., 2007). Inasmuch as STSS pathogenesis is largely mediated by 
streptococcal superantigens (Strep SAgs), and because HLA class II molecules serve as 
SAg receptors, such an association was expected. However, GAS is rich in many other 
virulence factors, and we believe that some of those virulence factors, beside SAgs, may 
also interact with additional host factors to modulate host responses to GAS infections.  
 
To identify additional host factors involved in GAS severity we needed an 
approach that allowed us to uncover the effect of interactions between complex, 
polymorphic genetic traits that may modulate sepsis outcomes. Previous animal models 
for GAS sepsis included various regular conventional inbred mouse strains (Medina et 
al., 2001; Goldmann et al., 2004b), congenic strains (Goldmann et al., 2005a), and HLA 
transgenic mice (Welcher et al., 2002; Nooh et al., 2007). These models confirmed that 
host genetic variability can have a strong effect on infection outcome. Despite their 
significant utility, these mouse models do not offer the genetic diversity that is 
characteristic of the human population.  
 
In this study, we used a panel of advanced recombinant inbred (ARI) mice as a 
genetically diverse, segregating reference population that affords a powerful tool for 
systems genetics approaches. Recombinant inbred (RI) strains have been successfully 
used to map quantitative trait loci (QTLs) associated with various phenotypes and 
diseases (Hardy et al., 2001; Rosen and Williams, 2001; Grizzle et al., 2002; Peirce et al., 
2003; Chesler et al., 2005; Mountz et al., 2005; Aziz et al., 2007; Miyairi et al., 2007). 
We used the BXD panel of ARI mice derived from C57BL/6J (B6) and DBA/2J (D2) 
strains and consisting of homozygous, inbred BXD lines, each of which is genetically 
distinct. Using this genetically diverse BXD panel, we mapped QTLs modulating GAS 
sepsis severity, and identified candidate genes within these QTLs that were parsed into 
pathways likely to modulate the severity of this complex infectious disease.  
Results 
Variable Susceptibility to Severe GAS Sepsis in Genetically Distinct Mice 
Our initial studies (Aziz et al., 2007) demonstrated that there is considerable 
variability among BXD strains with respect to susceptibility to severe GAS sepsis. To 
quantify differences among strains in this study, we used three main quantitative traits, 
namely animal survival, bacteremia, and bacterial dissemination to spleen. 
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We infected mice (n = 5–26 mice per strain), belonging to 32 strains (30 different 
BXD strains and their parental strains, B6 and D2), intravenously (i.v.) with the same 
bacterial dose (2  1.5 x 107 CFU/mouse). Survival was expressed as normalized 
corrected relative survival indices (cRSI) calculated for each of the 32 strains as detailed 
in materials and methods. We observed significant difference in relative susceptibility to 
GAS sepsis across the BXD panel (P ≤ 0.0001), Figure 3-1-A. This wide range of 
susceptibility across the various strains, together with the finding that some of the strains 
showed phenotypes considerably more exaggerated than the parental strains (B6 and D2), 
is an illustration of how different combination of polymorphic genes can manifest quite 
differently according to the overall genetic context. 
 
 Similarly, we determined bacterial load in blood (log CFU/ml blood), 24 h post-
infection and found considerable variation across the strains. In general there was an 
inverse correlation between mice survival and extent of bacteremia (r = – 0.471, P ≤ 
0.0001, R2 = 22.2%), Figure 3-1-B. Bacterial dissemination to spleen also varied across 
the strains, showing a stronger inverse correlation with mice survival (r = – 0.717, P ≤ 
0.0001, R2 = 51.4%), Figure 3-1-C.  
 
Although these inverse correlations between mice survival and bacterial load in 
blood and spleen made biological sense because it is anticipated that susceptible strains 
would have higher bacterial load than in resistant strains, there were several exceptions.  
For example, although strains BXD44 and BXD45 are ranked susceptible based on their 
survival, they showed low bacterial load in blood and spleen. Similarly, BXD43 and 
BXD85 strains, which are ranked resistant, had a high bacterial load in their spleen. 
Another interesting observation was that, in general, susceptible strains survival was 
better correlated with bacterial load in blood and spleen than resistant strains. Together, 
these findings confirm that there is more than one mechanism modulating differential 
susceptibility or resistance to severe GAS sepsis (Aziz et al., 2007). 
Genome-wide Scans for Mapping GAS Susceptibility Quantitative Trait Loci  
We used bioinformatics tools available through Gene Network (GN) to link 
measured phenotypes to strains genotypes. Each of the quantified phenotypes was 
analyzed in the context of the studied mice genotypes and single nucleotide 
polymorphism (SNPs) using 3795 SNPs and microsatellite markers for BXD strains.  
Significant QTLs modulating survival, bacteremia 24 h post-infection and bacterial 
dissemination to spleen mapped to mouse Chromosome (Chr) 2. 
 
The strongest QTL modulating mouse survival (cRSI) mapped to mouse Chr 2 
between 22–34 Mb, with an likelihood ratio statistic (LRS) of 34.2 (P ≤ 0.0000001), 
Figure 3-2-A. A second less significant QTL was also mapped on the same chromosome 
between 125–150 Mb with an LRS of 12 (P ≤ 0.001), and a third QTL on Chr X, Figure 
3-2-A. The QTLs for bacteremia and bacterial dissemination to spleen overlapped with  
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Figure 3-1. Differential susceptibility to GAS sepsis among different BXD strains 
and their parental strains. 
 
(A) Rank-ordered bar chart of survival expressed as mean values of coefficient of mean 
corrected relative survival indices (cRSI) across 30 different BXD strains and their 
parental strains (DBA/2J and C57Bl/6J). N = 489 belonging to 32 strains; number of 
mice used per strain is indicated.(B) Bar chart of GAS bacteremia expressed as 
coefficient of mean values of corrected log blood CFUs 24 h post injection (corrected log 
CFU/ml blood). (C) Bar chart of GAS dissemination to spleen expressed as coefficient of 
corrected bacterial load in spleen (log CFU/spleen). B and C Strains are ordered by their 
corrected relative survival indices with the parental strains at the two extremes of the X-
axis. Error bars represent the standard errors of the means. Statistical test is two-way 
ANOVA (with correction to covariates) P ≤ 0.0001.
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Figure 3-1. (Continued). 
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Figure 3-2. Genome-wide scan for mice susceptibility to GAS sepsis showing 
mapped QTL on Chr 2. 
 
Interval mapping of survival (expressed as corrected relative survival index, cRSI), 
showing a significant QTL (based on 1000 permutation tests) on Chr 2 between 22–34 
Mb with LRS of 34.2 (P ≤ 0.0000001), and a suggestive QTL between 125–150 Mb with 
LRS of 12 (P ≤ 0.001). (B) Whole genome interval mapping of GAS bacteremia using 
bacterial load 24 h post injection expressed as corrected log CFU/ml blood, showing two 
QTLs on Chr 2: first QTL between 22–34 Mb with LRS of 24.5 (P ≤ 0.00001) and a 
second with LRS of 17 (P ≤ 0.0001) between 125–150 Mb. (C) Whole genome mapping 
of GAS sepsis using tissue dissemination of GAS expressed as corrected log CFU/spleen 
with QTL between 125–150 Mb with LRS of 15 (P ≤ 0.0001). Red line indicates 
significant LRS, while grey line indicates suggestive LRS. Upper x-axis shows mouse 
chromosomes, and lower x-axis shows physical map in mega bases, y-axis represents 
linkage in LRS score.
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those for survival, with slight difference in significance. The first QTL modulating 
bacteremia mapped to Chr 2 between 22–34 Mb with an LRS of 24.5 (P ≤ 0.00001), 
Figure 3-2-B. The second QTL mapped to the same chromosome between 125–150 Mb 
with an LRS of 17 (P ≤ 0.0001), Figure 3-2-B. A QTL modulating bacterial 
dissemination to spleen also mapped to Chr 2 between 125–150 Mb with LRS of 15 (P ≤ 
0.001), Figure 3-2-C.  
 
To further investigate and narrow down the mapped region on Chr 2, we resorted 
to haplotype maps of BXD strains to select additional strains that may be informative in 
validating, and further confirming mapped QTLs. 
In silico Prediction of BXD Susceptibility to Severe GAS Sepsis 
Our mapped QTLs directed us to select more strains for survival experiments 
based on differences in their haplotypes within the QTLs.  For example, we selected 
BXD100 with a D haplotype at Chr 2 between 22–34 Mb region, Figure 3-3-A, and 
found it to be susceptible. Similarly, we tested BXD87 with a B haplotype in the same 
region and this strain as predicted, exhibited a resistant phenotype. To further narrow 
down the mapped QTLs, we chose strains with breakage in the mapped interval, i.e. with 
recombination at Chr 2 region 22–34 Mb for further survival testing (Figure 3-3-A). 
BXD34 with a B haplotype at Chr 2 between 24–33.15 Mb region was resistant, while 
BXD60 with a B haplotype at Chr 2 between 20–23.27 Mb region was susceptible, Figure 
3-1-A and 3-3-A. This narrowed down the relevant susceptibility region to Chr 2 between 
23.27–33.15 Mb. Using more strains with recombination at this narrowed region, we 
found BXD51, 64, and 79 to be quite interesting as they showed intermediate resistance 
suggesting that genes at this region are candidate modulators of the mapped QTL, Figure 
3-3-B. Another interesting strain was BXD94 that we found susceptible to infection, yet 
has a heterozygous genotyping, suggesting that D allele exhibited dominance, Figure  
3-3-B.  
 
Similarly, we inspected haplotypes of studied BXD strains at the second QTL 
between 125 –150Mb (Figure 3-3-C), the majority of susceptible strains had D alleles, 
while resistant strains had B alleles with some exceptions, for example BXD77 is a 
susceptible strain, yet had B alleles. It was interesting to find that the susceptible strain 
BXD44 had B alleles at this QTL (Figure 3-3-C), suggesting that observed lower 
bacterial load in blood compared to other susceptible strains (Figure 3-1-B) might be 
modulated by B allele in the second QTL. Meanwhile, BXD48, a resistant strain, has a 
breakage at 135.9 Mb (Figure 3-3-C) with D alleles suggesting that its relatively higher 
bacterial load in blood (Figure 3-1-B) might be modulated by the second QTL. 
Collectively, these findings suggest that both loci modulate different observed 
phenotypes of GAS sepsis severity. 
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Figure 3-3. Recombinant inbred BXD strain distribution patterns at region of 
interest on Chr 2. 
 
(A) Haplotype maps of the first QTL on Chr 2 between 20–34 Mb showing available 
BXD strains. Haplotype maps were used for in silico selection of strains for survival 
studies based on the strain distribution patterns, where B allele (blue bars) inherited from 
the resistant parent C57Bl/6J and D alleles form the susceptible parent DBA/2J, beige 
bars indicate strains that are heterozygous at this region, resembling an F1. Arrows 
indicate BXD strains 34, 51, 60, 64, 79, 94, and 100. Recombinant inbred BXD strain 
distribution patterns at region of interest on Chr 2. (B) Haplotype maps of the first QTL 
region on Chr 2 between 20—34 Mb across BXD strains used in the population-based 
survival experiments showing the pattern of alleles inherited from each parent at region 
of interest on Chr 2. The different BXD strains are rank-ordered according to their 
susceptibility to GAS sepsis from susceptible to more resistant. Resistant strains show a 
pattern of accumulation of alleles inherited from resistant parent (B) C57Bl/6J (blue bars) 
while the susceptible strains show a pattern of alleles from susceptible parent (D) 
DBA/2J (red bars), with the exception of BXD94 strain, heterozygous (beige bars) at the 
QTL region. (C) Haplotype maps of the second QTL region on Chr 2 between 125—150 
Mb across BXD strains used in the population-based survival experiments showing the 
pattern of alleles inherited from each parent at region of interest on Chr 2. The different 
BXD strains are rank-ordered according to their susceptibility to GAS sepsis from 
susceptible to more resistant. BXD genotype data set can be downloaded from 
www.genenetwork.org/genotypes/BXD.geno. 
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Figure 3-3. (Continued). 
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Mining for Candidate Genes and Pathways in Mapped Loci 
Based on our in silico strain selection and QTL validation by experimental 
assessment, we evaluated candidate genes within the mapped QTLs, taking into 
accountlinkage, gene ontology analyses, co-citation networks, and biological relevance. 
To categorize genes and transcripts in the mapped QTLs into functional pathways, we 
performed functional analyses using Ingenuity Pathways Analysis (IPA) 
(www.ingenuity.com). We parsed our genes into 50 functional networks; the most 
relevant networks involved those associated with immune response, cell signaling, 
cellular assembly and organization, and lipid metabolism. From these interrelated 
pathways, we selected 37 representative genes to study their role in GAS susceptibility 
QTL by quantitative analysis of their expression levels in selected resistant and 
susceptible strains (groups) pre- and post-infection (Appendix A. Table A-1).  
 
We found that 28 out of a representative 37 genes were differentially expressed 
post- infection (Appendix A. Table A-2), of those 14 genes were down regulated in the 
resistant group while up regulated in the susceptible group post-infection. Nine genes 
were down regulated in both groups post-infection, and five were up regulated in both 
groups post-infection (Appendix A. Table A-2). Fourteen of the 28 differentially 
expressed genes showed significant change post-infection in both resistant and 
susceptible strains (Table 3-1 and Figure 3-4). In general, susceptible strains showed an 
increase in the relative expression levels post-infection (19 genes) of both pro and anti-
inflammatory genes, e.g. interleukin1 alpha (Il1), and Il1 receptor antagonist (Il1rn) 
respectively. By contrast, in the resistant BXD strains, most of the tested genes showed a 
decrease (23 genes) in expression levels post-infection with few exceptions (five genes) 
e.g. TNF receptor associated factor 1 (Traf1) (Figure 3-4 and Appendix A. Table A-2). 
Differentially expressed genes were associated with both innate and early adaptive 
immune response. Among those associated with early immune response, Il1a, Il1rn, 
prostaglandin E synthase (Ptges), and Ptges2 were up regulated in susceptible strains, 
whereas their levels decreased in resistant strains. Several of the differentially expressed 
genes show polymorphisms as SNPs between the parental strains B6 and D2, suggesting 
that these polymorphic genes modulate differential response to infection (Appendix C). 
The differential expression of IL1 was confirmed at the protein level (data not shown).  
 
We parsed the differentially expressed genes into pathways, using IPA, IL1 and 
prostaglandins were key early response molecules modulating susceptibility to severe 
GAS sepsis in two of the mapped networks, which are shown merged in Figure 3-5. The 
first network (P <10–27) comprised of genes related to lipid metabolism and innate 
immunity, e.g. Il1a, Il1rn, Ptges, while the second network (P < 0.01) contained genes 
modulating nucleic acid metabolism, energy production and host responses to injury e.g. 
Ectonucleoside triphosphate diphosphohydrolase 2 (Entpd2) (Figure 3-5).  
Discussion  
It has been established that networks of multiple pathways, rather than a single 
gene, modulate traits and affect susceptibility and outcomes of virtually all diseases. The 
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Table 3-1. The relative expression levels of candidate genes post infection in resistant and susceptible strains expressed as ratio 
of post/pre infection in susceptible and resistant strains. 
Gene ID Gene Resistant 
Strains 
P-value a Susceptible  
Strains 
P-value
Genes down regulated in resistant group while up regulated  
in susceptible group 
Anapc2 Anaphase promoting complex subunit 2 0.551 0.022 * 1.475 0.509 
Il1 Interleukin 1 a 0.739 0.010 * 44.525 0.062 † 
Il1rn Interleukin 1receptor antagonist 0.851 0.680 54.687 0.221 
Ptges Prostaglandin E synthase 0.417 0.001 * 6.363 0.028 * 
Ptges2 Prostaglandin E synthase 2 0.913 0.774 1.456 0.005 * 
Sh2d3c SH2 domain containing 3C 0.162 0.055 † 1.009 0.980 
Genes down regulated in both resistant group and  
susceptible groups 
Entpd2 Ectonucleoside triphosphate diphosphohydrolase 2 0.359 0.010 * 0.654 0.064 † 
Edf1 Endothelial differentiation-related factor 1 0.349 0.095 † 0.470 0.014 * 
Garnl3 GTPase activating RANGAP domain-like 3 0.601 0.142 0.674 0.070 † 
Nfatc2 Nuclear factor of activated t-cells, cytoplasmic, 
calcineurin-dependent 2 
0.178 0.095 † 0.693 0.208 
Phpt1 Phosphohistidine phosphatase 1 0.229 0.077 † 0.714 0.233 
Psmd5 Proteasome (prosome, macropain) 26S subunit, 
non-ATPase 5 
0.644 0.006 * 0.963 0.652 
Ppp2r4 Protein phosphatase 2A regulatory subunit B 0.902 0.256 0.734 0.091 † 
Genes up regulated in both resistant group and 
susceptible group 
Traf1 TNF receptor associated factor 1 1.826 
 
0.300 5.995 0.066 † 
a Significance based on t-test, * P < 0.05, † P = 0.06–0.08 
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Figure 3-4. Patterns of differential gene expression levels of candidate genes post 
infection in susceptible and resistant strains. 
Quantitative PCR results showing levels of gene expression of 14 genes with 
significant (P = 0.05–0.08) change post-infection in susceptible and resistant strains, 
expressed as Log10 fold differences in gene expression level post-infection. Genes are 
grouped to three groups, a) genes up regulated in susceptible strains post-infection and 
decreased in resistant strains post-infection, b) genes down regulated in both 
susceptible and resistant strains post-infection, and c) genes up regulated in both 
susceptible and resistant strains post-infection. Susceptible strains are represented as 
solid black bars, we used two highly susceptible strains BXD61 and BXD90, and 
resistant strains as dashed bars, we used two highly resistant strains BXD 73 and 
BXD87. The bars represent 2–4 biological replicates run in three technical replicates 
each and significance is based on t-test. Anapc2, anaphase promoting complex subunit 
2; Entpd2, ectonucleoside triphosphate diphosphohydrolase 2; Edf1, endothelial 
differentiation-related factor 1; Garnl3, GTPase activating RANGAP domain-like 3; 
Il1a, interleukin 1 alpha; Il1rn, interleukin 1 receptor antagonist; Nfatc2, nuclear factor 
of activated t-cells, cytoplasmic, calcineurin-dependent 2; Phpt1, phosphohistidine 
phosphatase 1; Ptges, prostaglandin E synthase; Ptges2, prostaglandin E synthase 2; 
Psmd5, proteasome (prosome, macropain) 26S subunit, non-ATPase 5; Ppp2r4, 
Protein phosphatase 2A regulatory subunit B; Sh2d3c, SH2 domain containing 3C; 
Traf1, TNF alpha receptor associated factor.
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Figure 3-5. Functional network of genes modulating GAS QTL. 
 
 
Graphical representation of the molecular relationships between differentially expressed 
genes, showing the central role of IL1, IL1rn, PTGES, and PTGES2 in modulating 
response to GAS sepsis and their indirect interactions with IFN and IL2 networks in 
modulating bacterial sepsis. Genes are represented as nodes, and the biological 
relationship between two nodes is represented as line, solid lines represent direct 
interactions, dashed lines represent indirect interactions. Oval shapes represent 
chemical or drug, squares represent cytokines, diamond shapes represent enzymes, 
concentric circles represent group of family, and triangles represent phosphatases. Blue 
lines and arrows represent expression levels of resistant strains, while red lines and 
arrows represent susceptible strains expression levels. Apyrase, ATP 
diphosphohydorlase; ANAPC2, anaphase promoting complex subunit 2; CDC20 cell 
division cycle homolog 20; CXCL14, chemokine (c-x-c motif) ligand 14; ENTPD2, 
ectonucleoside triphosphate diphosphohydrolase 2; EDF1, endothelial differentiation-
related factor 1; JUN jun oncogene; IL1A, interleukin 1 alpha; IL1RN, interleukin 
1receptor antagonist; IFNG interferon gamma; IL2 interleukin2; PDCD1LG2, 
programmed cell death ligand 2; PTGES, prostaglandin E synthase; PTGES2, 
prostaglandin E synthase 2; PSMC3 proteasome (prosome, macropain) 26S subunit 
ATPase 3; PSMD5, proteasome (prosome, macropain) 26S subunit, non-ATPase 5; 
PPP2R4, protein phosphatase 2A regulatory subunit B; RBM39, RNA binding protein 
39; SH2D3C, SH2 domain containing 3C; SLC6A6, solute carrier family 6;  TP53 
tumor protein p53; TP53RK, TP53 regulating kinase; VTCN1, V-set domain containing 
T cell activation inhibitor 1. 
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ARI strains used in this study afford one of the best unbiased forward genetics 
approaches to determine how different combinations of polymorphic genes interact to 
shape disease phenotypes. Using ARI-BXD panel as a genetically diverse reference 
population, we were able to map QTLs modulating specific phenotypes associated with 
severe GAS sepsis.  
 
GAS causes a wide range of diseases depending on multiple factors including site 
and route of infection, interplay of the pathogen virulence factors with host immune 
defenses that are affected by the host immune status and difference in the genetic makeup 
of the host (Kotb et al., 2002). Thus, these bacteria represent a good model to explore the 
impact of host complex traits on susceptibility to infections. Previous studies have shown 
that host-pathogen interactions modulate the severity of GAS sepsis (Chatellier et al., 
2000; Medina et al., 2001; Kotb et al., 2002; Goldmann et al., 2004b), and we found that 
patients with GAS sepsis expressing HLA class II DRB1*15/DQB1*06 (DR15/DQ6) 
haplotype are protected from severe GAS sepsis, whereas those with HLA class II 
DRB1*14/DQB1*05 (DR14/DQ5) haplotype are at high risk for developing severe and 
often fatal forms of the disease (Kotb et al., 2002). The strong association between 
disease severity and HLA class II allelic polymorphism is primarily related to the 
differential ability of HLA class II alleles to present SAgs to T cells, where presentation 
of Strep SAgs by the protective HLA class II alleles results in a significantly attenuated 
response as compared to their presentation by the neutral or high-risk alleles (Kotb et al., 
2002; Norrby-Teglund et al., 2002; Nooh et al., 2007). While this association made 
perfect biological sense based on the known central role of SAgs in the human disease, 
mice are not susceptible to SAgs due to an inherent lower affinity of mouse MHC class II 
molecules to GAS SAgs. The role of GAS SAgs can be well investigated in HLA class II 
transgenic mice as others and we have reported (Leder et al., 1998; Andersen et al., 1999; 
Welcher et al., 2002; Nooh et al., 2007). However, due to the overwhelming response to 
SAgs in these mice, it is difficult to use them to dissect host response to other GAS 
virulence factors in the disease process. For this reason, our present ARI mouse model of 
sepsis is ideal for identifying host genetic variations, besides the MHC class II antigens, 
that may also contribute to differences in GAS sepsis severity.  
 
We invested time and effort to standardize the GAS infection model using a large 
number of BXD mice (n = 717) and this allowed us to optimize infection dose and 
identify significant covariates (e.g. age and sex) needed to be accounted for in our final 
analysis (Aziz et al., 2007). Although GAS strains can vary considerably with regards to 
virulence, we showed that the same virulent strain could cause diseases with starkly 
different severity in humans (Chatellier et al., 2000; Kotb et al., 2002). The strain used in 
this study is a hypervirulent derivative of the M1T1 clonal strain that emerged in the 
1980s at the same time that the severe forms of the invasive GAS infections resurged 
(Kazmi et al., 2001; Aziz et al., 2004a; Buchanan et al., 2006; Walker et al., 2007). 
Initial studies (Aziz et al., 2007) identified an optimal infection dose of 2 ± 1 x107 
CFU/mouse, and indicated the need to use mice with an age range of 40–120 days for 
linear correlation with survival. In addition, these pilot studies determined that sex has 
insignificant effect in this GAS sepsis model (Aziz et al., 2007) and revealed a stark 
variation among various BXD strains used with respect to their susceptibility to severe
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sepsis. However, precise mapping of QTLs required that we study more BXD strains and 
include more mice per BXD strain to obtain statistical power.  
 
With a total of 30 BXD strains and an average of 15 mice per strain, we mapped 
QTLs on Chr 2 that modulate severity to GAS sepsis, measured by comparing mice 
survival post-infection, bacterial load in blood, and bacterial dissemination to spleen 
across the BXD strains. Inasmuch as the BXD strains are heavily genotyped with more 
than 3600 genomic markers, identifying QTLs is relatively straightforward.  The mapped 
QTLs on Chr 2 harbor a relatively large number of candidate genes associated with 
various functional networks and signaling pathways including nuclear factor- kappa B 
(NF-KB) and p38 mitogen activated protein kinases (MAPK) pathways, proliferation of 
immune cells, and eicosanoid signaling. Such output is typical of unbiased genome-wide 
analysis studies, and required further analyses to determine which of these genes are the 
key modulators of the studied trait.  
 
To narrow down the gene list to a handful of genes that can be experimentally 
validated, we used multiple methods including linkage, gene ontology, and differential 
gene expression analyses. Our quantitative PCR analysis of 37 representative candidate 
genes showed that 28 genes were differentially expressed in selected susceptible and 
resistant strains post-infection. These differentially expressed genes fell into three main 
categories, genes associated with innate and adaptive immune response, and genes 
associated with apoptosis. Differentially expressed genes associated with innate immune 
response were both pro- and anti-inflammatory as well as adaptive immune response 
genes associated with T and B cell proliferation and differentiation, cell signaling and 
antigen processing and presentation.  
 
Differentially expressed genes associated with innate immune response were 
either related to pro- or anti-inflammatory responses. Both pro- and anti-inflammatory 
associated genes were up-regulated in the selected susceptible strains post-infection, and 
this is in agreement with a recent study by Goldmann, et al. (2007) who showed a mixed 
pro- and anti-inflammatory response belonging to M1 and M2 macrophage phenotypes in 
response to GAS infection. This increase in both pro- and anti-inflammatory response 
could be attributed to homeostatic mechanisms where, for example, the increase in Il1 
levels in the susceptible strains was accompanied by an increase in its endogenous 
antagonist Il1rn. This was not the case in the resistant strains that showed decreased 
levels of expression of pro- and anti-inflammatory related genes both pre- and post-
infection. These findings suggest that susceptibly to GAS sepsis is associated with an 
overzealous innate immune response as observed in susceptible BXD strains only. These 
results mirror previous findings in humans, where association of exaggerated 
inflammatory responses, including IL1, with susceptibility to GAS sepsis was detected 
(Norrby-Teglund et al., 2000; Norrby-Teglund and Kotb, 2000; Kotb et al., 2002).  
However, unlike what we found in this mouse model, human responses are dominated by 
high levels of IFN and TNFß, presumably because the human disease is driven primarily 
by SAgs (Norrby-Teglund et al., 1997; Norrby-Teglund et al., 2000).  
 
In general, differentially expressed genes associated with early adaptive immune 
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responses showed a pattern of decrease in expression levels in both susceptible and 
resistant strains with the exception of anaphase promoting complex subunit 2 (Anapc2) 
that was slightly increased in susceptible strains post-infection (Figure 3-5).  By contrast, 
several genes associated with pro- and anti-apoptotic response were differentially 
expressed in the selected susceptible and resistant strains post-infection (Figure 3-5). 
Apoptosis in streptococcal pathogenesis is affected by interacting factors including, 
context of infection (Marriott and Dockrell, 2006), cells undergoing apoptosis 
(Kobayashi et al., 2003; Nakagawa et al., 2004; Miyoshi-Akiyama et al., 2005), for 
example, apoptosis aids in the clearing of infection if macrophages are undergoing 
apoptosis, while it would be harmful to the host if lymphocytes are undergoing apoptosis. 
Other factors include, whether the bacteria is internalized or extracellular (Cywes Bentley 
et al., 2005) and accordingly the type of apoptosis pathways activated (Klenk et al., 
2005). In our murine GAS sepsis model, we have measured expression levels in whole 
spleens, which involved the response of various cells including macrophages, T and B 
lymphocytes, dendritic and endothelial cells etc.  Consequently, we expected to observe a 
mixed response; however, in our ongoing studies, we are examining possible alterations 
in splenic population profiles post-infection in the various BXD strains to determine 
which cell types are responsible for the major differences in cytokine levels seen post-
infection and to dissect the role of different cell populations in this GAS sepsis model.   
 
Another interesting observation was that the relative expression level of genes 
measured in the selected resistant strains showed a pattern of decrease post-infection, 
with the exception of five genes, heat shock 70KDa protein 5 (Hspa5), Traf1, Traf2, 
Notch gene homolog 1 (Notch1), and signal-regulatory protein alpha (Sirpa). It is worthy 
to note the link between these genes, as they are involved directly and indirectly with 
activation of early adaptive response.  Hspa5 is an Hsp70, which is associated with 
cytoprotection, anti-apoptosis, and anti-inflammation (Kiang and Tsokos, 1998; Yenari et 
al., 2005; Kim et al., 2006), and has been associated with immune response to sepsis 
(Kustanova et al., 2006; Singleton and Wischmeyer, 2006). Notch1 has been associated 
with the signaling involved in regulation of lymphocytes development and activation to 
effector cells (Minato and Yasutomo, 2005), natural killer cells development (van den 
Brandt et al., 2004; Garcia-Peydro et al., 2006; Rolink et al., 2006) and recently Notch1 
was associated with macrophage activation (Monsalve et al., 2006).We took into 
consideration in our experimental design that stress might alter the expression of  stress 
related genes especially heat shock proteins and chemokines, therefore, we subjected 
control mice to the same stress as infected mice by injecting control mice with saline, so 
that any change in expression levels would be accounted to GAS sepsis. 
 
Among the differentially expressed genes, four genes, Il1, Il1rn, Ptges, and 
Ptges2, showed marked up regulation in susceptible strains, while they showed no change 
or slight decrease in levels in resistant strains post-infection (Figure 3-5). Increase in 
expression of Ptges and Ptges2 genes is induced by the increased levels of Il1 (Bream et 
al., 2000), which is an indirect effect of the activation of IFN (Figure 3-5). Ptges and 
Ptges2 are prostaglandin synthases for the lipid inflammatory mediators PGE2, which 
along with platelet activating factor and leukotrienes; mediate vasodilatation in the early 
response to inflammation (Harris et al., 2002; Mosca et al., 2007). Vasodilatation in turn 
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leads to hypotension, a hallmark of STSS. Although the role of prostaglandins in 
inflammation and immune response has long been studied, their role in the immune 
response to infectious diseases has been lately pursued (Ruiz et al., 1998; Maloney et al., 
2000; Smith et al., 2002; Chen et al., 2004; Jobin et al., 2006; Woolard et al., 2007). 
Increased production of prostaglandins has been associated with various Gram positive 
bacterial infections including Streptococcus suis (Jobin et al., 2006), group B 
streptococcal (Maloney et al., 2000), and GAS skin infections (Ruiz et al., 1998).  
 
In conclusion, our holistic approach of studying the genetic basis of differential 
susceptibility to GAS sepsis revealed loci on Chr 2 that harbor major immune 
modulators. In the present study, we examined the interactions of pathogen multiple 
virulence factors with the host immune system in an in vivo model of sepsis using a 
genetically diverse reference population. This shed light on a network of host genes 
modulating variation in GAS severity, which includes cytokines, pro- and anti-
inflammatory mediators, and genes associated with apoptosis and early adaptive immune 
response. Our ongoing detailed studies to identify interactive molecular pathways 
contributing to the complex trait of GAS sepsis will undoubtedly help us dissect the 
various mechanisms by which the host interacts with the bacteria in vivo, resulting in 
resistance or increased susceptibility to severe GAS sepsis.  
Materials and Methods 
Mice 
We generated the BXD advanced recombinant inbred (ARI) mice at UTHSC by 
crossing B6 and D2 mice to generate F1 hybrids, which were crossed to generate F2 
progeny, each with random patterns of recombination. Random crossing of F2 mice 
generated F3 and so on, till F11 generation, after which we designated pairs of F11 
hybrids as parents of each BXD line, and inbred them by sib mating for >20 generations 
to achieve homozygosity for each genetically distinct BXD line. This breeding scheme 
was done to increase recombination events resulting in roughly double the number of 
recombinations per strain compared to conventional RI strains (Williams et al., 2001; 
Peirce et al., 2004). 
  
The genomes of the B6 and D2 parental strains have been sequenced and a 
database of their SNPs is available at the Gene Network (GN) web site 
(www.genenetwork.org/webqtl/snpBrowser.py). Simple sequence length polymorphism 
(SSLP) markers were typed for all BXD RI strains as previously described (Williams et 
al., 2001). The BXD progeny is genotyped at 13377 SNPs and microsatellite markers 
(Shifman et al., 2006), a selected subset of 3795 SNPs and microsatellite markers used by 
GN BXD genotype dataset for mapping traits, can be downloaded at 
www.genenetwork.org/genotypes/BXD.geno.  
 
We recently standardized the model of BXD ARI mice for use in GAS infection 
studies (Aziz et al., 2007). In the current study, a total of 696 mice were used, from 
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which 183 flagged mice were excluded based on predetermined criteria as previously 
detailed in (Aziz et al., 2007). All procedures involving mouse tissues were approved by 
the institutional animal care and use committee at the UTHSC. 
Experimental Design 
Population-based experiments 
Groups of 5–26 mice from a total of 30 BXD lines and their parental strains (B6 
and D2) were injected via tail vein with 2  1.5 x 107 CFU/mouse of a hypervirulent form 
of the clinical isolate GAS 5448 (M1T1) (Chatellier et al., 2000; Aziz et al., 2004a; Aziz 
et al., 2004b) as detailed previously (Aziz et al., 2007). Mortality and weight loss were 
recorded every 8 h for the ensuing 6 days. To normalize across experiments, we inspected 
survival days distribution clusters for each experiment and determined multimodal 
distribution and boundaries of each cluster for a total of three clusters: susceptible, 
intermediate, and resistant. Survival days within each cluster were then converted into a 
survival index ranging from 0.25–1, 1.25–2, and 2.25–3 for susceptible, intermediate, and 
resistant clusters respectively. The survival index was assigned to each mouse 
irrespective of its strain.  Indices for each strain, across experiments were then corrected 
for significant covariates (age, sex, body weight, and inocula) using multiple regression 
analyses.  
Phenotype assessment experiments 
We designed experiments for the assessment of survival, bacteremia, and bacterial 
dissemination to spleen. We assessed relative mice survival and bacteremia in the same 
experiment. We measured bacteremia as CFU/ml by culturing serial dilutions of blood 
drawn from mice tails 24 h post-injection. We determined bacterial load in spleen by 
homogenizing spleens of expired mice using tissue homogenizer, TH (Omni 
International, Marietta, GA). Each tissue homogenate was serially diluted 10 folds to 10-6 
fold, and each dilution was cultured for determination of bacterial load in spleens 
(CFU/ml) that was then normalized to spleen weight and expressed as CFU/spleen.  
Quantitative Trait Loci Mapping  
 We performed QTL mapping using web-based complex trait analysis available on 
the GN website and the mapping module which analyzes phenotypes in context of mouse 
genotypic differences. Interval mapping evaluates potential QTL at regular intervals and 
estimates the significance at each location using 1000 permutation tests (Churchill and 
Doerge, 1994). We performed three sets of analyses using strain means for the following 
three variables: (1) corrected relative survival index, described earlier, (2) log bacterial 
load in blood 24 h post injection, and (3) log bacterial load in spleen at expiration. 
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Quantitative PCR Analysis for Target Genes Expression  
 We investigated the differential expression of target genes in spleen of infected 
vs. control PBS-injected mice at selected time points; we selected strains based on their 
susceptibility, BXD61 and 90 representing susceptible strains, and BXD73 and 87, 
representing resistant strains. We performed 2–3 biological replicates of each set of 
paired susceptible and resistant (n = 6–8 per strain). Mice were sacrificed 40 h post i.v. 
injection with 2 ± 1.5 x 107 CFU/mouse of clinical isolate GAS 5448 (M1T1) and RNA 
from individual mice was extracted from spleens. Bacteremia was determined as 
described above. We isolated RNA using RNA-STAT 60 method and when necessary, 
we purified RNA samples using RNeasy mini kit clean up columns (Qiagen, Valencia, 
CA). We pooled RNA samples per strain with A260/280 ratios  1.8 for cDNA synthesis 
with SuperScript III reverse transcriptase kit (Invitrogen, Carlsbad CA) using oligo dT 
primers. We designed real time PCR assays, hydrolysis probes, and gene specific primers 
that span long introns to distinguish cDNA from genomic DNA using primer design 
online software universal probe library (UPL) at www.roche-applied-
science.com/sis/rtpcr/upl/index.jsp. We performed quantitative TaqMan PCR on light 
cycler LC480 (Roche Applied Science, Indianapolis, IN). We used the mouse 
housekeeping gene, hypoxanthine guanine phosphoribosyl transferase (Hprt1) as an 
endogenous control to which we normalized gene expression data. Primer sequences are 
listed in Appendix A Table A-1. Samples were analyzed in triplicates for each of 2–4 
biological replicates. We used delta delta Ct (threshold cycle) method for calculating 
relative expression levels expressed as fold differences between pre- and post-infection 
values for each gene analyzed. Student t-test was used to assess statistical significance. 
Identification of Differentially Expressed Genes in the Mapped Interval and 
Bioinformatics Functional Pathways Analyses  
 We generated functional analyses of genes within the QTLs using Ingenuity 
pathways analysis (IPA) (www.ingenuity.com). Each data set containing gene identifiers 
was uploaded into the online application, and each gene was overlaid onto a molecular 
network developed from information contained in the ingenuity pathways database. 
 Networks of genes were then generated based on their connectivity, and we chose the top 
50 significant networks. The significance of the association between the data set and the 
pathways was measured in two ways: (1) the ratio of the number of genes from the data 
set that map to the pathway divided by the total number of genes that map to the 
pathway; and (2) by Fischer’s exact test with P < 0.001. 
Statistical Analysis 
 We used the DataDesk 6.2 (www.datadesk.com) to calculate mean survival 
indices, corrected survival indices, and correlation coefficients. Covariates association 
was evaluated for significant associations by Spearman correlation as described 
previously (Aziz et al., 2007). Fischer exact test was used to analyze association of the 
analyzed differentially expressed genes with specific pathways. 
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Web Site URL  
Our data sets stored in WebQTL can be found at Gene Network 
(www.genenetwork.org) under BXD published phenotypes record ID 10836.  
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CHAPTER 4. IDENTIFICATION OF SOLUBLE AND GENETIC BIOMARKERS 
ASSOCIATED WITH DIFFERENT OUTCOMES OF GAS SEPSIS REVEALS 
UNDERLYING MECHANISMS OF DIFFERENTIAL HOST SUSCEPTIBILITY  
Summary 
Individuals infected with the same group A streptococcal (GAS) strain can 
develop starkly different disease progression and outcomes. My mentor’s laboratory have 
shown that the same GAS strain can cause a wide range of diseases, from mild 
bacteremia and erysipelas to streptococcal toxic shock syndrome (STSS) and necrotizing 
fasciitis (NF) (Chatellier et al., 2000). Difference in disease severity was associated with 
differences in the profile and magnitude of cytokine responses, where overzealous 
inflammatory cytokine responses, triggered mainly by streptococcal superantigens 
(SAgs), were associated with severe disease, including STSS and NF (Norrby-Teglund et 
al., 2000). Our group has found that HLA class II allelic variations contributed to the 
differences in cytokine responses in these patients, where individuals with DR14/DQ5 
HLA class II haplotypes, produced high levels of inflammatory cytokines and were at 
risk of developing severe systemic disease and STSS. Whereas, we found that patients 
who had DR15/DQ6 haplotype mounted moderate cytokine responses and experienced 
mild sepsis and/or cellulitis (Kotb et al., 2002; Norrby-Teglund et al., 2002).  
 
The HLA-II association was related to interactions of GAS SAgs with the host 
where GAS SAgs forced interactions of HLA-II on antigen presenting cells and T cell 
receptors on T helper cells stimulating both types of cells to mount cytokine responses 
which differed based on HLA-II alleles as described above. However, GAS is rich in 
many other virulence factors that are likely to engage other host defense mechanisms. 
Indeed, we have recently shown that additional host factors, other than HLA- II, are 
modulating host differential responses to GAS infections. Employing genome-wide 
association studies, we mapped differential susceptibility to severe GAS sepsis to QTLs 
on mouse Chr 2 and X (Abdeltawab et al., 2008). We found that within these QTLs most 
significant association with differential susceptibility to GAS sepsis was that of 
interleukin 1 and prostaglandin E pathways. We validated our results based on genome-
wide association studies (GWAS) using multiple bioinformatics tools and quantitative 
gene expression analyses (as detailed in chapter 3). However, we aimed to perform 
genome-wide expression analyses to study patterns associated with differential responses 
to GAS sepsis at early stages of infection. In the current chapter, we aimed to further 
dissect the mechanisms of the discovered pathways (discussed in chapter 3) and how they 
are associated with differential susceptibility. In the studies covered in this chapter, in 
addition to analyzing genome wide (GW) gene expression patterns, we also analyzed 
soluble biomarkers that are associated with pathways identified by both GW mapping and 
GW expression analyses.  
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Results and Discussion 
Comparison of Genome-wide Differential Expression in Blood between Susceptible 
and Resistant Strains at Selected Times Post Infection 
 In studies outlined in this dissertation, our overall aim was to investigate 
mechanisms underlying differential response to GAS sepsis. We employed genome-wide 
association studies (GWAS) adopting systems genetics approach as discussed in chapters 
2 and 3. Using these genome-wide association studies, we identified interleukin 1 and 
prostaglandin pathways as candidate pathways associated with modulation of differential 
susceptibility to severe GAS sepsis (chapter 3 and Abdeltawab et al. 2008). In this 
chapter, we sought to characterize and further dissect genetic and soluble biomarkers 
associated with differential susceptibility to GAS sepsis.  To do so, we first aimed to 
characterize differential gene expression patterns associated with differential 
susceptibility to GAS sepsis. We compared global gene expression differences (genetic 
biomarkers) and differences in a selected set of cytokines associated with sepsis (soluble 
biomarkers) between uninfected vs. infected mice of selected highly resistant and highly 
susceptible strains at 8, 12, and 24 hours post infection.  
 
 In our global gene expression analyses, we aimed to profile patterns associated 
with differential susceptibility to severe GAS sepsis. To achieve this aim, we compared 
infected mice at different stages of infection (8 and 12hours post GAS infection) to 
uninfected group of mice (0hrs) (experimental design illustrated in Figure 4-1). We used 
groups of ARI-BXD strains that displayed marked differences in response to severe GAS 
sepsis as characterized in studies outlined in chapters 2 and 3 of this dissertation and Aziz 
et al. 2007 and Abdeltawab et al 2008. We designed our experiments so that there were 
multiple levels of replication. First at the level of ARI-BXD strains used, we selected 
three highly susceptible ARI-BXD strains (BXD97, 100, and 77)* to represent the most 
susceptible side of strains (see gradient of differential susceptibility in Figure 3-1). 
Similarly for the resistant group, we chose to use three most resistant ARI-BXD strains 
(BXD48, 73, 87)†. In doing so, there were replicas on the level of both susceptible and 
resistant groups, instead of one strain representing the susceptible group; we collected 
data from three extremely susceptible strains and similarly for resistant strains as 
illustrated in Figure 4-1. Within each of these selected representative six strains, we 
collected and pooled blood from three mice per strain. Each pool of blood represented 
one strain at a selected time point; this represented biological replica (3 mice per strain). 
To guard against effects of stress due to multiple bleedings of the same mouse, we used 
three different sets of mice (3 different mice per set) to analyze each of the studied time 
points whether pre infection or at different stages of infection (Figure 4-1). 
                                                 
* According to our studies outlined in chapter 3 as illustrated in Figure 3-1, BXD94 and BXD90 
are among the extremely susceptible strains; however we did not use BXD94 and BXD90 as 
BXD94 is now extinct, while BXD90 has been recently difficult to breed in our hands. 
† Similarly for resistant strains, we used strains that exhibit extreme resistance as illustrated in 
Figure 3-1 (BXD48,, BXD73 and BXD87), however, we did not use BXD92 which is also 
extremely resistant as it has become extinct. 
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Figure 4-1. Experimental design to test gene expression differences associated with 
differential susceptibility to severe GAS sepsis at selected stages of infection. 
 
Illustration of experimental design used for the assessment of patterns of differential 
gene expression in blood associated with differential susceptibility to GAS sepsis at 
early stages of infection (8 and 12 hours post infection). We selected mice belonging to 
highly resistant strains (BXD48, 73 and 87) and highly susceptible strains (BXD100. 97 
and 77). Strains were chosen based on our previous differential susceptibility results 
detailed in chapter 3 of this dissertation. At each time point, 0 h representing uninfected 
mice and 8 and 12 hours post infection, we sacrificed three mice per strain and collected 
blood that was later pooled per strain, representing certain strain at a certain time point 
(e.g. BXD48 in the illustration, where RNA1 represents BXD48 0 h and RNA2 
represents BXD48 8h, each RNA sample was prepared from pooled blood of 3 mice). 
The same design was repeated for each and every strain. We extracted RNA from these 
pooled blood samples and hybridized purified high quality RNA to Illumina WG-6 V2.0 
mouse arrays (see methods for details of arrays processing).  We compared differentially 
expressed genes in the resistant group (as a whole) at 8 and 12 hours post infection to 
uninfected mice, and obtained a list of differentially expressed genes, denoted as A and 
B for resistant strains at 8 and 12 h respectively. Similarly, gene lists C and D for 
susceptible strains at 8 and 12 hours respectively as shown. We then parsed these 
differentially expressed gene lists associated with resistance and those with 
susceptibility into pathways. These pathways are shown in Figures 4-2 and 4-3, and 
methods used to generate these pathways are detailed in methods section. 
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 We adopted the design (illustrated in Figure 4-1) to allow us to investigate 
patterns of differentially expressed genes associated with differential susceptibility to 
severe GAS sepsis. In addition we wanted to investigate stage-specific differential gene 
expression patterns associated with differential susceptibility.  
 
We chose blood for our current analyses of early stage of infection as our 
genome-wide association studies revealed association of differential susceptibility to the 
innate immune cells, neutrophils and monocytes. In addition, blood is the main organ that 
mounts the first line of defense to this blood borne pathogen. Nonetheless, we also 
collected data for differentially expressed genes in the spleens of above-mentioned 
selected highly susceptible and highly resistant strains at multiple times post infection 
representing different stages of infection. We chose to also investigate genome-wide 
differential gene expression in the spleen due to the spleen role as one of the main 
secondary lymphoid tissues involved in clearance of extracellular blood borne bacteria. In 
future studies to be performed in the laboratory, we plan to also investigate differential 
gene expression in lungs of these differentially susceptible and resistant strains, as the 
lung is one of the main organs involved in the severe outcome of GAS sepsis associated 
with high mortality in clinical settings manifested by acute respiratory distress syndrome.  
 
 In our genome-wide differential gene expression analyses of blood, we aimed to 
analyze stage-specific patterns of resistant strains and susceptible strains compared to 
their uninfected control (Figure 4-1). For example gene expression levels at 8 hours post 
infection from three resistant strains compared to 0 hr (uninfected mice) of the same 
strains. Similarly for susceptible strains at 8 hours vs. 0 hours and also we performed 
similar analyses for 12hrs compared to 0 hrs for both resistant and susceptible groups 
(Figure 4-1).However, our current design allows us to analyze the data we generated in 
multiple ways asking different questions. For instance, we can ask the question of what 
are the patterns of different mechanisms of resistance by comparing the sets of 
differentially expressed genes of each of the tested three resistant strains, and similarly 
for susceptible strains. Another question we would like to address is: what are the 
differences in gene expression in blood cells between susceptible and resistant group pre-
infection (0h). This will help us address the question of possible predisposition to severe 
sepsis prior to GAS infection.  
 
We compared global gene expression in blood at 8 hours vs. 0 hours and found 
that 232 genes were differentially expressed in resistant strains, while 322 genes were 
differentially expressed in blood cells of susceptible strains (Figure 4-1, 4-2 and Table  
4-1). Comparing these two differentially expressed gene lists, we found that there were 
91 genes that were shared (common) between differentially expressed gene sets of 
susceptible and resistant strains (Figure 4-2). These shared genes fell into multiple 
pathways, including interferon signaling and interferon regulatory factor activation 
pathway. Both pathways were upregulated in both susceptible and resistant strains 
(Figure 4-2 and Table 4-1). However, there were quantitative differences between 
susceptible and resistant strains in this upregulation (Table 4-1). For example, interferon 
induced protein with tetratricopeptide repeats 3 (Ifit3) was upregulated at 8 h vs. 0 h in 
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Figure 4-2. Pathways associated with differentially expressed genes at 8 hours post 
infection in peripheral blood of resistant and susceptible strains compared to 
uninfected (0hr) mice of respective strains. 
 
Panel A. Venn diagram of differentially expressed genes in blood of resistant and 
susceptible strains, showing common (shared) and unique genes. Resistant strains had 
232 genes differentially expressed within these, 141 genes were unique to resistant 
strains while 91 genes were shared with susceptible strains. A total of 322 genes were 
differentially expressed in susceptible strains within these genes, 231 genes were unique 
to susceptible strains. These lists of differentially expressed genes were parsed into 
pathways using ingenuity pathway analysis tool (IPA) as detailed in methods section. 
Shown are the most significant pathways. We parsed common (shared) differentially 
expressed genes in both resistant and susceptible strains into pathways shown in panel B. 
The significant pathways associated with genes that are differentially expressed only in 
resistant strains are shown in panel C, while those associated only with susceptible 
strains are shown in panel D. Whether the genes within a pathway are up or down 
regulated is denoted in words and as arrows beside each pathway. The x-axis displays 
significance in (–log (p-value)) where the higher the number (the longer the blue bar) the 
more likely the association of the differentially expressed genes with the noted pathways 
is not by chance, this significance is also expressed as p-values on each bar. For each 
pathway we calculated a ratio (orange squares, and decimal number associated with it), 
the ratio is the number of differentially expressed genes divided by total number of 
molecules in the specified pathway. 
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A Venn diagram of differentially expressed genes at 8 h 
post infection in blood of resistant and susceptible 
strains, showing common (shared) and unique genes 
B Pathways of differentially expressed genes shared (common)  
between resistant and susceptible strains at 8 h post infection 
  62
C Pathways of differentially expressed genes 
associated with resistant strains at 8 h post infection 
D Pathways of differentially expressed genes associated only 
with susceptible strains at 8 h post infection 
Figure 4-2. (Continued). 
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Table 4-1. Differentially expressed genes in peripheral blood of resistant and susceptible strains at 8 hrs post GAS infection. 
 
Pathways and Genes/Transcripts Gene/Transcript Description Fold Change 
  Susceptible Resistant 
Top pathways associated with differentially 
expressed genes shared between susceptible 
and resistant strains 
   
Interferon signaling and activation of IRF by 
cytosolic pattern recognition receptors 
   
Ifit3 Interferon-induced protein with tetratricopeptide 
repeats 3 (Ifit3) 
19.83 29.42 
Ifit2 Interferon-induced protein with tetratricopeptide 
repeats 2 (Ifit2) 
5.58 9.57 
Stat2 Signal transducer and activator of transcription 2 
(Stat2) 
4.04 3.42 
Zbp1 Z-DNA binding protein 1 (Zbp1) 4.13 3.93 
Dhx58 DEXH (Asp-Glu-X-His) box polypeptide 58 (Dhx58) 8.50 8.79 
Oas1 2'-5' oligoadenylate synthetase 1G (Oas1 gamma) 12.14 11.48 
Top pathway associated with differentially 
expressed genes in resistant strains (8h vs. 0h) 
   
IL10 signaling    
Arg2 Arginase, type II  3.78 
Ikbke Inhibitor of kappa light polypeptide gene enhancer in 
B-cells, kinase epsilon 
 3.79 
Il1b Interleukin 1, beta  5.99 
Il1rn Interleukin 1 receptor antagonist  9.49 
Tnf Tumor necrosis factor (TNF superfamily, member 2)  4.63 
Jun Jun oncogene (Jun)  2.23 
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Table 4-1 (Continued).    
    
Pathways and Genes/Transcripts Gene/Transcript Description Fold Change 
  Susceptible Resistant 
Top pathway associated with differentially 
expressed genes in susceptible strains (8h vs. 0h) 
 -2.03  
Role of PKR in Interferon induction  -2.53  
Ikbk Inhibitor of kappa light polypeptide gene enhancer in 
B-cells, kinase gamma 
  
Map2k3 Mitogen-activated protein kinase kinase 3   
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susceptible group by ~20 folds vs. 29 folds in resistant group (Table 4-1). Similarly other 
quantitative differences between susceptible and resistant group were observed. 
However, we didn’t observe this quantitative difference between resistant and susceptible 
group at 12 hours post-infection (Table 4-1 and 4-2). Further studies, which are beyond 
the scope of this dissertation, are needed to elucidate if and how these observed 
quantitative differences relate to differential susceptibility to GAS sepsis. 
 
Among the top pathways (pathways with highest significance) associated with 
differentially expressed genes in resistant strains (8 vs. 0 hours) was IL10 signaling 
pathway (Figure 4-2 and Table 4-1). We found that most of the differentially expressed 
genes in IL10 signaling pathway were upregulated (Table 4-1).Of note was the 
upregulation of arginase II (Arg II) in resistant strains at 8 h post infection (Table 4-1). 
Arg II and nitric oxide synthase (NOS) compete for the same arginine pool with the 
production of L-ornithine or nitric oxide (NO) respectively. Therefore, upregulation of 
Arg II in resistant strains might reflect a plausible mechanism of resistance, where 
upregulation of Arg II might regulate the production of NO in endothelial cells by 
decreasing the bio availabity of arginine. This suggested that resistant strains might be 
upregulating Arg II to control a possible over production of NO. Over production of NO 
can lead to an increase in vascular permeability and leakage, leading to increase loss of 
fluids from vascular vessels, leading to hypotension which leads to shock, and 
consequently STSS.  
 
In addition, association of upregulation of IL10 signaling pathway with resistance 
(Figure 4-2) suggested that resistance might be initiated early on in infection with known 
involvement of IL10 signaling pathway in induction of tissue repair and its 
immunomodulatory responses. However, in our analyses, we did not find upregulation of 
Il10 gene itself upregulated; although its signaling pathway was upregulated. In addition 
to IL10 signaling pathway, multiple pathways associated with tissue development, cell 
proliferation, activation of macrophages, pattern recognition activation were associated 
with resistance (Figure 4-2). We also found that pathways associated with bacterial 
killing and reactive oxygen species (ROS) production were among pathways associated 
with differentially expressed genes in resistant strains only. It seems contradictory that 
we found that resistant strains had upregulation of both Arg II (associated with regulation 
of NO production) and ROS production pathways. However, it might be that these 
resistant strains exert an active suppression of over production of such ROS but not ROS 
production per se. Since overproduction of NO is associated with tissue damage and 
shock, resistant strains guard against these deleterious effects by using up arginine pools 
(Arg II upregulation), meanwhile adequate production of ROS is induced to control the 
bacterial infection. 
 
  In susceptible strains, we found that 231 genes were differentially expressed at 8 h 
post infection compared to 0 h (Figure 4-1 list C and 4-2). The top pathways associated 
with these differentially expressed genes were role of protein kinase receptor (PKR) 
interferon induction and CD40 signaling. Most of the differentially expressed genes 
belonging to both pathways were downregulated. This observed downregulation of PKR 
induced interferon signaling in susceptible strains at 8 hrs is in contrast to resistant strains 
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that manifested upregulation of the same pathway at same time point.CD40 signaling 
pathway is involved in a multitude of immune responses ranging from induction of pro-
inflammatory cytokines to activation of cell survival and was associated in the production 
of IL1 and IL8 from vascular endothelial cells, in addition, it is involved in the induction 
of prostaglandin endoperoxide synthase 2 (Ptgs2) and subsequent production of PGE2 
(Elgueta et al., 2009). The observed downregulation of genes associated with CD40 
signaling and PKR induction of interferon signaling in susceptible strains might be 
associated with the lack of mounting appropriate response to GAS infection. 
 
 Next, we examined differential gene expression patterns at 12 hours post 
infection; we found that 380 genes were differentially expressed in resistant strains at 12 
h compared to uninfected mice, out of which 268 genes were unique to resistant strains 
and 112 genes were shared with susceptible strains (Figure 4-3).Again similar to 8 h, the 
shared (common) differentially expressed genes between resistant and susceptible strains 
(112 genes) fell into pathways that included interferon signaling. However, the 
quantitative differences between susceptible and resistant strains were more towards 
higher levels in susceptible than resistant strains, while the reverse was true at 8h, e.g. 
Ifit3 levels at 8 vs. 12 hrs (common genes Table 4-1 and 4-2).The 268 genes 
differentially expressed in resistant strains only, fell into interferon signaling pathway and 
activation of interferon signaling by pattern recognition receptors and PKR signaling. We 
observed this upregulation of genes associated with interferon signaling at both 8 and 12 
hours in both susceptible and resistant strains however, the mechanism of induction was 
different and there was a down regulation of PKR induced interferon signaling in 
susceptible strains at 8 h. Further detailed studies might help in elucidating the details of 
mechanisms of interferon in modulating differential susceptibility. 
 
 Meanwhile, pathways associated with differentially expressed genes in the blood 
of susceptible strains at 12h post infection were mainly associated with induction of 
mitochondrial enzymes, induction of apoptosis and oxidative phosphorylation. Genes 
within these pathways were upregulated; this upregulation of mitochondrial pathways 
might be associated with bacterial induced mitochondrial injury and bioenergetic failure 
thus leading to sepsis-associatated multiple organ failure. This is further supported by our 
finding that in susceptible strains mitochondrial oxidative phosphorylation enzymes e.g. 
NADH dehydrogenase and succinate dehydrogenase were upregulated at both 8 and 12 h 
post infection (Figure 4-2, 4-3 and Table 4-2), suggesting that mitochondrial oxidative 
phosphorylation is upregulated to counteract the ROS produced. Furthermore, 
mitochondrial apoptosis related enzymes e.g. caspase 8 and cytochrome C-1, as well as 
pathways associated with induction of apoptosis were upregulated in only the susceptible 
strains at 12h (Figure 4-3 and Table 4-2). This simultaneous upregulation of electron 
transport chain (ETC) enzymes and mitochondrial-induced apoptosis signaling could be 
explained in terms of possible positive feedback between the cascades of oxidative 
phosphorylation provided by ETC to enhance apoptotic pathway. This fits with a recent 
report that showed that GAS can induce mitochondrial permeability leading to 
bioenergetic and redox damage. Thus evading host immune defense and causing  
inflammatory programmed cell death in monocytes (Goldmann 2009).  Furthermore, it 
results have been recently reported that GAS streptolysin S and O virulence factors 
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Figure 4-3. Pathway analysis of differentially expressed genes at 12 hrs post 
infection in peripheral blood of resistant and susceptible strains compared to 
uninfected (0hr) mice of respective strains. 
 
 
Panel A. Venn diagram of differentially expressed genes in blood of resistant and 
susceptible strains, showing common (shared) and unique genes. Resistant strains had 
380 genes differentially expressed within these, 268 genes were unique to resistant 
strains while 112 genes were shared with susceptible strains. A total of 650 genes were 
differentially expressed in susceptible strains within these genes, 538 genes were 
unique to susceptible strains. These lists of differentially expressed genes were parsed 
into pathways using ingenuity pathway analysis tool (IPA) as detailed in methods 
section. Shown are the most significant pathways. We parsed common (shared) 
differentially expressed genes in both resistant and susceptible strains into pathways 
shown in panel B. The significant pathways associated with genes that are differentially 
expressed only in resistant strains are shown in panel C, while those associated only 
with susceptible strains are shown in panel D. Whether the genes within a pathway are 
up or down regulated is denoted in words and as arrows beside each pathway. The x-
axis displays significance in (–log (p-value)) where the higher the number (the longer 
the blue bar) the more likely the association of the differentially expressed genes with 
the noted pathways is not by chance, this significance is also expressed as p-values on 
each bar. For each pathway we calculated a ratio (orange squares, and decimal number 
associated with it), the ratio is the number of differentially expressed genes divided by 
total number of molecules in the specified pathway. 
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B Pathways of differentially expressed genes shared (common) 
between resistant and susceptible strains at 12 h post infection 
A Venn diagram of differentially expressed genes at 12 h 
post infection in blood of resistant and susceptible 
strains, showing common (shared) and unique genes 
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D Pathways of differentially expressed genes associated only 
with susceptible strains at 12 h post infection 
C Pathways of differentially expressed genes associated 
with resistant strains at 12 h post infection 
Figure 4-3. (Continued). 
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Table 4-2. Differentially expressed genes in peripheral blood of resistant and susceptible strains at 12 hrs post GAS infection. 
 
Pathways and Genes/Transcripts Gene/Transcript Description Fold Change 
  Susceptible Resistant 
Top pathways associated with differentially 
expressed genes shared between susceptible and 
resistant strains 
   
Interferon signaling and LXR/RXR signaling 
pathways 
   
Ifit3 Interferon-induced protein with tetratricopeptide 
repeats 3 (Ifit3) 
22.93 22.31 
Tap1 Transporter 1, ATP-binding cassette, sub-family B 
(MDR/TAP) 
4.21 2.78 
Oas1 2'-5' oligoadenylate synthetase 1G (Oas1 gamma) 15.54 11.54 
Il18 Interleukin 18 6.84 5.03 
Il1rn Interleukin 1 receptor antagonist, transcript variant 1 5.41 5.75 
Nr1h3 Nuclear receptor subfamily 1, group H, member 3 17.61 15.80 
Tlr4 Toll-like receptor 4 2.59 2.67 
Top pathway associated with differentially 
expressed genes in resistant strains (12h vs. 0h) 
   
Interferon signaling pathway    
Stat1 Signal transducer and activator of transcription 1   4.00 
Stat2 Signal transducer and activator of transcription 2  2.82 
Top pathway associated with differentially 
expressed genes in susceptible strains (12h vs. 0h) 
   
Mitochondrial dysfunction    
App Amyloid beta (A4) precursor protein 8.51  
Casp8 Caspase 8, apoptosis-related cysteine peptidase 2.84  
Cyc1 Cytochrome c-1 2.61  
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Table 4-2 (Continued).    
    
Pathways and Genes/Transcripts Gene/Transcript Description Fold Change 
  Susceptible Resistant 
Htra2 HtrA serine peptidase 2 4.17  
Ndufa8 NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex 8, 19 kDa 
3.96  
Ndufa9 NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex 9, 39 kDa 
3.91  
Ndufs2 NADH dehydrogenase (ubiquinone) Fe-S protein 2, 
49 kDa 
2.45 
Ndufs3 NADH dehydrogenase (ubiquinone) Fe-S protein 3, 
30 kDa 
2.98 
Ndufs7 NADH dehydrogenase (ubiquinone) Fe-S protein 7, 
20 kDa 
2.45 
Ndufs8 NADH dehydrogenase (ubiquinone) Fe-S protein 8, 
23 kDa 
2.76  
Sdhb Succinate dehydrogenase complex, subunit B, iron 
sulfur (Ip) 
3.39  
Sdhc Succinate dehydrogenase complex, subunit C 2.24  
Uqcrc1 Ubiquinol-cytochrome c reductase core protein 1 2.92  
Xdh Xanthine dehydrogenase 6.20  
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specifically interfere with killing mechanisms by induction of mitochondrial dysfunction 
(Aikawa et al., 2010). Nonetheless, these previous studies did not elucidate the exact 
mechanisms and role of mitochondrial dysfunction in modulating severity of GAS sepsis. 
Therefore, more detailed studies with more time points focusing on the role of 
mitochondrial dysfunction in inducing multiple organ failure are required to further 
elucidate our results. 
 
 In general, our global gene expression studies comparing differential gene 
expression in blood of infected vs. uninfected susceptible and resistant strains at multiple 
times post infection gave us insight into some aspects of how the host might be 
modulating differential immune response to GAS sepsis. Our data suggested that the 
involvement of multiple pathways in modulating differential susceptibility, where starting 
as early as 8h post infection, IL10 signaling pathways were upregulated only in resistant 
strains. In addition, pathways associated with bacterial killing and resolution of infection 
were triggered in resistant strains at that early stage. It was noteworthy that genes and 
pathways involved in macrophage and neutrophils killing mechanisms were also 
associated with these discovered pathways.  
 
Next, we analyzed change in gene expression in spleen at 8, 12, 16, 24 and 36h 
post infection following the same design as blood microarrays studies detailed in Figure 
4-1. However, we chose to start by analyzing the 36 h post infection differential gene 
expression arrays, to investigate immune response after allowing enough time for the 
bacteria to disseminate to the spleen. Analysis of the differentially expressed genes in 
spleens of resistant and susceptible ARI-BXD strains revealed the engagement of the 
same pathways suggested by the systems genetics genome-wide association studies. 
These pathways encompass many of the genes located within all 3 survival QTLs, 
including the one on Chr X. In those studies, we infected susceptible and resistant ARI-
BXD strains with M1T1 GAS, uninfected control mice from the same strains were 
injected with saline. The data revealed significant changes in the expression of highly 
relevant genes in both susceptible and resistant mice, both pre- and post infection (Figure 
4-4). Many of those genes are located within our 3 mapped QTLs (e.g. Il1α, Il1β, and 
Il1rn) on Chr 2, in addition to Irf1 on Chr X. These genes and pathways are likely to 
contribute to the pathogenesis and differential severity of GAS sepsis. However, this 
spleen microarray data is very preliminary, with further analyses and more samples 
needed to be done for obtaining a clearer picture of mechanisms of differential 
susceptibility.  
Soluble Biomarkers Associated with Differential Susceptibility in Select Susceptible 
and Resistant Strains at Multiple Time Series Post-infection   
 Next, we wanted to dissect soluble biomarkers associated with differential 
response. Therefore, we aimed to analyze the kinetics of selected cytokines levels in 
plasma of uninfected vs. infected resistant and susceptible strains at selected time points 
post infection. We analyzed differences in the levels of selected cytokines that are known 
to be associated with modulation of differential severity of GAS sepsis and were 
associated with differential gene expression analyses detailed in the first section of
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Figure 4-4. Pathways associated with differentially expressed genes in spleens of uninfected versus infected resistant and 
susceptible ARI-BXD strains at 36h post GAS infection.* 
                                                 
* Data represented in this Figure is preliminary, as we are planning to do more analysis aswell as more time points that we have already collected  
samples, these samples represent earlier stages of infection. We are continuing to analyze these data to elucidate mechanisms associated with 
differential response. 
We infected selected highly susceptible and highly resistant ARI-BXD strains (n = 3–4 strains in each group, 3–5 mice per strain 
per time point) with M1T1 GAS strain. In parallel, a control group of mice was injected with saline. Differentially expressed 
genes in spleen at 36h post infection were parsed into pathways, shown are the most significant pathways in resistant and 
susceptible group. The x-axis displays significance in (–log (P-value)) where the higher the number the more likely the association 
is not by chance. Matching pathways shown were connected with arrows in light blue. 
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Chapter 4. We investigated selected pro-inflammatory cytokines, interleukin 6 (IL-6), 
interferon gamma (IFNγ) and tumor necrosis factor alpha (TNFα) and anti-inflammatory 
cytokine, IL10 at selected time points post-infection (0, 8, 12 and 24 hours).  
 
We first aimed to analyze stage specific differences within each group, i.e. 
susceptible group at different time points post infection and similarly resistant group. We 
found that in susceptible strains TNFα showed significant increase in plasma levels at 8 
hours post infection, followed by a drop in plasma levels at 12 hours to almost the same 
levels as “zero” or uninfected control mice, then no changes at 24 h from 12 h (Figure  
4-5-A)*.  This might suggest that there might be a possible early induction of acute 
systemic sepsis manifested by the observed high systemic levels of TNFα at 8 hours in 
susceptible strains only. As for the resistant strains studied, we found that levels of TNFα 
significantly increase in the plasma only at 24 h post infection (compared to uninfected 
mice) (Figure 4-5-B). This might suggest that the release of TNFα at that stage of 
infection is more beneficial and induces appropriate response to resolve infection as these 
strains are protected against sepsis. However, on comparing TNFα levels in resistant vs. 
susceptible group at each of studied stages of infection, there were trends of differences 
but none reached significant (Figure 4-5-C).  
 
For IL6 both susceptible and resistant strains showed significant increase in 
plasma levels at 12 and 24 hours post infection in comparison to 0 h (uninfected controls) 
(Figure 4-6-A and 4-6-B). However, the levels of IL6 in susceptible strains at 24 hours 
post infection were almost double that of resistant strains, yet it didn’t reach statistical 
significance differences due to the spread of data points (Figure 4-6- C). Collectively, 
TNFα and IL6 pro-inflammatory cytokines and crucial mediators of systemic sepsis 
didn’t show differences in the levels between susceptible and resistant strains. However, 
we realize that this might due to assessing plasma levels of these cytokines, which does 
not reflect the actual producing cells; therefore, we plan to perform intracellular cytokine 
staining, where we can determine which cells are producing theses cytokines at the 
studied stages of infection and hence draw a more definitive conclusion. Yet, our results 
indicate that at these early time points, systemic levels of IL6 and TNFα do not differ 
between susceptible and resistant strains at the selected time points. 
 
Next we looked at levels of anti-inflammatory cytokine IL10 in susceptible and 
resistant strains at multiple stages of infection. We found that both susceptible and 
resistant strains showed significantly high levels at 8 and 12 hours post-infection (Figure 
4-7-A and 4-7-B). However, levels of IL10 were 2-3 folds higher in resistant strains than 
susceptible strains; indeed comparing susceptible to resistant strains, showed that higher 
levels of IL10 were associated with resistant strains at as early as 8 and 12 hours post  
 
                                                 
* The analyzed data shown in Figures 4-5 to 4-9 are representive of susceptible and resistant 
groups, where  2 mice per strain per time point were analyzed,  with the exception of:a) 
susceptible group, where we used 4 mice at 8 h and 12h for BXD 97 and for BXD77 we used 4 
and 6 mice at 12 and 24 h respectively b) Resistant group, we used 4 mice at 8, 12 and 24 h of 
BXD87 and one mouse at 8 hours of BXD48. We collected far more plasna samples that are to 
be assayed.  All other data shown is for 2 mice per strain (3 strains used) per time point (4 time 
points analyzed). 
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Figure 4-5. TNFα plasma levels profiles across early time points post infection 
comparing selected highly susceptible and highly resistant ARI-BXD strains. 
 
 
 
 
We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and 
three highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107 
CFU/mouse of hypervirulent M1T1 GAS strain, design of study is similar to 
microarray studies shown in Figure 4-1, further details of cytokine measurements in 
methods section. We sacrificed and collected plasma for a set of mice per strain at 
each time point post infection, 8, 12, and 24 hours, therefore, there were no multiple 
bleedings of any of the mice used. In parallel, a control group of uninfected mice 
were used for collection of plasma for estimating normal levels of TNFα in these 
selected strains. (A). Comparison of medians of levels of TNFα in susceptible mice 
showed that levels of TNFα increased significantly at 8 hours post-infection, then 
significantly drop back to almost the zero levels at 12 hours post infection. Panel (B). 
Resistant strains showed significant increase in levels of TNFα only at 24 hours post-
infection. Panel C. We compared TNFα plasma levels in susceptible (red dots) vs. 
resistant (blue dots) groups at the analyzed time points. There were differences in 
levels of TNFα but none reached statistical significance based on Mann-Whitney test. 
We applied Kruskal-wallis test to assess statistical significance of differences in 
levels of TNFα between and across time points (stages of infection) (panels A and B). 
In general a p value of < 0.05 was considered significant. 
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Figure 4-6. IL6 plasma levels profiles across early time points post infection  
comparing selected highly susceptible and highly resistant ARI-BXD strains. 
 
 We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and three 
highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107 CFU/mouse of 
hypervirulent M1T1 GAS strain We sacrificed and collected plasma for a set of mice 
per strain at each time point post infection, 8, 12, and 24 hours, therefore, there were 
no multiple bleedings of any of the mice used. In parallel, a control group of 
uninfected mice were used for collection of plasma for estimating normal levels of IL6 
in these selected strains. (A). Comparison of medians of levels of IL6 in susceptible 
mice showed that levels of IL6 increased significantly at 12 and 24 hours post-
infection compared to pre-infection (zero hour). Panel B. Similarly, resistant strains 
showed significant increase in levels of IL6 12 and 24 hours post-infection, however, 
the maximum value and hence the range of IL6 levels was higher and wider in 
susceptible strains, up to 3500 pg/ml vs. 1800 pg/ml in resistant strains. Panel C. We 
compared IL6 plasma levels in susceptible (red dots) vs. resistant (blue dots) groups at 
the analyzed time points. There were differences in levels of IL6 but none reached 
statistical significance based on Mann-Whitney test. We applied Kruskal-wallis test to 
assess statistical significance of differences in levels of IL6 between and across time 
points (stages of infection) (panels A and B). In general a p-value of < 0.05 was 
considered significant. (For number of samples analyzed please refer to page 65 
footnote). 
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Figure 4-7. IL10 plasma levels profiles across early time points post infection 
comparing selected highly susceptible and highly resistant ARI-BXD strains. 
 
We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and three 
highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107 CFU/mouse of 
hypervirulent M1T1 GAS strain We sacrificed and collected plasma for a set of mice per 
strain at each time point post infection, 8, 12, and 24 hours, therefore, there were no 
multiple bleedings of any of the mice used. In parallel, a control group of uninfected 
mice were used for collection of plasma for estimating normal levels of IL10 in these 
selected strains. (A). Comparison of medians of levels of IL10 in susceptible mice 
showed that levels of IL10 increased significantly at 8 hours post-infection compared to 
pre-infection (zero hour), then dropped at 12 and 24 hours with significant drop at 24 to 
almost same as “zero” hour. Panel B. Similarly, resistant strains showed significant 
increase in levels of IL10 at 8 hours post infection, with a drop at 12 and 24 hours post-
infection, however, levels at 12 hours were still significantly higher than zero hour. In 
addition, in general the resistant strains had higher levels of IL10 levels than the 
susceptible strains. Panel C. We compared IL10 plasma levels in susceptible (red dots) 
vs. resistant (blue dots) groups at the selected analyzed time points. We found that IL10 
levels were significantly higher in plasma of resistant strains at early time points (8 and 
12 hours) however, at 24 hours post infection both susceptible and resistant strains IL10 
levels dropped and no statistical differences between their levels. Significance between 
susceptible and resistant strains IL10 levels were calculated based on Mann-Whitney 
test. We applied Kruskal-wallis test to assess statistical significance of differences in 
levels of IL10 between and across time points (stages of infection) (panels A and B). In 
general a p-value of < 0.05 was considered significant. (For number of samples analyzed 
please refer to page 65 footnote).  
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infection (Figure 4-7-C). The association of higher levels of anti-inflammatory IL10 
suggested that an active immunosuppressive of the cytokine avalanche might be the 
mechanism of resistance and protection against sepsis. While highly susceptible strains 
had lower levels of IL10 suggesting an unchecked cytokine response was associated with 
higher severity of sepsis.  
 
IFNγ was significantly higher in susceptible strains at 24 hours post infection; 
however, in resistant strains there were no significant increase in levels of IFNγ (Figure 
4-8-A and 4-8-B). Comparing levels of IFNγ resistant to susceptible strains, again 24 
hours susceptible strains had higher levels, this being a biologically relevant time point 
for IFNγ actions. (Figure 4-8-C) Collectively, results from pro-inflammatory cytokines, 
IL6, TNFα and IFNγ, showed increase in levels in susceptible across time points 
suggested that systemic acute response in susceptible strains. However, these increase 
were also seen in resistant strains (Figures 4-5, 4-6, and 4-8 panels A and B), yet we 
postulated that the increase in these pro-inflammatory cytokines was neutralized or 
modulated by anti-inflammatory cytokines in resistant strains. Therefore, we compared 
anti- to pro- inflammatory cytokines ratios, as shown in Figure 4-9 comparing IL10/IFNγ 
ratios. This comparison reveled that resistant strains had higher levels of IL10/IFNγ ratio 
at all time points post infection and even at 0 h prior to infection. Collectively, our data 
suggest that susceptibility to severe GAS sepsis is mainly associated with unchecked 
production of pro-inflammatory cytokines and mediators at early time points. Meanwhile, 
protected mice are better able to down regulate excessive inflammatory responses and 
hence are protected against STSS. Our cytokine profiling analyses validated the pathways 
discovered through our transcriptome profiling of blood cells from the mice at different 
time points post infection in addition to our GWAS mapping results. 
 
 Moreover, our findings outlined in chapters 3 and 4 of this dissertation are in 
concordance to the clinical disease data; where our recent human ex vivo data showed 
that IL10 exerts active suppression of exaggerated immune responses in individuals 
carrying protective HLA-II alleles (DR15/DQ6) (Nooh and Kotb in press). Whereas 
individuals carrying the STSS high-risk alleles (DR14/DQ5) mounted significantly lower 
levels of IL10 and higher levels of IFNγ (Nooh and Kotb in press).Further validation was 
done by the addition of exogenous rIL10 to PBMCs isolated from individuals carrying 
high-risk HLA-II alleles (DR14/DQ5) decreased SAg-induced T cell proliferation and 
cytokine responses (Nooh and Kotb in press). Moreover, the association of higher levels 
of IL10 with protection from sepsis was also observed in our human transcriptome 
profiles of patients with severe vs. non-severe GAS sepsis (Kanasal and Kotb in final 
preparation).  
 
Collectively, our murine in vivo and in vitro data with our human ex vivo data 
support our hypothesis that resistance (protection) is actively exerted by the production of 
the anti-inflammatory immunomodulatory IL10. In addition, IL10 is highly regulated and 
can be produced by a number of innate immune cells, including dendritic cells, 
macrophages, and most recently it has been shown to be produced by neutrophils 
(Saraiva and O'Garra, 2010).We observed that IL10 in plasma was detected at a rather 
early stage of the infection (8 and 12). Therefore, it is likely that innate immune cells are 
producing IL10. Interestingly, recent reports indicated that neutrophils can exert
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Figure 4-8. IFNγ plasma levels profiles across early time points post infection 
comparing selected highly susceptible and highly resistant ARI-BXD strains. 
We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and three 
highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107 CFU/mouse of 
hypervirulent M1T1 GAS strain We sacrificed and collected plasma for a set of mice 
per strain at each time point post infection, 8, 12, and 24 hours, therefore, there were no 
multiple bleedings of any of the mice used. In parallel, a control group of uninfected 
mice were used for collection of plasma for estimating normal levels of IFNγ in these 
selected strains. (A). Comparison of medians of levels of IFNγ in susceptible mice 
showed that levels of IFNγ increased significantly only at 24 hours post-infection 
compared to pre-infection (zero hour). In addition, levels at 24 hours were significantly 
higher than 12 hours post infection Panel B. Resistant strains showed increase in levels 
of IFNγ post-infection, however, none reached statistical significance. Panel C. We 
compared IFNγ plasma levels in susceptible (red dots) vs. resistant (blue dots) groups at 
the analyzed time points. There were significant differences in levels of IFNγ between 
resistant and susceptible strains only at 24 hours, which is the biologically relevant time 
point for IFNγ actions. Statistical significance comparing resistant to susceptible groups 
was based on Mann-Whitney test. We applied Kruskal-wallis test to assess statistical 
significance of differences in levels of IFNγ between and across time points (stages of 
infection) analyzed (panels A and B). In general a p-value of < 0.05 was considered 
significant. (For number of samples analyzed please refer to page 65 footnote). 
  83
B Resistant strains  A Susceptible strains 
C 
  84
Figure 4-9. Comparison of ratios of anti-inflammatory to pro-inflammatory 
cytokines, comparing ratios of medians of IL10/IFNγ plasma levels across early time 
points post infection in selected highly susceptible and highly resistant ARI-BXD 
strains. 
 
 
 
We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and three 
highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107 CFU/mouse of 
hypervirulent M1T1 GAS strain We sacrificed and collected plasma for a set of mice 
per strain at each time point post infection, 8, 12, and 24 hours, therefore, there were no 
multiple bleedings of any of the mice used. In parallel, a control group of uninfected 
mice were used for collection of plasma for estimating normal levels of IL10 and IFNγ 
in these selected strains. Data for individual cytokines were shown in Figures 4-7 and 4-
8. Shown here are data from Figures 4-7 and 4-8 reanalyzed where medians of each 
cytokine at each time point was calculated and ratio of medians of IL10/IFNγ was 
calculated. Resistant group showed higher ratio of IL10/IFNγ than susceptible group at 
all the compared time points, indicating that anti-inflammatory levels are governing the 
immune response in resistant strains, adjusting the pro-inflammatory levels to 
appropriate levels and keeping the pro-inflammatory cytokines in check. Higher levels 
of IL10 were generally associated with protection, where we postulate that uncontrolled 
pro-inflammatory cytokine avalanche leads to sepsis in the current studied GAS sepsis 
model. (For number of samples analyzed please refer to matierials and methods 
section). 
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immunomodulatory effects by secreting IL10 (Cassatella et al., 2009; Zhang et al., 
2009b). These findings are interesting as it agrees with our hypothesis of IL10 exerting 
active suppression of exaggerated immune responses and hence high levels of IL10 are 
associated with protection. More detailed studies to support or refute this hypothesis are 
needed, with further dissection of the causal agent and modulator of IL10 levels, which 
we hypothesized to be PGE2 as discussed in the next section. In conclusion, the 
association of GAS sepsis severity with cytokines exerting their effects temporally 
underscores the complexity of traits modulating severe GAS sepsis. 
Analysis of the Role of Prostaglandin at Early Stage of Infection 
The QTLs we mapped to Chr 2 have several immune-related genes that are 
polymorphic and made biological sense. We narrowed down our QTLs using multiple 
bioinformatics tools including linkage analyses, gene ontology analyses, and 
polymorphism analyses; at this point we had a candidate gene list that we parsed into 
pathways. The resultant pathways were validated by selecting key genes in each pathway 
and validating differential levels in susceptible and resistant strains post infection (as 
detailed in chapter 3). Real time PCR analyses associated differential susceptibility with 
two main pathways, IL1 and prostaglandin E pathways (Abdeltawab et al. 2008 and 
chapter 3 in this dissertation). In this section of the dissertation, I am going to focus on 
studies we performed to find prostaglandins association with differential susceptibility to 
GAS sepsis.  
 
There are a total of five prostaglandins genes located either within our two main 
mapped QTLs on Chr 2 or located in their proximity. These genes were differentially 
expressed in our quantitative PCR analyses, however, we didn’t detect these differences 
in our array data at the time points we selected. The five prostaglandin genes in our QTL 
include, prostaglandin D2 synthase (Ptgds), Chr 2 (25.28 Mb), which is a polymorphic 
(see Appendix C) gene encoding a lipocalin-type prostaglandin. Over expression of Ptgds 
in lung was associated with better outcomes in bacterial pneumonia model (Joo et al., 
2007). Two other prostaglandins are located in the proximity of mapped QTLs, 
prostaglandin-endoperoxide synthase 1 (Cox-1) (Chr 2 (36.05 Mb)) and prostaglandin I2 
(Ptgis) aka prostacyclin (Chr 2 (166.89 Mb)). Prostacyclin has immunoregulatory 
properties similar to PGE2, with immunosuppressive actions on macrophage in infectious 
diseases (Aronoff et al., 2007). Of particular interest are prostaglandin E synthases 1 
(Ptges) and 2 (Ptges2), on Chr 2, at 30.71 and 32.21Mb, respectively. These two genes 
were quite interesting as we found that increased expression levels of Ptges and Ptges2 
were associated with increased susceptibility to GAS sepsis (chapter 3 in this dissertation 
and (Abdeltawab et al., 2008). Although following Occam’s razor principle one would 
postulate that one gene within these QTLs might be the modulator of the differential 
susceptibility observed. In addition, it might be that the co-existence of these immune-
related genes is by chance since the QTL is huge (~10Mb in size) allowing co-existence 
of multiple immune-related genes. However, we found that these candidate genes were 
polymorphic (Appendix C), in addition, pathway analyses revealed that these mapped 
genes act together, moreover, our QTL acts as cis-acting QTL.
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  Based on our QTL analyses and our quantitative gene expression analyses and 
literature associated with other infectious diseases, we hypothesized that exaggerated 
production of prostaglandins E2 (PGE2), the product of PTGES, in susceptible strains 
might predispose them to severe response to GAS. Meanwhile, controlled amounts of 
PGE2 in resistant strains could modulate a balanced response. To test our hypothesis, we 
aimed to quantify PGE2 levels in susceptible and resistant strains at early time points post 
infection that are more relevant to the quick responses mounted by PGE2. Being a lipid 
mediator, PGE2 can exert its actions within few minutes post infection and is crucial in 
the first 24 hours of infection (reviewed in [Harris et al., 2002; Bos et al., 2004; Sakata et 
al., 2010]). Therefore, we investigated the levels of PGE2 at 30 minutes intervals after 
infecting susceptible and resistant strains with the hypervirulent M1T1 GAS strain. We 
sacrificed 4 mice per strain at each time point, examining the first 2 hours in 30 minutes 
intervals (30, 60, 90 and 120 minutes) following infection (Figure 4-10). We found that 
susceptible strains had significantly higher PGE2 levels compared to resistant mice, 
especially during the first 60 min post-infection (Figure 4-10). This suggested that our 
hypothesis is valid and matched our real time PCR expression data of Ptges and Ptges2, 
our mapped QTL, and the association between increased levels of PGE2 and severe of 
GAS sepsis. Further studies to elucidate the mechanism of action are undergone in the 
laboratory.  
 
Our finding that higher levels of PGE2 association with severe GAS sepsis along 
with our finding its synthases in our mapped QTL in our GWAS (Chapter 3, Appendix A 
and Abdeltawab et al. 2008). These synthases are polymorphic (Appendix C) and their 
levels are differential expressed as observed in our qPCR results (Chapter 3 and 
Abdeltawab et al. 2008). Collectively this led us to believe that PGE2 is an excellent 
candidate modulator of differential susceptibility, however, the mechanism of modulation 
needs further studies especially that PGE2 mechanism of action is complicated by the 
fact that it acts as a Janus mediator. PGE2 can act as pro-inflammatory mediator inducing 
IL6 production and causing vasodilatation and vascular leakage in inflammatory 
responses (reviewed in [Harris et al., 2002; Bos et al., 2004; Sakata et al., 2010]). Both 
events are crucial in GAS sepsis severity. In addition, PGE2 can act as an 
immunosuppressive, reducing neutrophil migration and bacterial killing by macrophages, 
by blocking production of reactive oxygen intermediates (ROI) (Sakata et al. 2010). 
 
Moreover, it has been debated whether PGE2 promotes Th1 or Th2 responses, 
however, recent studies show that PGE2 activates its EP2 and EP4 receptors, and 
promotes Th1 differentiation and Th17 expansion (Yao et al., 2009)However, the two 
faces of PGE2 are not mutually exclusive, as PGE2 actions depend on multiple factors, 
including the cells it is exerting its actions on, stage of infection, receptors being 
activated and nature of the activation signal, and more importantly the concentration of 
PGE2. Where studies have shown that if the fine balance of this mediator is disturbed it 
can lead to pathological consequences. For example alterations in the amounts of PGE2 
are associated with high risk of infection with HIV, cancer, and malnutrition (Lima et al., 
2006; Anstead et al., 2009; Greenhough et al., 2009). 
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Figure 4-10. Analysis of prostaglandin role at early stages of severe GAS sepsis. 
Higher levels of PGE2 in susceptible strains at all examined stages of infection were 
observed. We used the parental strains of BXD panel, C57Bl/6J (B6) and DBA/2J (D2), 
(n = 4 mice per strain per time point). The time points examined were, 0, 30, 60, 90 and 
120 minutes post infection. Data shows that D2 (the susceptible parental strain) has 
higher levels of PGE2 compared to B6 even before infection (0hr). Following infection 
with GAS (2X107 CFU), D2 PGE2 levels remained high throughout the observed 120 
min following infection except for a drop at 90 min. Meanwhile, B6 seemed to maintain 
a steady level of PGE2 with a trend of slight increase at 30-60 min then back to starting 
levels at 90-120 min. 
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  Excitingly, studies have shown that PGE2 can inhibit production of IL10 from T 
cells, and to exacerbate Th17 mediated inflammation (Boniface et al., 2009; Yao et al., 
2009). In the studies outlined in this dissertation we have shown that susceptibility and 
poor outcome of sepsis were associated with higher levels of PGE2 (Figure 4-10), and 
IFN (Figure 4-8) and lower levels of IL10 (Figure 4-7). Therefore, we hypothesis that 
PGE2 can act as a “switch”, where in susceptible strains PGE2 can inhibit IL10 
production, and increase IFN levels, thereby promoting Th17 mediated inflammation. 
Meanwhile, we believe that in resistant strains PGE2 is produced in controlled levels, 
allowing Th1 and Th17 polarization and subsequent containment of infection. We are 
even more interested in this interactive role of PGE2 and IL10 as our recent in vitro 
human studies showed that IL10 mediates protection against severe GAS sepsis 
(discussed above). In addition, our mouse genome-wide expression pathway analyses 
identified IL10 pathways to be upregulated in resistant strains at early time points (8h) 
(Figure 4-2) associating high levels of IL10 with resistance to GAS sepsis and better 
outcomes of infection.  
Conclusion 
 Our genome-wide transcriptional analyses of infected vs. uninfected resistant and 
susceptible strains revealed differentially expressed genes that belong to innate immune 
response pathways that matched our mapped QTLs pathways. Moreover, our analyses of 
secreted soluble biomarkers (cytokines and prostaglandins) at the studied time points 
validated the pathways identified through GWAS and GW expression analyses. This 
shows the power of the systems genetics approach in identifying disease mechanisms, 
biomarkers and pathways that are associated with differential susceptibility to severe 
GAS sepsis. Importantly our pathway discovered in mouse matched our findings from 
clinical studies. This showed that pathways to pathways comparisons between mouse and 
human can be more readily translated than comparing gene to gene. 
Materials and Methods 
Bacteria and Infection Studies Using Mice 
 We used hypervirulent M1T1 GAS strain clinical isolate GAS 5448 (Chatellier et 
al., 2000). Bacterial culture and inoculum used in infection studies were prepared as 
detailed previously (Aziz et al., 2007). The institutional animal care and use committee 
(IACUC) at the University of Cincinnati, OH approved all procedures involving mice and 
mice tissues described in current study. 
Experimental Design of Time Series Infection Studies  
 To study the kinetics of cytokines and differential gene expression post GAS 
sepsis, we designed time course (series) experiments. In these experiments, we infected a 
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group of mice belonging to selected highly resistant and highly susceptible ARI-BXD 
strains and sacrificed the mice at selected time points post infection. In parallel, we 
injected saline to control group of mice belonging to those selected strains as above. At 
each time point, we sacrificed the mice, collected blood, using cardiac puncture 
procedure, and harvested spleens. Blood was used to isolate plasma for cytokine analyses 
and reconstituted blood (with nuclease-free saline) and preserved blood in RNALater for 
blood RNA purification at a later stage. Harvested spleens were immediately 
homogenized in RLT buffer and frozen at -80ºC till further purification of spleen RNA. 
Processing of Blood and Spleen Samples and Purification of RNA  
 We investigated the global gene expression in spleen and blood of infected vs. 
control groups of mice at selected time points. We selected highly susceptible strains 
(BXD97, BXD100, and BXD77) and highly resistant strains (BXD87, BXD48, and 
BXD73) for our analyses. We performed 2–3 biological replicates (experiments) for each 
selected highly susceptible and highly resistant strains, n = 3 mice per strain per time 
point (Figure 4-1). Data represents 7 different experiments with the use of the same 
strains overlapping multiple cohorts and comparing expression from same strain used in 
different experiments. We isolated spleen RNA using RNeasy mini (Qiagen, Valencia, 
CA) and isolated blood RNA using Mouse RiboPure kit (Ambion, Austin, Texas) 
according to manufacturer’s protocol. We pooled RNA samples per strain using RNA 
samples that passed our quality control testing of integrity and purity as detailed below. 
Globin mRNA was removed from all blood RNA using GlobinClear kit (Ambion). All 
RNA samples (blood and spleen) were treated for removal of DNA contamination and 
RNA was further purified by re-precipitation using ethanol precipitation. All RNA 
samples were checked for RNA purity and integrity. RNA purity was evaluated using the 
260/280 and 260/230 absorbance ratios; RNA samples with 260/280 and 260/230 values 
of ≥1.8 were chosen. Further, RNA integrity was assessed using 1% RNA denaturing 
agarose gels. We required clear sharp bands of 18S and 28S rRNA for all samples 
compared to a control RNA sample to ensure intactness of RNA. 
Microarray Platform and Design 
  We used Illumina mouse GW-6 v2.0 BeadChip; probes cover more than 45,200 
transcripts per sample, targeting genes and known alternative splice variants. The probes 
content is derived from the NCBI Reference Sequence (RefSeq) (Build 36, Release 22), 
supplemented with probes derived from the Mouse Exonic Evidence Based 
Oligonucliotide (MEEBO) set, as well as exemplar protein-coding sequences described in 
the RIKEN FANTOM2 database. 
  
We used RNA samples that passed quality control as detailed above and of 
concentration ≥ 50ng/ul for cRNA synthesis using Illumina TotalPrep RNA amplification 
kit (Ambion) according to manufacturer protocol. The basic outline of the procedure 
involves reverse transcription of RNA to synthesize cDNA using oligo (dT) primer, 
followed by in vitro transcription of purified dsDNA to synthesize amplified biotinylated 
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cRNA (aRNA). We evaluated purified labeled cRNA using same methods as mentioned 
above for RNA samples. cRNA samples of good quality were then used to hybridize to 
Illumina mouseWG-6 v2.0 according to Illumina standard protocols. 
 
 This data set consists of arrays processed in four batches or groups, where groups 
of 2, 4, 1, and 4 beadchips were scanned at a time. Samples from seven different ARI-
BXD strains were compared at 5 time points (0, 8, 12, 16 and 24 hours post infection) 
belonging to two different tissues, blood and spleen. A single operator processed all 
arrays using illumina protocol for hybridization, washing and scanning. All samples in a 
group were labeled on one day and chips were scanned using BeadArray Reader. 
Microarray Data Processing and Analysis 
 Pooled RNA samples from blood and spleens (n = 60 samples) were processed 
using a total of 10 Illumina mouseWG-6 BeadChips. All chips passed quality control and 
error checking. This data set was extracted and processed using the Bead Studio 3. We 
applied 75th percentile normalization to all the samples and the resulting expression 
values were analyzed for statistical significance of differences between susceptible and 
resistant strains at different time points in the studied tissues.  
Identification of Differentially Expressed Genes and Functional Pathways Analyses  
 We performed functional analyses of differentially expressed genes from our 
genome-wide transcriptome analyses using Ingenuity pathways analysis (IPA) 
(www.ingenuity.com). Each data set containing gene identifiers was uploaded into the 
online application, and each gene was overlaid onto a molecular network developed from 
information contained in the ingenuity pathways database. We chose IPA most 
significant “Canonical Pathways”, which are pathways identified from the Ingenuity 
Pathways Analysis library of pathways to be most significant to the data set. The 
Canonical Pathways are displayed as y-axis in bar charts; x-axis displays the significance 
in (–log (P-value)) where the higher the number the more likely the association is not by 
chance. In addition a ratio is calculated for each pathway, which is the number of 
differentially expressed genes divided by total number of molecules in this pathway. 
Therefore, taller bars have more genes associated with the Canonical Pathway than 
shorter bars. The significance of the association between the dataset and the pathways 
was measured in two ways: (1) the ratio (described above) and (2) by Fisher’s exact test 
with P < 0.001. 
Cytokine Measurements and Analyses 
 We studied the kinetics of plasma cytokine production in selected highly resistant 
and susceptible strains. Groups of 3–5 mice per strain per time point from selected highly 
susceptible and highly resistant ARI-BXD strains, which were infected with 2 ± 1.5 x 107 
CFU/mouse of a hypervirulent M1T1 GAS strain. In parallel, a control group of 
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uninfected mice were used for collection of plasma for estimating normal levels of 
cytokines in these selected ARI-BXD strains. We euthanized mice and collected blood 
using cardiac puncture procedure into heparin-coated tubes. We separated plasma from 
individual mice, added protease inhibitor cocktail to each plasma sample and stored 
samples at -20ºC till further use. We measured cytokines levels in plasma of 
representative 2 mice per strain of highly resistant (BXD48, 73 and 87) and highly 
susceptible strains (BXD100, 77 and 97), with exceptions where we assayed more 
samples from some strains as indicated in footnote of Figure 4-5. We analyzed data 
collected for time points 8, 12, and 24 hours post-infection. We used a multiplex cytokine 
ELISA kit from Millipore (Billerica, MA) to detect 4 cytokines: interleukin 6 (IL6), IL10, 
tumor necrosis factor alpha (TNF), and gamma interferon IFNγ. The analyzed data 
shown in Figures 4-5 to 4-9 are representive of susceptible and resistant groups, where 2 
mice per strain (mentioned above) per time point were analyzed,  with the exception of 
BXD 97 at 8 and 12h we used 4 mice and for BXD77 we used 4 and 6 mice at 12 and 24 
h respectively, and BXD87 at 8, 12 and 24 h 4 mice were used and one mouse at 8 hours 
of BXD48. We collected far more plasna samples that are to be assayed.  All other data 
shown in Figures 4-5 to 4-9  are for 2 mice per strain (3 strains used) per time point (4 
time points analyzed). 
Prostaglandin Studies 
  We selected parental strains for studying the role of prostaglandins in modulating 
differential susceptibility to infection. Mice (6-8 weeks-old mice of DBA/2J susceptible 
parent strain and the C57Bl/6J resistant parent strain) were purchased from The Jackson 
Laboratory (Bar Harbor, Maine). To test the effect of prostaglandins on differential 
responses to GAS sepsis, we studied early systemic prostaglandin E2 (PGE2) production 
(within the first 2 hours of infection) in 30 minute intervals (30, 60, 90 and 120 minutes) 
following inoculation. We infected mice with 2 X 107 CFU/mouse of the hypervirulent 
M1T1 GAS strain, and sacrificed 4 mice per strain per time point. Bacterial suspensions 
used for infection of mice were prepared as detailed in Aziz et al. (2007). We collected 
blood using a standard cardiac puncture procedure and dissected the spleens and 
homogenized them using a tissue homogenizer, TH (Omni International, Marietta, GA) in 
2 ml of PBS. Tissue homogenates were stored frozen at -20ºC and sent on dry ice to the 
University of Michigan, Ann Arbor, MI. The homogenates were thawed then centrifuged 
at high speed (13,000 RPM) for 5 min to remove particulates. PGE2 levels were 
quantified in spleen homogenate supernatants using an enzyme-linked immunosorbent 
assay (ELISA) PGE2 kit according to the manufacturer’s instructions (Assay Designs, 
Ann Arbor, Michigan). 
Statistical Analyses  
 We used ANOVA and t unpaired test to assess significance of differentially 
expressed genes in either resistant or susceptible group at a given stage of infection 
compared to its uninfected control group, using GeneSpring GX 11.0 (Agilent 
technologies, Inc.). Normalization of microarray data is detailed above.  
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We used Kolmogorov-Smirnov test to assess normal distribution of our cytokine 
data, we found that our cytokine data was not normally distributed, and since the number 
of samples in some of the tested groups was less than 10, we didn’t apply any 
normalization methods. Since our data showed that samples had non-normal distribution, 
we applied the non-parametric tests detailed below To assess statistical significance of 
differences in levels of different cytokines across time points analyzed we used Kruskal-
Wallis test. We evaluated the statistical significance of levels of a given cytokine at a 
given time point in resistant vs. susceptible strains by using Mann-Whitney test. In all the 
statistical tests we performed, a P-value less than 0.05 was considered significant. All 
data was analyzed using GraphPad Prism (La Jolla, CA).  
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CHAPTER 5. ANALYSIS OF CELLULAR POPULATIONS MODULATING 
DIFFERENTIAL RESPONSE TO SEVERE GAS SEPSIS 
Summary  
 We have previously mapped quantitative trait loci (QTLs) associated with 
differential susceptibility to severe GAS sepsis using advanced recombinant inbred (ARI) 
ARI-BXD strains (Abdeltawab et al., 2008).We narrowed down these QTLs and parsed 
candidate genes into pathways associated with severity to GAS sepsis. We then compared 
pathways discovered through in vivo genome-wide association studies with those 
discovered through genome-wide transcriptome analyses and found that they matched 
quite well and even more interestingly, some of these pathways were interacting with 
each other. Subsequently, we aimed to explore the role of the key genes in those 
discovered pathways in modulating differential host responses to GAS sepsis (covered in 
Chapter 4).  
  
 In this chapter, we examined the cellular differences between resistant and 
susceptible strains to help us further elucidate cellular mechanisms underlying the 
differentially expressed candidate genes in modulating the differential susceptibility to 
GAS sepsis. To achieve this, we first aimed to examine and characterize differences in 
immune cell populations of blood and spleen of selected resistant and susceptible strains 
under normal physiological conditions and found that there were no significant 
differences between the susceptible and resistant strains with respect to the numbers and 
percentages of examined immune cells in both blood and spleen. This suggested that 
inherent variations in percentages of immune cell population among the 
immunophenotyped BXD strains were not linked to their differential susceptibility to 
severe GAS sepsis. Accordingly, we aimed to examine the hypothesis that migratory and 
functional differences rather than cellular availability might be a possible mechanism of 
resistance.  
 
 Subsequently, we aimed to examine the possibility that differences in cellular 
responses may account for the differential susceptibility to GAS sepsis in our mouse 
model. Specifically, we wanted to test the hypothesis that effective innate responses in 
the early stages of infection is directly associated with resolution of GAS infection, and 
better outcome of GAS sepsis. We based our hypothesis on studies from our group and 
other groups that showed that neutrophils (Voyich et al., 2004; Buchanan et al., 2006; 
Nilsson et al., 2006; Soehnlein et al., 2008a; Navarini et al., 2009), macrophages 
(Goldmann et al., 2004a; Thulin et al., 2006; Goldmann et al., 2009), NK cells 
(Goldmann et al., 2005b; Takahashi et al., 2007) and dendritic cells (Loof et al., 2008; 
Cortes and Wessels, 2009; Yong et al., 2009), each play an important role in 
streptococcal infections according to the site and the stage of infection. We started our 
cellular dissection by examining the role of neutrophils in differential susceptibility to 
GAS sepsis. Neutrophils are dominant cells in circulation and thus mediate early innate 
immune response. It has been shown that recruitment, migratory and functional defects in 
neutrophils result in increased mortality post bacterial infection (reviewed in [Nauseef, 
2007]).  
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 To examine the likely contribution of neutrophils in modulating differential 
susceptibility in our GAS sepsis model, we first depleted neutrophils and assessed how 
this may affect infection outcomes in susceptible vs. resistant ARI-BXD strains. We 
depleted neutrophils using anti-mouse Ly-6G and Ly-6C (RB6-8C5) (Czuprynski et al., 
1994) 24h prior to infection and found that this rendered resistant BXD strains 
susceptible. This was associated with an increased bacterial load in depleted mice vs. 
control mice. The reversal of phenotype of resistant strains, while susceptibility was 
exaggerated in susceptible strains, confirmed the key role of neutrophils in controlling 
GAS sepsis.  
 
 We also depleted macrophages using clodronate liposome (Van Rooijen and 
Sanders, 1994) in susceptible and resistant strains and found similar results with reversal 
of phenotype of resistant strains and exaggerated susceptibility of the susceptible strains. 
These results demonstrate the important role of both neutrophils and macrophages in 
modulating differential host responses in GAS sepsis. We also examined the kinetics of 
neutrophils and macrophages in the first 24 h post infection and found no significant 
differences between susceptible and resistant BXD strains. However, peripheral blood 
monocytes were significantly higher in susceptible strain at 16h post infection further 
showing that even higher numbers of monocytes did not contribute to better outcome of 
sepsis.  
 
 The above data suggested that the numbers of neutrophils and macrophages are 
not the determinant of the outcome of infection as susceptible strains had an equal or 
higher numbers of these cells as the resistant strains. Collectively, our data suggest that 
functional and/or migratory differences in these cells play an important role in 
modulating differential susceptibility. 
Results and Discussion  
Profiling of Blood Cell Populations across Selected Resistant and Susceptible 
Strains Reveals Possible Migratory and Functional Differences Rather than Cellular 
Availability as a Possible Mechanism of Individual Variations in Susceptibility to 
Severe GAS Sepsis 
 Homeostasis is a dynamic system regulated by complex interactions between 
environmental and genetic factors. Blood cellular percentages, platelet counts and 
erythroid traits have been associated with several QTLs using both inbred and BXD 
strains (Chen and Harrison, 2002; Peters et al., 2005; Ferreira et al., 2009) GAS has 
multiple virulence factors that affect and interfere with host homeostasis, for example, 
interruption of coagulation system (Tapper and Herwald, 2000; Frick et al., 2007), as one 
of the causes of pathogenesis. 
  
 The parental strains of the BXD panel, C57Bl/6J and DBA/2J, show significant 
differences in numbers and percentages of lymphocytes and granulocytes populations in 
blood (Chen and Harrison, 2002; Kile et al., 2003; Petkova et al., 2008). Therefore, we 
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wanted to examine if observed differential susceptibility to GAS sepsis was due to 
differences in availability of immune cells. Hence, we aimed to explore differences in the 
percentages of immune cells in the blood of selected highly resistant and highly 
susceptible ARI-BXD strains prior to infection and/or any manipulation. Using complete 
blood counts (CBC), we profiled five immune cells populations in blood (neutrophils, 
monocytes, lymphocytes, eosinophils and basophils) of highly susceptible strains 
(BXD100, BXD90, BXD75) and highly resistant strains (BXD73, BXD87 and BXD69), 
Figures 5-1 and 5-2.  
  
 We found no significant differences between resistant and susceptible strains 
indicating that differences in response to GAS sepsis is not due to differences in cellular 
populations of susceptible strains vs. resistant strains. We also found that each strain 
irrespective of its susceptibility had a unique percentage of different immune cell 
populations, for example, neutrophil percentages (NE %) was variable among susceptible 
strains ranging from 23–37 % while in resistant strains it ranged from 14.7–27 %. 
Showing no significant differences between resistant and susceptible groups, indicating 
that variability in number of cells is irrespective of their differential susceptibility, and 
that differential response to GAS sepsis is not related to inherent differences in these 
immune cells numbers. 
Immunophenotyping Analyses of Cellular Population under Normal Physiological 
Conditions in Spleen of BXD Strains Revealed No Differences in Cellular Numbers 
or Relative Percentages among Susceptible and Resistant Strains 
 We immunophenotyped spleen cellular populations in selected resistant and 
susceptible BXD strains. The spleen as a blood filtering lymphoid organ, is involved in 
mounting immune responses to extracellular blood borne pathogens such as GAS 
(Mebius and Kraal, 2005). We wanted to examine if there were any inherent differences 
in number of immune cells in spleen due to strains variability. We found no significant 
differences in the analyzed immune cell populations in spleen among highly susceptible 
and highly resistant strains under normal physiological conditions (Figure 5-3).  
  
 Altogether, these data illustrated how different combinations of polymorphic 
genes and recombinations, can result in a different manifestation from the ancestral 
parent of these strains. However, in the current study, variations in numbers of immune 
cells in both spleen and blood of selected highly resistant and susceptible strains were not 
linked to differential susceptibility to severe GAS sepsis. Our data suggest that possible 
migratory and functional differences rather than cellular availability as a possible 
mechanism of differential susceptibility to severe GAS sepsis.  
In vivo Manipulation of Cellular Populations in Susceptible and Resistant Strains: 
Depletion of Gr-1+ Cells and Macrophages Rendered Resistant Strains Susceptible 
 To this extent we have established that the numbers of immune cells at 
physiological state were not different between examined highly resistant and susceptible
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Figure 5-1. Differential blood count of selected susceptible and resistant BXD 
strains. 
 
We used 4–8 mice per sex, per strain, 8–12 weeks-old. The data show no significant 
differences between resistant and susceptible strains. Since there were significant 
differences in NE% between sexes of same strain (BXD69), we are showing males 
separate from females for all the results. LY lymphocytes, NE neutrophils, MO 
monocytes, BA basophiles, EO eosinophils. Significance based on Student t-test p < 
0.01. 
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Figure 5-2. Diagram showing a scheme for flow cytometric analysis of immune cell 
populations in spleen employed in the current study. 
We used CD19-FITC to characterize total B cells in spleens (panel A). To characterize 
main subpopulations of T lymphocytes, we used a mixture of CD3-FITC, CD8-PE and 
CD4-APC, we defined CD3+, CD4+ as T helper cells (panel B), and CD3+ CD8+ as T 
cytotoxic cells (panel C). Natural killer cells were gated as CD3-, CD49b+, where CD49b 
is a pan NK cells marker that is expressed on both parental strains NK cells. We 
differentiated between granulocytes and macrophages based on granularity (side scatter 
(SSC)) and CD11b staining as shown in panel E, where we gated on CD11b+ with high 
granularity and designated this as total granulocytes (panel G) while CD11b+ cells with 
lower granularity (SSClo) were assigned a separate gate and designated as macrophages 
(panel F). Macrophages were then categorized based on their Gr-1 and CD11c expression 
into resident and inflammatory macrophages (Mø) as shown in panel F. Total 
granulocytes population (panel G) were then analyzed based on their Gr-1 and SSC into 
neutrophils and eosinophils as indicated in panel G.  
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Figure 5-3. Immunophenotyping of spleen cellular populations in selected resistant 
and susceptible BXD strains. 
 
 
 
We used 3–8 mice per sex per strain; age 8–12 weeks old. There were no significant 
differences in any of the analyzed cellular populations due to sex; therefore, data shown 
in this Figure represents pooled males and females per strain.  There were no significant 
differences (P ≤ 0.01) between resistant and susceptible strains when comparing 
different immune cell populations in spleen. NE neutrophils, Mø macrophages, EO 
eosinophils, and NK natural killer cells. † NK cells were not analyzed for BXD73. 
 
† 
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strains. Therefore, migratory and/or functional differences rather than cellular availability 
may possibly account for the differential susceptibility to severe GAS sepsis. Therefore, 
we aimed to dissect the role of neutrophils and macrophage in differential susceptibility 
to severe GAS sepsis. We selected neutrophils (PMNs) and macrophages as our genome-
wide association studies and our transcriptome analyses suggested key roles for these two 
cell populations in modulating severe GAS sepsis (Abdeltawab et al., 2008).  
 
 Neutrophils and macrophages play an important role in modulating host responses 
to GAS sepsis (Goldmann et al., 2004a; Voyich et al., 2004; Medina and Lengeling, 
2005). To dissect the role of these cells, we examined the effect of depleting them in vivo 
on differential mice susceptibility to severe GAS sepsis. We selected highly susceptible 
strains (BXD100 and BXD77) and highly resistant strains (BXD48 and BXD69) to test 
the effect of depleting Gr-1+ cells on GAS sepsis severity and outcomes (Figure 5-4). 
 
 Two days prior to the infection, we quantified the PMNs in all mice, and then at 
24 hours prior to the infection, we injected a group of mice i.v. with 200 g of anti-
mouse Ly-6G and Ly-6C (RB6-8C5) antibody (Ab) which depletes Gr1+ cells within 12-
24 hours. This depletion only lasts for 48h at which point PMNs are replenished by the 
bone marrow. In parallel, we injected a matching control group with isotypic control Ab 
(purified rat anti-mouse IgG2b κ).  To verify neutrophil depletion in the (RB6-8C5) Ab 
treated group, we measured CBC/differential blood counts. 
 
 We then infected both groups with 107 CFU/mouse of hypervirulent M1T1 GAS 
strain, and monitored their survival every 2 hours for the first 44 hours then every 8h till 
day 6 post infection, when all surviving mice were sacrificed. We found that the Gr-1 
depleted resistant mice were rendered susceptible; indicating the key role of Gr-1 cells 
(PMNs and monocytes) in host defense against GAS sepsis. We found similar results 
when we depleted macrophages using clodronate liposomes. Both studies emphasize the 
role played by neutrophils and macrophages in resistance to severe GAS sepsis. Our 
results indicated that the first 24 hours of infection are crucial in determining the outcome 
of infection and the fate of the mice whether the mice will survive or succumb to the 
infection. This conclusion is based on the finding that despite the fact that PMNs are 
replenished at 48 hours post depletion and are increased in numbers this did not help 
anymore in fighting the infection (Figure 5-4). Our results are in concordance with 
(Goldmann et al., 2004b) where depletion of macrophages prior to or during the first 24 h 
of infection affected mice susceptibility and that depletion of macrophages 48 hours post 
infection had no effect on mice survival.Therefore, our next step was to examine the 
kinetics of cellular populations in blood in the first 24 hours of infection in highly 
susceptible and resistant strains. 
 
To examine the kinetics of neutrophils and monocytes in blood post infection, we 
measured percentages of these cells in susceptible and resistant strains at 8, 12 and 16 h 
post infection. We found no significant differences between resistant and susceptible 
strains (Figure 5-5). We also examined if there were any differences in further earlier 
time points of infection (2 hours) at intervals of 30 minutes, and we again found that 
there were no significant differences in numbers or percentages of neutrophils between 
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Figure 5-4. Depletion of Gr-1+ cells in selected resistant and susceptible BXD strains 
shows reversal of survival in response to GAS sepsis. 
 
Summary of Gr-1+ depletion studies showing survival curves as percent survival on the 
right hand side, where depleted group are in solid lines and control group injected with 
isotypic control in dashed lines. Resistant strains were rendered susceptible, indicating 
the beneficiary effect of NEUTROPHILs in modulating host response to severe GAS 
sepsis. The bar graphs on the left represent percentage of neutrophils pre antibody 
injection, 24 hours post antibody injection and 24h post infection with GAS. 
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Figure 5-5. Kinetics of neutrophils and monocytes at early time points post GAS 
infection. 
Susceptible and resistant strains were infected with 2 X 107 CFU/mouse of M1T1 
hypervirulent GAS strain. We collected blood from 3–4 mice per strain per time point 
and evaluated percentages of neutrophils and monocytes at selected time points post 
infection. There were no significant differences in percentages of neutrophil at examined 
time points between susceptible strains compared to resistant ones.  Interestingly, 
monocytes were higher at 16 h post infection in susceptible strains. Significance was 
calculated using on Student’s t-test, with p ≤ 0.05 considered significant. 
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resistant and susceptible strains at 30–90 minutes post infection. However, at 120 minutes 
(2h) post infection susceptible strains had significantly higher numbers of neutrophils 
(Figure 5-6). 
Conclusions 
 In this chapter, we found that there were no significant quantitative differences in 
the number of immune cells in blood and spleens of resistant and susceptible strains 
under normal physiological conditions. This led us to investigate if neutrophils and 
macrophages play a role in modulating differential response in GAS sepsis. We found 
that depletion of both cell types prior to, or within 24 h of GAS infection rendered 
resistant strains susceptible. We then examined the kinetics of neutrophils and monocytes 
post infection in susceptible and resistant strains and found no significant differences in 
numbers post infection. This suggested that numbers of neutrophils and monocytes 
available may not be a major determinant factors of the outcome of infection as 
susceptible and resistant strains had an equivalent numbers of these cells. Together our 
data suggest that functional differences in these cells may play an important role in 
modulating differential susceptibility. 
 
This led us to initiate studies analyzing the role of neutrophils and pattern 
recognition receptors, NOD like receptor family (NLR) and in particular Nlrp3 (Craven 
et al., 2009; Harder et al., 2009; Munoz-Planillo et al., 2009), in modulating differential 
response to bacterial sepsis. This work along with further in vitro functional assays are 
being planned and outlined and will be a future direction for the project after completion 
of the current dissertation. 
Materials and Methods 
Experimental Design of Immunophenotyping Studies 
 To characterize the main immune cell populations in blood and spleen of BXD 
strains displaying differential susceptibility to GAS sepsis, we selected highly resistant 
strains (BXD73, BXD69, and BXD87) and highly susceptible strains (BXD100, BXD90, 
and BXD75). We collected blood and harvested spleens from 8–16 mice per strain, 8–12 
weeks-old, age-matched males and females at physiological conditions. Where the mice 
were housed in a pathogen-free colony in autoclaved pressurized individual ventilation 
(PIV) cages (4 mice/cage) at the University of Cincinnati, Cincinnati, OH. The mice used 
in the immunophenotyping studies were maintained on a 12 hours light dark cycle, and 
were fed ad libitum sterile irradiated rodent chow (Harlan Teklad, Madison, WI). All 
procedures involving mice were approved by the institutional animal care and use 
committee (IACUC) at the University of Cincinnati. 
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Figure 5-6. Comparison of the kinetics of neutrophils and monocytes numbers in 
susceptible versus resistant strains during the first 2 hours post GAS infection. 
Susceptible and resistant strains were infected with 2 X 107 CFU/mouse of M1T1 
hypervirulent GAS strain. We collected blood from 3–4 mice per strain per time point 
and evaluated percentages of neutrophils and monocytes at selected time points post 
infection. There were no significant differences in percentages of neutrophil at examined 
time points. Significance was calculated using on Student’s t-test, with p ≤ 0.05 
considered significant. 
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Differential Blood Counts 
 We measured numbers and percentage of different immune cells populations in 
blood using automated complete blood counts (CBC) with differentials. We euthanized 
age-matched (8–12 weeks-old) mice (n = 4–8 mice/sex/strain) and collected their blood 
using cardiac puncture immediately into 0.5 M K2EDTA coated tubes. We performed 
CBC with differentials using Hemavet 950 automated hematology analyzer (Drew 
Scientific Inc, Oxford CT). We collected data for 5 immune cell populations: 
lymphocytes, monocytes, eosinophils, basophiles and neutrophils across selected 
susceptible and resistant ARI-BXD strains. 
Flow Cytometric Analyses of Splenocytes 
 We used flow cytometric analysis to inspect percentages of different immune cell 
populations in spleens. We harvested spleens from 8–16 mice/strain, age-matched (8–12 
weeks-old) males and females belonging to the above-mentioned BXD strains. We 
prepared single cell suspension of splenocytes using cell strainer method using a nylon 
mesh 70 μm (BD Biosciences, San Jose, CA). During the following procedures, 
splenocytes were kept on ice at all possible times. Cell suspensions were pelleted by 
centrifugation at 400 xg for 5 minutes at room temperature. We discarded the 
supernatants and lysed RBCs using 1X RBC lysis buffer (eBioscience, Inc, San Diego, 
CA). We washed the cells twice with FACS buffer (phosphate buffered saline (PBS), 2% 
fetal bovine serum (FBS) and 2 mM EDTA), and resuspended the cells in 10 ml of FACS 
buffer. We counted the splenocytes single cell suspensions using hemocytometer and 
brought the samples to a concentration of 107 cells/ml in FACS buffer. 
 
We stained 106 cells with the following anti-mouse antibodies, CD19-FITC, 
CD3-FITC, CD8-PE, CD4-APC, CD49b-PE, CD11b-FITC, CD11c-APC, Gr-1-PE (Ly-
6G and Ly-6C, RB6-8C5), and corresponding isotype controls (BD Biosciences, San 
Jose, CA). Cell populations and cell surface markers used to identify these populations 
are listed in Table 5-1. Data acquisition and preliminary analysis were done using BD 
CellQuest Pro on a BD FACSCalibur flow cytometer (BD Biosciences). Detailed flow 
cytometeric analyses were done using FlowJo software (Tree Star, Inc, Ashland, OR). 
We used single color staining for CD19, and staining was analyzed using single 
histogram statistics (Figure 5-1). We performed 2-color staining for NK cells (CD3 and 
CD49b), we chose CD49b as an NK cell marker as it is a pan NK cells marker that is 
expressed on both parental strains (B6 and D2) NK cells. We used 3-color staining for T 
cells (CD3, CD4 and CD8) and myeloid cells (Gr-1, CD11b and CD11c). Figure 5-1 
shows scheme of analysis of different cell populations. 
Cellular Depletion Studies 
 We used anti-mouse Ly-6G and Ly-6C (RB6-8C5) antibody (Ab) for depletion of 
Gr1+ cells. We injected 8 weeks-old males belonging to highly susceptible and highly 
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Table 5-1. Cell surface markers that were used to define spleen immune cells 
populations characterized in the current study. 
 
Cell Population Cell Surface Markers Used to 
Define the Cell Population 
T cytotoxic cells (Tc cells) CD3+, CD8+ 
T helper cells (Th cells) CD3+, CD4+ 
B lymphocytes (B cells) CD19+ 
Natural killer cells (NK cells) CD3-, CD49b+ 
Neutrophil granulocytes, leukocyte (PMNs) CD11b+, SSChi, Gr-1hi 
Eosinophils (EO) CD11b+, SSChi, Gr-1mid-low 
Resident macrophage (Mø) & dendritic cells (DC) CD11b+, SSClow , Gr-1-, CD11c+ 
 
 
resistant strains with 200 ug/mouse of RB6-8C5 Ab (iv tail) injections (Czuprynski et al., 
1994). In parallel, we injected a control group of mice with 200 ug/mouse of isotypic 
control Ab of purified rat anti-mouse IgG2b κ. We confirmed depletion by measuring 
neutrophils in blood 24 hours post Ab injections. We infected control group and Gr-1+ 
depleted group with 107 CFU/mouse of hypervirulent M1T1 GAS strain. Bacterial 
suspensions used for infection of mice were prepared as detailed in (Aziz et al., 
2007).We monitored mice survival every 2 hours for the first 44 hours until all depleted 
mice expired and then every 8h till day 6 post infection when all surviving mice were 
sacrificed. Similarly, we depleted monocytes and tissue macrophages using iv tail 
injection of clodronate-loaded liposomes (CLLs) as previously described in (Van Rooijen 
and Sanders, 1994). We followed same design for infection as above where control group 
were injected with PBS-loaded liposomes. 
Data Analysis and Statistical Analyses 
 We used FlowJo software (Tree Star, Inc, Ashland, OR) for analysis of flow 
cytometry data. Statistical analysis and graphical presentation of flow cytometry and 
CBC/differential data was done in GraphPad Prism (GraphPad Software, La Jolla, CA). 
For granulocyte depletion studies, survival fractions were estimated using Kaplan-Meier 
method and curves generated were compared using log rank test. In various experiments, 
statistical significance was based on Student’s t-test, a P-value of ≤ 0.01 was considered 
significant.  
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CHAPTER 6. SUMMARY FUTURE DIRECTIONS AND CONCLUSIONS 
Summary  
 In the studies outlined in this dissertation, we aimed to delineate host genetic 
factors modulating differential susceptibility to severe GAS sepsis.  
 
 Our laboratory has previously found an association between variations in host 
HLA-II alleles and the severity of disease outcomes. These findings were based on 
extensive epidemiological studies, which were initiated based on two important findings. 
First, the isolation of genetically identical GAS strains from both severe and non-severe 
cases of GAS sepsis underscored the role of host variation in modulating outcome of 
infection (Chatellier et al., 2000). Secondly, subsequent studies showed that there were 
variations in the magnitude of inflammatory responses elicited by the same GAS 
superantigens (SAgs) and that this correlated with the severity of GAS sepsis outcomes 
(Norrby-Teglund et al., 2000). Because SAgs are presented to T cells by HLA-II 
molecules, they hypothesized that host HLA-II allelic variations could be modulating the 
observed differential response to the same GAS isolate (Chatellier et al., 2000). 
 
 Therefore, extensive epidemiological studies were undertaken to determine the 
distribution of HLA-II haplotypes among patients with varying degrees of invasive GAS 
infections. Kotb et al. (2002) found associations between certain HLA-II haplotypes and 
high risk for STSS and that other haplotypes were associated with protection from STSS 
and/or NF (Kotb et al., 2002; Kotb et al., 2003). These breakthrough studies were then 
taken a step further to study mechanisms of interactions of the ternary complex of HLA-
II–SAgs–TCR in vivo and in vitro. Validation and dissection of the role of in HLA-II 
variation in GAS sepsis were conducted using HLA-tg mice and bare lymphocyte 
syndrome (BLS) cell lines expressing either high risk or protective HLA-II alleles (Nooh 
et al., 2007). The intriguing HLA-II studies in our laboratory are providing us with new 
exciting mechanistic data each day.  
 
 Despite the strong association between severity of GAS sepsis and host HLA-II 
polymorphism, GAS sepsis is a complex trait disease, affected by multiple interacting 
mechanisms. This elusive bacterium is rich in many other virulence factors, beside SAgs, 
of which may interact with additional host factors, other than HLA-II, to modulate 
disease outcomes. Therefore, we saw a great potential in adopting a systems approach to 
explore additional host factors modulating the severity of GAS sepsis.  
 
 A systems genetics approach is a hypothesis-free approach made feasible due to 
the coupling of powerful genetic and bioinformatics tools (Morahan and Williams, 2007; 
Chesler et al., 2008). As detailed in the introductory chapter of this dissertation, ARI-
BXD strains, which were used as a genetic reference population in our studies, are a well-
defined, genetically diverse mouse population. These strains are well defined as they are 
heavily genotyped and their ancestral parents are fully sequenced (Williams et al., 2001; 
Peirce et al., 2004; Shifman et al., 2006). This coupled with statistical analyses tools 
offered by the WebQTL platform (Wang et al., 2003; Peirce et al., 2008) provides 
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researchers, like myself, a great advantage of allowing us to easily link our measured 
traits of interest with mice genotypes and map genetic loci associated with observed 
differential response. The ARI-BXD strains, being genetically diverse, offer a huge 
advantage of having a vast genetic pool for mapping studies. This is in contrast to 
common inbred mice whose genetic pool is limited, thus in using ARI-BXD we are 
trying to mimic the genetic diversity of the human population. 
 
 Systems genetics approaches are novel in GAS sepsis field, and have just been 
recently employed in other infectious diseases (Hardy et al., 2001; Miyairi et al., 2007). 
To take advantage of such approaches, we first aimed to carefully account for and to take 
into consideration any non-genetic or environmental variations that might affect mice 
differential response to GAS sepsis. Our analyses revealed that among the various 
cofactors, age was the only significant cofactor that confounded differential response to 
GAS sepsis (Aziz et al., 2007). This was predictable based on known effects of aging on 
innate immune responses (Gomez et al., 2008) and in particular on those relating to 
sepsis (Turnbull et al., 2009). Interestingly, a recent study has dissected such age-related 
differences in immune responses in relation to severe GAS sepsis in mice (Goldmann et 
al., 2010). Based on our studies, we standardized an age range for our mice to be between 
40 to 120 days that reflects differential response and in later studies of dissecting the 
mechanisms of differential susceptibility we used age range of 60 to 90 days. 
 
  We then mapped disease-associated traits of survival, bacteremia, and bacterial 
dissemination to organs to 2 QTLs on Chr 2. The survival phenotype also mapped to an 
additional QTL on Chr X (Abdeltawab et al., 2008). Excitingly, we had a strong cis-
acting QTL and the genes within these QTLs were polymorphic and associated with 
immune response pathways which made biological sense. We then narrowed down our 
QTLs using multiple bioinformatics tools including linkage analyses, SNP 
polymorphism, gene ontology, and pathway analyses. We then validated selected key 
genes within our candidate pathways by comparing gene expression levels (qPCR) in 
selected infected vs. uninfected highly resistant and highly susceptible BXD strains.  
 
 Collectively our data suggested the involvement of two key pathways of IL1 and 
prostaglandins in modulating differential susceptibility to GAS sepsis (Abdeltawab et al., 
2008). For the survival phenotype, we found that genes within all 3 QTLs (two on Chr 2 
and one on Chr X) fell in the same or interactive pathways. In addition the QTL on Chr X 
also harbors genes likely to be involved in host-mediated pathogenesis (e.g. thrombosis, 
and coagulation). However, to further embrace our unbiased approach of systems 
genetics and to dissect mechanisms of differential susceptibility to severe GAS sepsis, we 
sought to compare genome-wide (GW) differential gene expression associated with 
differential response at different stages of infection. We designed these experiments so 
that we can gain insight into the dynamics of the host immune response during the 
infection. We compared GW differential gene expression of infected vs. uninfected mice 
of highly resistant and susceptible strains at selected times post infection.  
 
 We aimed to explore the basis of how mice react differently based on their genetic 
differences, which modulated the outcome of infection into the observed differential 
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susceptibility. In addition, we aimed to delineate stages of the infection at which 
divergence in response between susceptible and resistant strains occurs, i.e. stage at 
which their fates are being decided. We were excited to find that the same or interacting 
pathways were also pulled out with this GW transcriptome analysis approach (Chapter 4 
in this dissertation). Moreover, we found that certain pathways were associated with 
certain times post infection i.e. infection stage-specific. This was exemplified by changes 
in the IL10 signaling pathways, which were only seen in resistant strains only at 8 h post 
infection (in blood as studied “organ”). This will help us tremendously in understanding 
the molecular mechanisms underlying each stage of the infection. To add to the 
excitement, IL10 cytokine levels correlated with protection from disease severity, as IL10 
levels were significantly higher in resistant strains (p < 0.01) at early times post infection. 
Interestingly, we found significant differences between susceptible and resistant strains 
only in levels of IL10 and IFN and at certain times post infection corresponding with the 
expected time and role of each cytokine in sepsis modulation. The levels of IL10 were 
significantly higher in resistant strains starting at 8 h but showed no differences at 24 h. 
This suggests that IL10 may play an active role in regulating immune response within the 
early stage of the infection.  
  
 This becomes exceedingly exciting, when taken together with our in vitro HLA-II 
studies which showed that the protective HLA-II alleles induce high levels of IL10 
production, suggesting an active suppression as mechanism of protection against STSS. 
Further support was achieved via in vitro studies, where adding exogenous r-IL10 to 
PBMCs isolated from individuals expressing high-risk HLA alleles decreased their SAg-
induced proliferative and cytokine responses. Meanwhile, adding anti-IL10 to PBMCs 
isolated from individuals expressing protective HLA alleles increased their SAg-induced 
responses (Nooh and Kotb in press). The IL10 story gets even far more exciting with our 
microarray data on tissue samples from patients with severe and non severe GAS sepsis, 
which showed the IL10 signaling pathways as top differentially expressed pathways 
associated with disease outcomes (Kansal and Kotb in final preparation). 
 
 To further add to all the above exciting results, and to shape a bigger picture, our 
prostaglandin studies revealed that high levels of PGE2 were associated with increased 
severity of sepsis in inverse correlation with IL10 levels (chapter 4 in this dissertation). 
This is in agreement with previous studies showing that PGE2 can down regulate the 
production of IL10 and drives immune cellular responses towards an exaggerated Th17 
inflammatory response (Boniface et al., 2009; Yao et al., 2009). However, it has been 
shown that PGE2 effects are affected by its concentration, type of cells it is acting upon, 
status of the relevant receptors activated and the site and stage of infection (Bos et al., 
2004; Tober et al., 2007; Sakata et al 2010.). Therefore, it seems that a very fine balance 
of its concentration is required for an effective immune response. This led us to formulate 
our hypothesis that PGE2 acts as a suppressor of IL10 production in susceptible strains, 
where at high concentrations of PGE2, IL10 will be inhibited and Th17 inflammation 
ensues with severe sepsis as an outcome. To test this hypothesis at a cellular mechanism 
level, we first wanted to profile cellular population percentages across resistant and 
susceptible strains under physiological conditions. In doing so, we wanted to account for 
any quantitative differences in number of immune cells of resistant vs. susceptible strains 
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prior to infection that might affect their differential response. We immunophenotyped 
cells from blood and spleen of selected highly resistant and highly susceptible strains and 
found no quantitative differences between these stains under normal physiological 
conditions. Furthermore, there were no significant differences in number of neutrophils 
post infection at selected times post infection. 
 
  Our finding of no significant differences in numbers of immune cells between 
susceptible and resistant strains was very interesting, as it has been previously noted that 
both qualitative and quantitative differences in neutrophils affect outcomes of infection 
(Nauseef, 2007). However, an interesting recent study showed that in severe bacterial 
infections including GAS infection, high bacterial loads induced depletion of bone 
marrow neutrophils, as it triggered TLR2 activation leading to over-activation of immune 
response mechanisms and blocking of recruitment of neutrphils to infectious abscess, as 
bone marrow became depleted of neutrophils (exhausted bone marrow) (Navarini et al., 
2009).  
 
 Our data continue to point to the important role played by neutrophils and 
macrophages in modulating the severity and outcomes of GAS sepsis. GAS has 
developed specific mechanisms to evade killing by these two cellular populations. For 
example, studies have shown invasive GAS strains to specifically develop mechanisms to 
evade PMN killing. For example, GAS produces virulence factors that specifically impair 
PMN chemotaxis, migration and function. C5a peptidase (ScpA) degrades host C5a while 
IL8 degrading enzyme (ScpC) degrades host IL8 and thus impairing neutrophil 
chemotaxis (Sjolinder et al., 2008; Gleich-Theurer et al., 2009). Another example of 
GAS interfering with PMN killing mechanisms is Sda1, a potent DNase produced by 
M1T1 (GAS strain under study). Sda1 dissolves neutrophil extracellular traps (NETs) 
allowing the bacteria to escape the entrapment and killing by PMN (Aziz et al., 2004b; 
Buchanan et al., 2006; Walker et al., 2007). Studies analyzing the role of macrophages in 
modulating differential susceptibility to GAS, using transcriptome analyses of GAS 
infected macrophages; found that GAS stimulates an “unusual” macrophage response. As 
the transcriptional profiles were a mix of pro and anti-inflammatory response, including 
profiles characteristic of both M1 and M2 macrophages (Goldmann et al., 2007). 
Nonetheless, PMN and macrophages are in constant interplay, where in GAS sepsis, 
PMN release antimicrobial LL37 and heparin binding protein (HBP), thereby increasing 
the extravasations of inflammatory monocytes (Soehnlein et al., 2008b). Put together 
with our results, we can hypothesize that functional and/or migratory differences in 
neutrophils and/or monocytes between susceptible and resistant strains might modulate 
their differential response to GAS sepsis.  
 
 In conclusion, we aimed to determine host immunogenetic factors modulating 
differential host responses to GAS sepsis. To accomplish this aim, we employed systems 
genetics approaches to study the genetic and molecular basis of host-pathogen 
interactions leading to differential responses to GAS severe sepsis. We assessed 
variations in traits associated with severity of GAS sepsis across a genetically diverse 
reference population (ARI-BXD strains). We then performed genome-wide association 
scans (GWAS), mapping differential susceptibility to QTLs on mouse Chr 2 and X. 
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Combining genome-wide differential gene expression analyses with GWAS, and further 
biomarker and cellular validations, indicated that PGE2 pathways and IL10 signaling 
pathways modulate differential responses to GAS sepsis. In addition, our data suggested 
that prostaglandin itself might act as a key modulator, controlling a network of genes 
involved in innate immune response to GAS sepsis. We also showed using transcriptome 
analyses and soluble biomarker analyses, that pathways involving activation of IL10 
signaling and IL10 high levels were associated with resistance to infection. Our 
contribution to the vertical growth of the GAS sepsis field is that we highlighted 
interactions of prostaglandins and IL10 with networks of candidate genes affect host 
differential susceptibility to severe GAS sepsis. Our future studies will be focused on 
further dissecting the molecular mechanisms of the differential susceptibility, these are 
outlined below.  
Future Directions  
 Studies outlined in this dissertation have answered the original questions we 
asked, and raised other questions for follow up in future studies. I would like to believe 
that my studies helped in setting the foundation for future studies to answer some of the 
raised questions. I believe that with the knowledge we gained from my studies and the 
tools we are currently acquiring, answers to some of the raised questions are very 
plausible in the near future. However, some questions might remain as open-ended 
questions, which I hope we will someday answer to help us reach the laboratory mission 
of moving from bench side to bedside and finding better therapeutics that take into 
account individual variations and that incorporate the information generated to develop 
more targeted interventions for this aggressive disease. 
Dissection of Migratory and Functional Differences of Immune Cell Populations 
between Susceptible and Resistant Strains 
 Our results strongly suggested that migratory and/or functional differences in 
neutrophils and/or monocytes between resistant and susceptible strains are governing 
differential response to GAS sepsis, as there were no significant differences in numbers 
of immune cells of blood and spleen of differentially susceptible strains. Moreover, 
comparison of neutrophil counts in susceptible and resistant strains post infection showed 
no association with differential susceptibility. Studies of various GAS virulence factors 
showed that several affect neutrophil recruitment, migration, and killing mechanisms 
(Buchanan et al., 2006; Nilsson et al., 2006; Sjolinder et al., 2008; Sumby et al., 2008; 
Zinkernagel et al., 2008; Lin et al., 2009; Alexander et al., 2010). Although these studies 
gave us insight into how the bacteria affect neutrophil killing mechanisms, however, the 
focus of these studies was to dissect bacterial virulence factors rather than to investigate 
differences in host neutrophils killing mechanisms that can vary between resistant and 
susceptible individuals.  
 
 I believe that studies to test our hypothesis of differences in migratory and 
functional properties of PMNs and macrophage as a means of host differential 
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susceptibility to GAS sepsis will give us great insight into mechanisms involved in 
differential susceptibility to severe sepsis. To compare differences in functionality of 
these cells, we will select highly susceptible and highly resistant BXD strains and isolate 
neutrophils from blood and macrophages from peritoneum, spleen and bone marrow. 
Then we will compare differences in phagocytic capacities, and production of reactive 
oxygen species (ROS) and reactive nitrogen species (RNS).  In addition, we will measure 
effective bacterial killing by neutrophils/macrophages isolated from susceptible vs. 
resistant mouse strains, as it has been shown that although phagocytosized, GAS can 
survive intracellularly in APCs including neutrophils and monocytes (Medina et al., 
2003a; Medina et al., 2003b; Staali et al., 2006; Thulin et al., 2006). 
 
 Based on the mapped QTLs and genes associated with GAS severity as well as 
our present neutrophil depletion studies, we are tempted to believe that the 
neutrophils/macrophages of the resistant strains will have a better bactericidal activity 
compared to the susceptible strains. In case we fail to observe expected differences in 
their in vitro function, an alternate approach would be to test if there are differences in 
the migration of these cells from lymphoid organs to periphery or vice versa following 
infection. We will use several in vivo and in vitro methods to study neutrophil migration.  
 
 For studying in vivo migration of neutrophils, we will use mouse air pouch 
technique.  Air pouches will be formed on the back of susceptible and resistant BXD 
mice by subcutaneous injection of sterile air. Mice will then be infected intravenously 
with GAS and sacrificed at 1-4h post infection. The cells migrated in the pouches will be 
collected in sterile PBS, and counted with a hemocytometer. Leukocyte subpopulations 
will be distinguished by flow cytometry. Other studies have shown that neutrophils 
accounted for 80-95% of accumulated cells (Ben Yebdri et al., 2009; Hattori et al., 2010; 
Heissig et al., 2010). In vitro neutrophil transmigration assay will be carried out in a 
Boyden chamber system. These studies should give us insight into the cellular 
mechanisms modulating susceptible and resistant strains differential susceptibility to 
GAS sepsis. 
Analysis of Relationship of Prostaglandins and Modulation of Differential Response 
to GAS 
 PGE2 acts as a fast acting, delicately balanced lipid mediator that can act as either 
an immunosuppressor or immunoactivator depending on PGE2: a) concentration, b) cells 
it is activating, c) combination of receptors being activated, d) nature of activation signal 
and e) stage of infection (Bos et al., 2004; Tober et al., 2007; Sakata et al., 2010). PGE2 
as an immunosuppressor promotes inflammation, induces IL6 and causes vasodilatation, 
and vascular leakage; it can also reduce PMN migration and bacterial killing by 
macrophages, by blocking production of reactive oxygen intermediates (ROI) (Aronoff et 
al., 2004; White et al., 2005; Nakayama et al., 2006; Huang et al., 2007; Serezani et al., 
2007). However, recent studies have shown that it can be a regulator of that immune 
inflammation (immunoactivator) by activation of Th1 differentiation and Th17 expansion 
(Boniface et al., 2009; Yao et al., 2009; Sakata et al., 2010). 
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 If the fine balance of this mediator is disrupted, it can lead to serious pathological 
consequences. For example alterations in the amounts of PGE2 are associated with high 
risk of infection with HIV, cancer, and malnutrition (Lima et al., 2006; Anstead et al., 
2009; Greenhough et al., 2009). In promoting Th1 differentiation, PGE2 induces the 
production of IFN and via its EP4 receptor; PGE2 inhibits production of IL10 
exacerbating Th17 mediated inflammation (Boniface et al., 2009; Yao et al., 2009). 
Excitingly, the outlined studies in this dissertation showed that susceptible stains had 
higher levels of PGE2, and IFN and low levels of IL10 while the reverse was true for 
resistant strains. Therefore, we hypothesize that PGE2 can act as a “switch”, wherein 
susceptible strains PGE2 inhibits IL10 production, and increase IFN, exacerbating Th17 
mediated inflammation. Meanwhile, in resistant strains, PGE2 is produced at controlled 
levels, allowing Th1 and Th17 polarization and subsequent containment of infection. We 
are even more interested in this interactive role of PGE2 and IL10 as our studies in the 
HLA-tg mice have shown that IL10 mediates protection against severe GAS sepsis. In 
addition, our genome-wide expression pathway analyses identified IL10 pathways being 
up regulated in resistant strains at early time points (8h) associating high levels of IL10 
with resistance to GAS sepsis and better outcomes of infection.  
 
  A likely applicable hypothesis is that PGE2 modulates differential susceptibility 
on more than one level, by inhibiting IL10 production, increasing IFN levels, promoting 
Th17 expansion but into exaggerated response and subsequent altering of neutrophils 
and/or macrophages recruitment and functionality. However, further studies are needed to 
dissect its role in each of these levels, therefore as a future direction of the work 
presented herein, follow up studies dissecting the role of PGE2 in relation to IL10 in 
modulating differential susceptibility would be quite interesting.   
 
 For these studies, to further explore the role of PGE2, one approach is to use 
knockout mice of receptors relevant to PGE2 immune actions. PGE2 has four receptors, 
prostanoid E receptor (EP) 1 through 4 (Narumiya et al., 1999; Breyer et al., 2001). EP2 
and EP4 receptors are heavily involved in inflammatory and immune responses, 
migration of antigen presenting cells (APC) and in cancer research (Kobayashi and 
Narumiya, 2002; Greenhough et al., 2009). A large body of research on prostaglandins 
associates the net action of PGE2 with the balance by which PGE2 activates “receptor 
pairs”. For example, in blood pressure regulation, PGE2 can activate EP2/EP4 (leading to 
vasodilatation) or EP1/EP3 (leading to vasoconstriction), depending on the balance it can 
shift to one action or the other (Zhang et al., 2000). 
 
 Therefore, it would be interesting to test knockout mice of EP2 and EP4 
receptors, which are involved in inflammatory and immune responses. We have two 
knockout mice already in line for future studies on the role of PGE2, these are 
microsomal prostaglandin E synthase 1 (mPGES1) and EP2 KO mice, which were made 
in DBA/1J and B6 backgrounds respectively. In our ongoing collaboration with Dr. 
Aronoff, of Univ. Michigan, we would like to determine how PGE2 might modulate 
disease severity. I predict that EP2-KO mice would be resistant (as resistant as B6 or 
more), but the main focus is to determine the mechanism of resistance, through functional 
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assays, including phagocytosis, production of ROI, and bacterial killing (clearing of 
bacteria) as detailed above. 
Cytokine Profiling Associated with Susceptibility to GAS Sepsis 
 We have measured levels of selected cytokines in selected resistant and 
susceptible strains and found that IL10 is a promising candidate modulator of severity of 
sepsis as it was associated with differential response to GAS sepsis. I believe that a 
carefully designed study can be initiated using levels of IL10 at 8 h and/or 12h, as both 
time points had the highest correlation with disease severity (Figure 4-4), across BXD 
strains and map differential responses due to cytokine level differences. We have 
previously used survival, bacteremia and bacterial load in spleen as traits to map 
differential severity of GAS sepsis and all these traits mapped to Chr 2 QTLs 
(Abdeltawab et al., 2008). However, we have found that survival was the only trait that 
mapped a QTL to Chr X. This suggested that genes within this QTL might be primarily 
engaged in host-mediated pathogenesis, which we found true when we inspected this 
QTL closely (data not shown).  
 Therefore, we are hoping that cytokine data will reveal QTLs associated with 
modulation of cytokine response in GAS sepsis. We postulate that this might be a totally 
different QTL, as it is known that complex interacting regulatory mechanisms govern 
cytokine production in sepsis (reviewed in [Cohen, 2002; Rittirsch et al., 2008]). In 
addition, IL10 is of particular interest due to results shown in this dissertation, where it is 
correlated with better outcome of sepsis and is in inverse relation to PGE2 levels, another 
mediator that can be used for mapping.  
 The association of GAS sepsis severity with multiple cytokines exerting their 
effects temporally underscores the complexity of traits modulating severe GAS sepsis 
and emphasizes the importance of the time of administration of appropriate cytokine 
intervention to aid in the prevention of shock in severe GAS sepsis. 
Analysis of the Role of Nod-like Receptors as a Candidate Pattern Recognition 
Receptor Associated with Modulation of Differential Response to GAS Sepsis  
 It has been recently found that Streptolysin O (SLO) produced by GAS (Harder et 
al., 2009) and hemolysin produced by Staphylococcus aureus (Craven et al., 2009) 
activate nucleotide-binding domain (NOD) like receptor (NLR) pyrin domain containing 
3 (NLRP3) inflammasome, indicating that GAS activation of the inflammasome was 
independent of TLR signaling.  NLRP3 inflammasome is involved in the regulation of 
caspase-1, which in turn regulates the processing and secretion of IL1 cytokine family 
including IL1ß and IL18, which are both parts of the pathways modulating susceptibility 
to GAS sepsis which were found by both our genome-wide mapping and transcriptional 
studies. NLR family acts as a pattern recognition mediating cytoplasmic recognition of 
bacterial products (Ting et al., 2008; Ye and Ting, 2008). It will be particularly 
interesting to study the role of the inflammasome in our current GAS model given the 
growing connections and pointers that it might be associated with signaling pathways 
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modulating observed differential response. We have started collaboration with Dr. Jenny 
Ting, at UNC, where I will pursue this project as part of the immediate future directions 
of my studies. In these studies we are going to use knockout mice of Nlrp3 and ASC 
(Apoptosis-associated speck-like protein containing a CARD, also known as PYCARD), 
both mediators have been associated with modulation of NLRP3 inflammasome 
(reviewed [Cassel et al., 2009; Lamkanfi and Kanneganti, 2010]). 
Concluding Remarks 
 The studies presented in this dissertation have helped shed some light on host 
mechanisms of differential susceptibility to GAS sepsis. We were the first to find an 
association between differential susceptibility to GAS sepsis and QTLs on mouse Chr 2 
and X.Some studies have found associations between genes or QTLs on Chr 2 and 
susceptibility to other infectious diseases (Appendix D), however none were for 
differential susceptibility to GAS sepsis.We validated our mapped QTLs and parsed the 
genes within those QTLs into pathways. This allowed us to explore plausible 
mechanisms of differential susceptibility. The data suggested that prostaglandin might act 
as a key modulator, controlling a network of genes involved in innate immune response 
to GAS sepsis. In addition, pathways involving activation of IL10 production and 
signaling (including PGE2) are likely to be associated with resistance to infection. 
Despite differences between mouse and human immune systems (Mestas and Hughes, 
2004), our results match beautifully with results obtained from human patients and its 
validation using in vivo humanized HLA-tg mice. This demonstrates the strength of the 
systems genetics approach employed and how comparisons of pathways rather than genes 
can help us translate our findings from mouse to human. 
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APPENDIX A. PRIMER SEQUENCES USED FOR QPCR AND THE RELATIVE 
EXPRESSION LEVELS OF CANDIDATE GENES 
This appendix contains two supplementary tables for Chapter 3: 
 
 Table A-1. Primer sequences used in quantitative PCR assays for candidate genes.  
 Table A-2. Relative expression levels of candidate gene list expressed as mean fold 
difference between pre- and post-infection ± standard deviation (SD) in selected 
resistant and susceptible strains.  
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Table A-1. Primer sequences used in quantitative PCR assays for candidate genes. 
 
Gene Gene Description Accession 
Number 
Forward 5’ Reverse 3’ 
Anapc2 Anaphase promoting complex subunit 2 NM_175300 ctcaaggtggccctagagact agagtgatgatgtcacatgtgttg 
Asb6 Ankyrin repeat and SOCS box-containing protein 6 NM_133346 aggagcccctggatgatt cagctccgtgaggaccag 
Edf1 Endothelial differentiation-related factor 1 NM_021519 ccgcacaggccaagtcta aatggaatgctgcttgttctg 
Entpd2 Ectonucleoside triphosphate diphosphohydrolase 2 NM_009849 cagagaccacctgcaacca ggtctgctgtccgggtact 
Fbxw2 F-box and WD-40  domain protein 2 NM_013890 caaagtcaagtctctcttgcaca tcccaattggccaaatctt 
Garnl3 GTPase activating RANGAP domain-like 3 NM_178888 tccaccatgttgccatattc caatgtggcgcttccttt 
Gpr107 G protein-coupled receptor 107 NM_178760 cctgcagctctctcaggaag cacacccgatgtcgtcacta 
Hspa5 Heat shock 70kD protein 5 ( glucose-regulated protein ) NM_022310 ctgaggcgtatttgggaaag cagcatctttggttgcttgtc 
Il1 Interleukin 1 alpha  NM_010554.4  ttggttaaatgacctgcaaca gagcgctcacgaacagttg 
Il1rn Interleukin 1 receptor antagonist NM_031167 tgtgccaagtctggagatga ttctttgttcttgctcagatcagt 
Mapkap1 Mitogen-activated protein kinase associated protein 1 NM_177345 accttgccgaggagaagag gcgtcggactcgaagtacag 
Nfatc2 Nfatc2  nuclear factor of activated t-cells, cytoplasmic, 
calcineurin-dependent 2* 
NM_010899 
NM_001037177 
NM_001037178 
caggaggacaccctgtgg tcatctgctgtcccaatgaa 
Notch1 Notch gene homolog 1 ( Drosophila ) NM_008714 tgcaactgtcctctgccata gtagcacatggggccaac 
Noxa1 NADPH oxidase activator 1 NM_172204 atctggagcccatggattt gcgttgtggtcatcaggaat 
Phpt1 Phosphohistidine phosphatase 1 NM_029293 cagagccaggacaggaagata ttggctttgatcttctcagttg 
Phyhd1 Phytanoyl-CoA dioxygenase domain containing 1 NM_172267 gtctggagcccagggaat gggcctttagctgtagagtgg 
Ppp2r4  Protein phosphatase 2A ,  regulatory subunit B NM_138748 ggcagctcacagctcataga gccttctcatccacgaaatg 
Psmd5  Proteasome ( prosome ,  macropain )  26S subunit ,  non-ATPase ,  5 NM_080554 gacgggtgaggacgtgtta cgtccgtgatgggtataagc 
Ptges Prostaglandin E synthase NM_022415 gcacactgctggtcatcaag acgtttcagcgcatcctc 
Ptges2 Prostaglandin E synthase 2 NM_133783 cccaggaaggagacagctt aggtaggtcttgagggcactaat 
Rab14  RAB14 ,  member RAS oncogene family NM_026697 aggtgcgctcatggtgtat caaccagctgcttaagtggtta 
Sh2d3c SH2  domain containing 3C NM_013781 cagatcccagatctccactca agcatggactcgggttacag 
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Table A-1. (Continued).    
     
Gene Gene Description Accession 
Number 
Forward 5’ Reverse 3’ 
Sirpa Signal-regulatory protein alpha  NM_007547.2  agggagcatgcaaaccttc tttgatccggaggaggtaga 
Traf1 TNF receptor associated factor 1 NM_009421 gagcacatcctgagcttgg tctttttgagccagggtttg 
Traf2 TNF receptor associated factor 2 NM_009422 gctccttctgcctgacca agacacaggcagcacagttc 
Tubb2c1  Tubulin beta 2c NM_146116.1 gctcctcttctacagctgttcc cgctgattacctcccagaact 
Ubadc1 Ubiquitin associated domain containing 1 NM_133835 gaacaacaaccagcagaacg tccaattcctcaggggatg 
Urm1 Ubiquitin related modifier 1  homolog ( S .  cerevisiae ) NM_026615 gagcgaccagagctgttcat ggcatcattaatcagcacca 
 
* Nfatc2 has three transcript variants; we designed a common assay for the three transcripts, and differentiating assays for each 
isofrom. All assays showed similar results, shown are primers sets of common assay for the three transcript variants. 
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Table A-2. Relative expression levels of candidate gene list expressed as mean fold difference between pre- and post-infection ± 
standard deviation (SD) in selected resistant and susceptible strains.  
 
Gene ID Gene Resistant SD Susceptible SD 
Genes down regulated in resistant group while up regulated in susceptible group 
Anapc2 Anaphase promoting complex subunit 2 0.551 0.022 1.475 0.691 
Asb6 Ankyrin repeat and SOCS box-containing protein 6 0.573 0.482 2.300 1.801 
Fbxw2 F-box and WD-40 domain protein 2 0.930 0.384 1.159 0.268 
Gpr107 G protein-coupled receptor 107 0.866 0.481 2.196 0.758 
Il1 Interleukin 1 alpha  0.739 0.045 54.687 0.011 
Il1rn Interleukin 1 receptor antagonist 0.851 0.384 55.909 0.274 
Mapkap1 Mitogen-activated protein kinase associated protein 1 0.732 0.199 1.189 0.460 
Noxa1 NADPH oxidase activator 1 0.270 0.164 1.086 0.151 
Phpt1 Phosphohistidine phosphatase 1 0.229 0.133 0.714 0.155 
Ptges Prostaglandin E synthase 0.417 0.101 5.046 0.679 
Ptges2 Prostaglandin E synthase 2 0.913 0.553 1.456 0.122 
Rab14 RAB14, member RAS oncogene family 0.704 0.268 1.411 0.711 
Sh2d3c SH2 domain containing 3C 0.162 0.102 1.009 0.389 
Phyhd1 Phytanoyl-CoA dioxygenase domain containing 1 0.806 0.727 1.288 0.288 
Urm1 Ubiquitin related modifier 1 homolog (S. cerevisiae) 0.834 0.625 1.277 0.309 
Genes down regulated in both resistant group and susceptible groups 
pd2 Ectonucleoside triphosphate diphosphohydrolase 2 0.359 0.114 0.654 0.160 
Edf1 Endothelial differentiation-related factor 1 0.350 0.375 0.470 0.109 
Garnl3 GTPase activating RANGAP domain-like 3 0.601 0.292 0.674 0.158 
Nfatc2 Nuclear factor of activated t-cells, cytoplasmic, calcineurin-dependent 2 0.178 0.174 0.693 0.147 
Psmd5 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 0.644 0.049 0.963 0.123 
Ppp2r4 Protein phosphatase 2A, regulatory subunit B  0.902 0.108 0.734 0.150 
Ubac1 Ubiquitin associated domain containing 1 0.865 0.960 0.730 0.971 
Tubb2c Tubulin beta 2c  0.846 0.506 0.925 0.477 
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Table A-2. (Continued).     
      
Gene ID Gene Resistant SD Susceptible SD 
Genes up regulated in both resistant group and susceptible group 
Hspa5 Heat shock 70kD protein 5 (glucose-regulated protein) 1.717 1.016 4.040 2.587 
Notch1 Notch gene homolog 1 (Drosophila) 2.005 1.192 10.424 7.833 
Traf1 Tnf receptor-associated factor 1 1.826 0.596 5.995 0.733 
Traf2 Tnf receptor-associated factor 2 2.369 2.694 2.421 0.844 
Sirpa Signal-regulatory protein alpha  4.092 6.024 1.607 1.034 
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APPENDIX B. LIST OF GENES AND TRANSCRIPTS IN THE MAPPED LOCI 
This appendix contains lists of genes and transcripts in the mapped quantitative 
trait loci (QTLs) associated with differential susceptibility to severe group A 
streptococcal (GAS) sepsis. Public access to an update list of transcripts is available 
online at www.genenetwork.org under BXD published phenotypes, trait ID 10836. To 
search for this trait ID, access the search databases page at the above link, use mice as 
species, BXD as the group, phenotypes as type and BXD published phenotypes as 
database, and then enter Abdeltawab as the search term and from the retrieved results 
select trait ID 10836. 
 
This appendix contains three tables: 
 
 Table B-1. Genes and their SNPs in mapped locus on Chr 2 between 22-34 Mb. 
 Table B-2. Genes and their SNPs in mapped locus on Chr 2 between 124-150 Mb. 
 Table B-3. Genes and their SNPs in mapped locus on Chr X between 50-100 Mb. 
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Table B-1. Genes and their SNPs in mapped locus on Chr 2 between 22-34 Mb. 
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Table B-1. (Continued). 
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Table B-1. (Continued). 
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 Table B-1. (Continued). 
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Table B-2. Genes and their SNPs in mapped locus on Chr 2 between 124-150 Mb.  
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Table B-2. (Continued). 
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Table B-2. (Continued). 
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Table B-2. (Continued). 
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Table B-3. Genes and their SNPs in mapped locus on Chr X between 50-100Mb.  
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Table B-3. (Continued). 
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 Table B-3. (Continued). 
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 Table B-3. (Continued). 
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 Table B-3. (Continued). 
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APPENDIX C. POLYMORPHISM ANALYSIS OF GENES AND TRANSCRIPTS 
IN THE MAPPED LOCI 
This appendix contains lists of single nucleotide polymorphism (SNPs) of genes 
and transcripts in the mapped quantitative trait loci (QTLs) associated with differential 
susceptibility to severe group A streptococcal (GAS) sepsis. The analysis was done on 
selected highly susceptible and highly resistant strains, namely, BXD77, 97, 100 and 75 
as highly susceptible strains. In contrast, BXD69, 73, 48 and 87 are highly resistant 
strains, in addition, both parental strains B6 and D2 were included in this analysis. I 
performed the analysis on May 1, 2010 using mouse phenome database (MPD) 
employing the SNP wizard online tool at http://phenome.jax.org/SNP. The retrieved data 
was based on several databases including; national center for biotechnology information 
(NCBI) Mouse Build 37 (known as mm9), NCBI SNP database (dbSNP) build 128 and 
the joint project of the European Molecular Biology Laboratory (EMBL), European 
Bioinformatics Institute (EBI) and the Wellcome Trust Sanger Institute, (Ensembl) build 
48. SNPs among BXD strains were based on Wellcome-CTC Mouse Strain SNP 
Genotype Set (Shifman et al., 2006). 
 
 There are three tables in this appendix: 
 
 Table C-1. SNP analysis of genes in mapped locus on Chr 2 between 22-34 Mb. 
 Table C-2. SNP analysis of genes in mapped locus on Chr 2 between 125-150 Mb. 
 Table C-3. SNP analysis of genes in mapped locus on Chr X between 50-100 Mb. 
 
The tables in this appendix contain the following abbreviations for SNP 
functional classes retrieved: 
 
Cn Coding non-synonymous; SNP changes the amino acid/peptide, 
Cs Coding synonymous; SNP does not change the amino acid/peptide, 
UTR Untranslated region, SNP is in non-coding interval of mRNA, 
S SNP is in a splice-site; first two or last two bases of intron (few), 
I SNP is in an intron, except first 2 and last 2 bases (see above splice-site SNP), and 
L Locus region; not assigned to a gene; can be in region of gene but not in 
transcribed region; or may be in regulatory region. 
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Table C-1. SNP analysis of genes in mapped locus on Chr 2 between 22-34 Mb.
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Table C-2. SNP analysis of genes in mapped locus on Chr 2 between 125-150 Mb. 
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 Table C-2. (Continued).  
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Table C-2. (Continued). 
  160
Table C-3. SNP analysis of genes in mapped locus on Chr X between 50-100 Mb.
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Table C-3. (Continued).  
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Table C-3. (Continued). 
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APPENDIX D. LIST OF PUBLISHED LOCI AND GENES ON CHROMOSOME 2 
THAT ARE ASSOCIATED WITH DIFFERENTIAL SUSCEPTIBILITY TO 
INFECTIOUS DISEASES 
This appendix contains a list of quantitative trait loci (QTLs) and genes on Chr 2 
that were found by published studies investigating susceptibility to infectious diseases 
other than GAS sepsis, based on literature search on May 3, 2010. From the list below, 
only one study used recombinant inbred (RI) mice strains (CXB-RI strains) (Thach et al., 
2001). Other retrieved studies used either F2 crosses or backcrossed of some strains of 
interest.  
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Table D-1. Diseases and mouse models associated with quantitative trait loci and genes located at Chromosome 2 loci mapped 
in current study. 
 
Disease Model and Strain Used Candidate Genes/Loci References 
Neuroadapted Sindbis 
virus (NSV) 
C57Bl/6J and Balb/cBy, CXB inbred 
mice 
QTL on Chr 2 near D2Mit447 
(60cM) 
(Thach et al., 2001) 
Chlamydia trachomatis C57Bl/6J and C3H/HeJ and F2 crosses 
and congenic 
QTLs on Chr 2, 3 and 11 (Bernstein-Hanley et 
al., 2006) 
Borrelia burgdorferi 
(lyme disease) 
C57BL/6N X C3H/HeN 
(C57BL/6N X C3H/HeN) F1 X C3H/HeN 
and (C57BL/6N X C3H/HeN) F1 X 
C57BL/6N backcrosses 
Bbaa15 locus and proximity of 
markers D2Mit278 and D2Mit224 
(Roper et al., 2001) 
Leishmania major  
 
F2 crosses of (CcS-16 x BALB/c) Lmr14 (Havelkova et al., 
2006) (Zhang and 
Matlashewski, 2004) 
(Vladimirov et al., 
2003) 
Leishmania donovani  
 
B10.LP-H-3 b and B10.CE(30NX) and 
(B10.LP-H-3 b × B10)F1 
Immune response locus 2 (Ir2)  DeTolla 1980 
Candida albicans. 
 
 [A/J x C57BL/6J] F2 crosses Hemolytic complement (Hc or C5) (Tuite et al., 2004; 
Tuite et al., 2005) 
Salmonella typhimurium (AcB61 x 129S6) F2 crosses Hemolytic complement (Hc or C5) (Roy et al., 2007) 
Listeria monocytogenes  A/J and B6 Hemolytic complement (Hc or C5) (Czuprynski et al., 
2003) 
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